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The ability of the urothelium to act as a urinary barrier is afforded by two key 
features:  1) It has the tightest barrier function of any epithelium, generated by 
tight junctions which assemble upon differentiation;  2) In response to damage, the 
quiescent urothelium can rapidly switch to a regenerative phenotype to enable 
regeneration and restitution of barrier function.   
Central to repair is the ability for the urothelium to sense damage; a process 
hypothesised to involve cell-cell communication.  Direct cell-cell communication 
occurs through gap junctions, channels comprising connexin (Cx) proteins which 
allow for the passage of signalling molecules.  Cxs have been linked to wound 
healing, as well as to maintenance of polarity and homeostasis in other epithelia, by 
both communication-dependent and -independent mechanisms.  A systematic 
characterisation of Cx expression has not been performed in urothelium and the 
significance of specific Cxs to urothelial physiology is not understood.  
This study aimed to investigate whether specific Cx proteins contribute to the 
regulation of barrier maintenance and restitution in human urothelium.  Analysis of 
Cx transcripts identified Cx32, which was expressed in situ and highly induced upon 
in vitro differentiation of normal human urothelial (NHU) cells using two 
independent methods.  In differentiated NHU cells, Cx32 proteins assembled into 
functional gap junction channels at cell borders, co-localising with the 
barrier-defining tight junction proteins occludin and ZO-2.  shRNA studies 
demonstrated that normal tight junction development and barrier function were 
dependent on the presence of intercellular Cx32, but not gap junction 
communication.    
In wound-healing experiments, intercellular communication through Cx32 channels 
inhibited urothelial cell migration and proliferation, in a process which involved 
suppression of activated SMAD3.  Together the evidence presented here supports 
an unanticipated central role for Cx32 in orchestrating the homeostasis between 
barrier function and repair in human urothelium. 
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1.1 The Urothelium 
1.1.1 The Urinary System 
The urinary system in man comprises the kidneys, ureters, bladder and urethra.  
The kidneys function to filter waste products and surplus water from the blood 
stream, thereby producing urine which drains into the bladder via the ureters, 
before expulsion via the urethra.  The primary function of the urinary bladder is to 
contain urine at low pressure whilst accommodating large fluctuations in volume, 
to spare renal damage due to reflux.  The kidneys and ureters are derived from 
intermediate mesoderm, whilst the bladder and urethra develop from the 
endodermally-derived urogenital sinus, prior to the 10th week of gestation (McHugo 
et al. 2001).   
 
Despite their different histogenesis, all portions of the urinary tract from the renal 
pelvis to the proximal urethra are lined by a common epithelium known as 
urothelium, which acts as a barrier to urine. 
 
1.1.2 Morphology and key features of the urothelium 
The thickness of human urothelium can vary from 2-7 cells depending on the 
degree of bladder distension.  A distinct three-layered morphology is apparent with 
distinct levels of specialisation (or differentiation).  The urothelium is separated 
from the suburothelial lamina propria by a basement membrane. Adjoining the 
basement membrane are a single layer of small cuboidal basal cells, which sit 
beneath 1-5 layers of larger polygonal intermediate cells.  On the most superficial 
surface (luminal surface) are a single layer of large, flattened superficial cells (Fig 
1.1), the apical surface of which are lumen-facing and therefore interface directly 
with urine.  The urothelium is described as a transitional epithelium since it 
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contains features in common with both columnar and stratified squamous 
epithelia.   
 
The superficial cells (often descriptively called umbrella cells) are commonly 
binucleate.  Their apical surface is covered with a layer of rigid hexagonal plaques of 
asymmetric unit membrane (AUM), composed of proteins restricted to the 
urothelium known as uroplakins.  Uroplakin proteins in mammals are highly 
conserved and are considered to be the culminating feature of urothelial cell 
differentiation (Wu et al. 1994).  Another key feature of urothelium is that it is 
mitotically-quiescent with a turnover rate of approximately 200 days (Walker 1960).  
However, in response to insult or injury the urothrelium has an exceptionally high 




Figure 1.1  Haematoxylin and Eosin stain of normal human ureteric urothelium. 
Scale bar = 50µM 
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1.1.3 Physiological function of the urothelium  
The major function of the urothelium is to act as a barrier to urine and it is thought 
to be the tightest, most impermeable epithelium in the human body.  The highest 
recorded transepithelial electrical resistance (TER) was found to be in the urinary 
bladder (Lewis et al. 1982, Negrete et al. 1996) and this is thought to be the result 
of a complex network of interlocking tight junctions.   
 
To maintain barrier function, the urothelium has a remarkable ability to repair 
damage and urothelial cells are able to rapidly migrate in a coordinated manner to 
repair damage (Rebel et al. 1994, Shabir et al. 2008).  The urothelium is able to 
flatten and stretch to accommodate large changes in surface area, a feature 
supported by uroplakin-containing fusiform vesicles in the superficial cells, which 
insert AUM into the luminal surface to stabilise the apical membrane, reviewed in 
(Khandelwal et al. 2009).   
 
Whilst barrier function is the primary function of urothelium, it is also well 
documented that the urothelium is implicated in several mechanosensory 
functions. Urothelial distension and pressure changes acting upon superficial cells 
invoke the release of ATP, which has been closely linked to the activation of 
afferent nerve signalling in the lamina propria and purinergic receptor subtypes are 
expressed in the urothelium (Ferguson et al. 1997, Vlaskovska et al. 2001, Shabir et 
al. 2013).  Whilst ATP plays an important role in chemical communication within the 
bladder, other signalling molecules including the ATP break-down product 
adenosine and nitric oxide have been suggested to have chemical-signalling roles in 
the urothelium, reviewed in (Winder et al. 2014) 
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1.1.4 Urothelial Pathologies 
Bladder malignancy is the 7th most common cancer in the UK and the 4th most 
common cancer in men, with most people diagnosed between the ages of 50 and 
80 (Cancer Research UK). Transitional Cell Carcinoma (TCC) accounts for 
approximately 90% of bladder malignancies and is thought to be associated with 
prolonged exposure of the urothelium to urine-derived carcinogens.  
 
Urinary Tract Infections (UTI) affect more than half of women during their lifetime 
and are generally caused by uropathogenic E.coli (UPEC) bacteria.  Interstitial 
cystitis (IC) is a chronic and painful bladder inflammatory disorder with similar 
symptoms to UTI, but in the absence of infection.  IC mostly affects women, for 
which a single causal mechanism is unknown; however several studies have 
implicated a defective urinary barrier (Slobodov et al. 2004, Southgate et al. 2007, 
Liu et al. 2012).   
 
1.1.5 Urothelial Differentiation 
Several groups of proteins are identified as markers of urothelial 
cytodifferentiation; these include transcription factors which are activated in 
response to urothelial differentiation cues and drive expression of the programme 
of genes which contribute to urothelial physiology.  Those whose expression is 
restricted to the superficial cell layer have often been described as markers of 
terminal differentiation, since this cell layer contains a number of specialist 
molecular features which are crucial to urinary barrier function, such as uroplakins 
and tight junction proteins.   
 
1.1.5.1 Uroplakins 
Uroplakins are a group of integral membrane proteins which make up the 
Asymmetric Unit Membrane (AUM) covering the apical surface of much of the 
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urothelium.  The AUM is a hallmark of urothelial differentiation and provides a 
barrier to the transcellular movement of water and solutes across the apical 
membrane (Hu et al. 2002).  There are five uroplakin proteins, UPK1a, UPK1b, UPK2, 
UPK3a and UPK3b arranged as 16 nm hexagonal plaques, which were first isolated 
from bovine bladders (Wu et al. 1990).  Deletion of the UPK3a gene results in major 
changes to urothelial physiology including an increase in transcellular permeability 
(Hu et al. 2002).    
 
1.1.5.2 Cytokeratins 
Cytokeratins (CKs) are intermediate filament proteins found in the cytoskeleton of 
epithelial cells.  The specific cytokeratin profile expressed is a distinguishing feature 
of epithelial tissue type and differentiation status and in some cases can act as a 
predictive tool for tumour prognosis. For example in normal urothelium, CK20 
expression is confined to the superficial cell layer.  Retention of a normal CK20 
immunolabelling pattern was found to be predictive of tumour non-recurrence over 
a 5 year period, whilst full-thickness expression of CK20 was found to be associated 
with recurrence (Harnden et al. 1995).   
 
Normal urothelial cells in situ express a profile of cytokeratins characteristic of both 
“simple” and stratified epithelia.  CK7, CK8, CK18 and CK19 are expressed 
throughout the urothelium.  CK13 is expressed in all but the superficial cell layer, 
CK17 and CK5 are basally expressed and CK20 is expressed by superficial cells 
(Southgate et al. 1999).   
 
1.1.5.3 Transcription Factors 
Several transcription factors have been identified as key regulators of urothelial 
cytodifferentiation.  One of these is the ligand-activated nuclear receptor PPARγ 
(Peroxisome Proliferator-activated receptor gamma), which is a key regulator of 
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adipocyte differentiation.  When bound to its heterodimer partner retinoid x 
receptor α (RXRα), PPARγ binds to specific promoter elements known as 
peroxisome proliferator response elements (PPREs) in target genes (Blanquart et al. 
2003).  PPRE binding of the heterodimer induces gene expression of downstream 
intermediate transcription factors such as FOXA1 and IRF-1 (Varley et al. 2009), 
which then act downstream to drive the terminal differentiation of human 
urothelial cells including expression of the uroplakin genes (Varley et al. 2004a, 
Varley et al. 2004b).  The epithelium-specific Ets domain transcription factor ELF3 
has also been implicated to promote urothelial cytodifferentiation in a manner 
which is PPARγ-dependent (Bӧck et al. 2014).  This study also demonstrated that 
knock-down of ELF3 in urothelial cultures disrupted the expression of FOXA1, as 
well as another transcription factor which is thought to be essential for the 
development of the superficial cell layer in mice, GRHL3 (Yu et al. 2009).  Whilst the 
sequence of events surrounding transcriptional factor activation has yet to be fully 
established for human urothelium, it has been proposed that the transcription 
factor KLF-5 may play a major regulatory role in the urothelial cytodifferentiation 
programme (Bell et al. 2011).  This study in mice suggests that KLF-5 may function 
upstream of PPARγ, in the transcription factor hierarchy required for urothelial 
maturation. 
 
1.1.5.4 Other significant markers of urothelial differentiation 
Aquaporins (AQPs) are a group of proteins which selectively allow passage of water 
down an osmotic gradient (as well as some small neutrally charged solutes).  The 
presence of these water channels in human urothelium has been characterised 
(Rubenwolf et al. 2009) and provides a basis to support previous work which 
suggested that the urothelium of some mammalian species is capable of 
reabsorption in order to modify urine concentration (Negrete et al. 1996).  Of 
particular interest was AQP3, which is thought to be associated with a 
differentiated urothelial phenotype (Spector et al. 2002, Rubenwolf et al. 2009).  
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Unpublished data from our laboratory indicates that expression of AQP3 is driven 
by PPARγ.   
 
Tight junction proteins provide barrier function to the urothelium and are another 
key set of proteins which are regulated during differentiation to produce a mature, 
functional urothelium.  Their contribution to urothelial physiology is discussed in 
further detail in section 1.2.3. 
 
1.1.6 Urothelial Cells in vitro 
Isolation and subculture of human urothelial cells has proved to be an 
indispensable tool for studying the cell biology of human urothelial cells.   Normal 
human urothelial (NHU) cells can be isolated from patient biopsies of bladder, 
ureter or renal pelvis tissue (Southgate et al. 1994).  In this method, tissues are 
placed into a calcium-chelating or “stripping” solution in order to dissociate the 
urothelial cell layer from the basement membrane.  Intact sheets of urothelium are 
then disaggregated by incubation in collagenase before seeding onto an 
appropriate substrate for culture in low calcium (0.09 mM) keratinocyte serum-free 
medium (KSFM) supplemented with recombinant human epidermal growth factor, 
bovine pituitary extract and cholera toxin which has been demonstrated to improve 
NHU cell attachment in culture (Southgate et al. 1994).  The supplemented KSFM is 
referred to as KSFMc.  
  
1.1.6.1 Phenotype of normal human urothelial cells in vitro 
Upon seeding into primary culture, the differentiated phenotype of NHU cells is 
rapidly lost in low calcium serum-free growth conditions, whereby the normally 
quiescent cells adopt a highly migratory and proliferative phenotype, with a 
population doubling time of approximately 24 hours (Southgate et al. 1994).  NHU 
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cells have a finite lifespan in culture, with senescence normally occurring between 
6-12 passages.   
 
In vitro, NHU cells lose markers associated with normal urothelial cell specialisation, 
such as most uroplakins (with the exception of UP1b), CK20, CK13 and tight junction 
proteins and show increased expression of CK14 and CK16, indicative of a change to 
a squamous phenotype (Southgate et al. 1994, Lobban et al. 1998, Varley et al. 
2004b).    NHU cells do not spontaneously stratify or differentiate upon confluence, 
but instead grow as monolayer cultures and exhibit reversible contact inhibition of 
growth as confluence is reached (Southgate et al. 1994).  They do however continue 
to express some markers associated with a basal/intermediate phenotype such as 
CK7, CK8, CK17, CK18 and CK19.   
 
1.1.6.2 Proliferation of normal human urothelial cells in culture  
In low-calcium, serum-free medium, NHU cells display a high growth rate for at 
least 6 passages before showing signs of senescence.  In vitro NHU cell growth 
occurs through autocrine activation of epidermal growth factor receptor (EGFR) 
signalling (Varley et al. 2005). 
 
1.1.6.3 Stratification of normal human urothelial cells in vitro 
NHU cultures can be induced to form a stratified epithelium by adapting the 
concentration of calcium in the growth medium to near physiological levels (2 mM).  
This is associated with formation of desmosomes, adherens junctions and the 
formation of primitive tight junctions, but not cytodifferentiation (Southgate et al. 
1994, Southgate et al. 1995).  The barrier function as measured by TER remains 
non-functional in stratified cultures (Cross et al. 2005) 
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1.1.6.4 Cytodifferentiation of normal human urothelial cells in vitro 
Although NHU cells propagated in serum-free low calcium conditions do not exhibit 
a differentiated phenotype, they can be induced to differentiate in the presence of 
differentiation cues, irrespective of the urothelial layer the original culture was 
derived from (basal, intermediate or superficial cells) (Scriven et al. 1997, Wezel et 
al. 2014).    
 
Cytodifferentiation of NHU cells can be achieved in vitro.  Studies within the scope 
of this thesis will focus on two experimental culture systems which have been well 
characterised.  The first (termed “TZ/PD”) is an experimental system which involves 
pharmacologically-driven urothelial cytodifferentiation by activation of the nuclear 
receptor PPARγ, using the thiazolidinedione compound troglitazone (TZ).  With 
concurrent inhibition of EGFR signalling (using the EGF receptor tyrosine kinase 
inhibitor PD153035), TZ is highly effective at initiating the urothelial gene 
expression programme in NHU cultures and results in increased expression of 
uroplakins, CK13 and tight junction proteins (as well as intermediate transcription 
factors known to be involved in urothelial differentiation such as FOXA1 and IRF-1) 
and a loss of CK14 (Varley et al. 2004a, Varley et al. 2006, Varley et al. 2009, Bӧck et 
al. 2014).  However the TZ-treated cultures fail to stratify and produce a barrier 
epithelium and differentiation appears to occur on a cellular level rather than 
producing an integrated functional epithelium.  The second method relies on the 
culture of NHU cells in bovine serum with near physiological concentrations of 
calcium (termed “ABS/Ca2+”).  These cultures express markers associated with 
terminal differentiation, as with the TZ/PD model, however they also self-organise 
into a multi-layered urothelium with a functional barrier as demonstrated by high 
TER values of >3000 Ω.cm2 (Cross et al. 2005).  Whilst the ABS/Ca2+ method appears 
to provide the closest approximation to urothelium in a culture model, the specific 
details surrounding the reprogramming of NHU cells into a differentiated 
phenotype are undefined and the specific factors within serum responsible for 
activating differentiation-promoting transcription factors remain to be determined.   
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However it seems likely that PPARγ-activation alone is not sufficient to promote 
tissue organisation and that there may be many factors in serum, such as fatty acids 
and retinoids, which drive other pathways crucial to urothelial tissue development.  
A diagram which summarises both methods can be found in chapter 2 (Fig 2.1). 
 
1.2 Cell-cell interactions 
Cell-cell interactions are essential for the normal function of cells in most tissues of 
an organism.  In epithelial tissues, cell-cell connectivity is maintained by complexes 
which form the intercellular junctions; desmosomes, adherens junctions, tight 
junctions and gap junctions.  Desmosomes and adherens junctions provide 
mechanical strength to epithelial cell contacts.  Tight junctions act to control the 
selective paracellular permeability of the epithelial layer to solutes and ions, whilst 
gap junctions act to enable cell-cell communication by allowing the passage of 
signalling molecules between cells.  A summary of cell-cell junctions is shown in 
figure 1.2. 
 





Figure 1.2  Simplified Overview of cell-cell junctions found in typical polarized 
epithelia. 
Four major cell junctional subtypes are illustrated in the order in which these structures 
would normally be organised in epithelia.  The tight junctions are localised to the most 
apical aspect of the cell-cell junction.   
 
  




Desmosomes are strongly adhesive intercellular junctions which allow stratified and 
differentiated tissues to resist mechanical stress.  They contain heterotypic 
transmembrane proteins and provide mechanical strength by linking the 
intermediate filament cytoskeleton of adjacent cells at defined spots along the 
lateral membrane.  Their adhesive properties are thought to be dynamic, for 
example during embryonic development and tissue repair, desmosomal 
adhesiveness is thought to be of lower affinity, with evidence suggesting that this 
occurs under the control of protein kinase C (Wallis et al. 2000, Kimura et al. 2007).  
Desmosomes are comprised of desmoplakin (links the intermediate filaments to the 
desmosomal adhesion plaque), plakoglobin and plakophilin (which form the 
desmosomal adhesion plaque) and the desmosomal cadherins, desmocollin and 
desmoglein (which span the membrane regions), reviewed in (Garrod et al. 2008). 
 
1.2.2 Adherens Junctions 
Adherens junctions are cell junctions which (like desmosomes) provide mechanical 
support to tissues to enable movement of cells in a coordinated manner.  Adherens 
junctions are composed of single pass transmembrane cadherin proteins which 
homodimerise with cadherins on adjacent cells in a calcium-dependent manner, 
reviewed in (Meng et al. 2009).  The cytoplasmic portion of cadherin proteins 
interacts with linker proteins including α- and β-catenin and ZO-1 to facilitate actin 
cytoskeletal binding. 
 
1.2.3 Tight Junctions 
1.2.3.1 Function of Tight Junctions 
The tight junction (TJ) in epithelia is found at the apical-most region of contact 
between two cell membranes and serves to provide barrier function to restrict 
passage of solutes and ions.  The TJ’s pull together cell membranes on adjacent cells 
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such that the intercellular space appears to be non-existent on electron 
micrographs (Farquhar et al. 1963).   The TJ serves two major roles, the first, to 
restrict the paracellular transport of substances across an epithelium providing a 
barrier or “gate” function, although more recent studies suggest that the tight 
junction functions to establish a permeability barrier which “limits” rather than 
prevents paracellular permeation (Angelow et al. 2006). Secondly, TJs function to 
prevent the free-movement of proteins between the apical and basolateral 
membrane domains of a cell, thereby establishing polarity and providing what is 
described as a “fence” function.   
Measurement of the TER across different epithelia has demonstrated variability 
between epithelia, with the highest recorded barrier function of any tissue 
observed in the urinary bladder (Negrete et al. 1996, Anderson et al. 2009).  Whilst 
it is known that the AUM prevents transcellular permeability of urine across the 
urothelium, this does not contribute to the high TER observed (Hu et al. 2002).  The 
value of the TER is reflected by the resistance of the tight junction.   
Epithelia which display a TER of >500 Ω.cm2 are considered “tight”, whereas a TER 
of below 500 Ω.cm2 is considered “leaky” (Fromter et al. 1972).  The protein 
components which make up the tight junction are thought to dictate permeability 
properties. 
 
1.2.3.2 Tight Junction Proteins 
Tight junctions have a complex molecular organisation, composed of members of 
the claudin family, of which there are 24 genes in man, along with occludin, 
junctional adhesion molecule (JAM) 1, 2 and 3 and the PDZ-containing zonula 
occludens (ZO) proteins (ZO-1, 2 and 3).  Claudins are tetraspanning membrane 
proteins (with two extracellular loops and intracellular N- and C-terminal domains), 
which form oligomeric strands.  The claudins form the “sealing strands” of the tight 
junction, pulling together the adjacent membranes which link to the cytoskeleton 
to create a contractile phenotype.  It is believed that the external loop domains 
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determine the barrier properties afforded by each claudin (Mrsny et al. 2008).  The 
ZO proteins serve to link the claudin proteins to the cytoskeleton and play a critical 
role in the spatiotemporal organisation of claudins at TJ strands (Umeda et al. 
2006).  The claudins are thought to be the barrier-defining components of TJs by 
regulating permselectivity and have been shown to be crucial for the barrier 
function of mammalian skin (Furuse et al. 2002).  It is believed that tissue-specific 
expression of claudins is important in defining overall tight junction barrier 
properties and whilst the ZO proteins are required for tight junction stability, they 
do not play a role in limiting paracellular movement of solutes (Van Itallie et al. 
2009, Rosenthal et al. 2010).  Claudin 2 is often associated with “leaky” water-
transporting epithelia such as found in the proximal tubule of the kidney and a 
recent study has demonstrated that claudin 2 forms a paracellular water channel 
(Rosenthal et al. 2010), whilst claudin 3 has been proposed as a sealing component 
of the TJ.  Claudin 3 overexpression has been shown to be associated associated 
with increased barrier function and reduced permeability in MDCK cells (Milatz et 
al. 2010).   
 
1.2.3.3 Urothelial Tight Junctions 
The development of mature tight junction complexes is of vital importance to 
urothelial tissue function.  Differentiation of NHU cells in vitro (using the TZ/PD 
model described in section 1.1.6.4) and in situ studies, have revealed that claudins 
3, 4, 5 and 7, as well as occludin and ZO-1 are differentiation-associated (Varley et 
al. 2006), whilst claudin 1 was downregulated in response to NHU cell 
differentiation and claudin 6 was absent. The same study demonstrated that NHU 
stratification (by increasing exogenous calcium to near a near physiological 
concentration of 2 mM), resulted in an upregulated expression of both occludin and 
ZO-1 proteins, but not claudins 4, 5 or 7.  Another study in immortalised ureteric-
derived human urothelial cells cultured in calcium and bovine serum demonstrated 
the presence of occludin, JAM-1 and ZO-1, 2 and 3 at cell margins (Rickard et al. 
2008).  




Inspection of TJ protein distribution in urothelial tissue sections revealed that 
claudin 3 and ZO-1 displayed a restricted expression pattern, between the points of 
membrane contact at the apical-most aspect of superficial cells (Varley et al. 2006).  
A detailed analysis of claudin 3 and ZO-1 isoforms in differentiated NHU cells (using 
the ABS/Ca2+ model), demonstrated that claudin 3 is an essential component of the 
urothelial TJ and is required for barrier development, as well as identifying a 
“switch” in ZO-1 splice variant expression during differentiation, from ZO-1α- to the 
longer ZO-1α+ isoform (Smith NJ et al. 2015).  Interestingly, forced expression of 
claudin 3 was not enough to induce barrier formation in non-differentiated NHU 
cells, thus highlighting a more complex interaction of proteins at the TJ is required 
for barrier function.  The individual contribution of other urothelial-associated 
claudins such as claudins 4 and 5 to barrier function is yet to be studied.    
 
1.2.4 Gap Junctions 
In multicellular organisms cell-cell communication within tissues is crucial to enable 
a community of cells to behave as a tissue, coordinating wound repair and 
homeostasis.  Whilst paracrine signalling permits limited local communication, the 
results are relatively slow and short-lived when compared with direct cell-cell 
communication via gap junction (GJ) channels.  Gap junctions are the primary 
means by which cells can directly connect and communicate with one another. 
 
1.2.4.1 Gap Junction Proteins 
GJs are composed of connexin (Cx) proteins, six of which combine to form a hemi-
channel or connexon which are inserted into the cell membrane.  Alignment of two 
connexons in adjacent cells provides a continuous hydrophilic pore approximately 
6-7 Å in radius (Unger et al. 1999) connecting the two cell interiors and permitting 
the passage of signalling molecules.  More recently, three additional 
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communicating junction proteins known as Pannexins have been identified, 
however their major function is believed to be as single membrane channels, rather 
than for direct cell-cell communication (Penuela et al. 2013). 
Cxs are a multigene family of tetraspanning proteins with intracellular amino and 
carboxy groups.  Approximately twenty members have been identified in the 
human genome with cell-type regulated expression.  It is common for many 
connexin family members to be expressed by a single cell type and it unclear 
whether this is for selectivity purposes or if connexins have overlapping redundant 
functions.   
Cxs are commonly named after their molecular weight (e.g the connexin protein 
with a molecular weight of 43kD is known as Cx43); however this has proven 
confusing when comparing Cxs between species, due to modifications in molecular 
mass.  Therefore, gene names are commonly sorted into two major evolutionary 
subclasses, the α and β forms (GJA and GJB respectively) and minor C, D and E 
groupings, followed by a number e.g. The gene name for Cx43 is GJA1 (Kumar et al. 
1992). 
1.2.4.2 The Function of Gap Junctions 
GJ channels are dynamic and can flip between open and closed states to mediate 
the diffusion of small molecules and ions with low molecular mass (generally less 
than 1kD), including Ca2+, amino acids, nucleotides and the intracellular mediators 
ATP, cyclic AMP (cAMP) and inositol 1,4,5-triphosphate (IP3), thus providing a 
mechanism for the movement of molecular information between cells.  
Intercellular communication via gap junctions has been shown to be critical to 
many physiological processes such as electrical coupling (Saffitz et al. 2007), 
embryonic development (Fleming et al. 2000, Eckert et al. 2005), differentiation 
(Piechocki et al. 2000), apoptosis (Kameritsch et al. 2013) and tissue homeostasis (Li 
et al. 2010, Scott et al. 2012). 
Cxs are known to combine in both homomeric & heteromeric gap junction channels 
allowing for a further level of control in channel stoichiometry and therefore 
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selectivity.  For example, in murine mammary gland development heteromeric 
Cx26-Cx32 channels were found to be selectively permeable to cAMP, cGMP and 
IP3, but homomeric channels were not (Locke et al. 2004).   
 
1.2.4.3 Connexins and Disease  
Insight into the functional roles of Cxs has been revealed by studying a number of 
human diseases which are caused by mutations or dysregulation in Cx genes.  In 
some cases loss or mutation in a single connexin can result in disease or abnormal 
development, for example site-specific mutations in Cx26 result in keratitis 
ichthyosis deafness syndrome (Richard et al. 2002).  Additionally Cxs 26 and 30 
were ranked among the most upregulated genes in psoriatic lesions when 
compared to normal skin, even though keratinocytes are known to express at least 
ten members of the connexin family (Martin et al. 2015), suggesting that Cx26 and 
Cx30 play crucial and unique functions in human skin (Li et al. 2014).  It has been 
demonstrated that Cx43 plays a role in wound healing of the skin and abnormal 
Cx43 expression has been linked to the poor rate of skin healing in diabetic chronic 
wounds (Becker et al. 2012). 
Charcot-Marie-Tooth disease is a heterogeneous neuro-genetic disorder, affecting 
peripheral motor and sensory nerves. It is one of the most common peripheral 
neuropathies presenting a phenotype which involves distal limb muscle wasting and 
sensory loss, becoming progressively worse over time.  The X-linked form of 
Charcot-Marie-Tooth disease (CMT1X) is one of the most widely recognised disease 
states occurring as a result of a Cx defect.  Over 400 germline mutations in Cx32 
have been described (http://www.molgen.ua.ac.be/cmtmutations/Mutations), 
spanning the entire coding region resulting in partial or total loss of channel 
function (Patel et al. 1994, Scherer et al. 1999, Kleopa 2011), as well as in the nerve-
specific 5’ UTR which prohibits Cx32 expression (Murphy et al. 2011).  Several 
CMT1X patients (both male and female) have been reported with deletions in the 
entire GJB1 coding sequence (Gonzaga-Jauregui et al. 2010), demonstrating that 
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loss of Cx32 is not embryonic lethal.  This finding is also supported by the study of 
Cx32 knock-out mice, which have an extremely dysfunctional physiology with 
peripheral neuropathies consistent with human CMTX disease (Nelles et al. 1996, 
Scherer et al. 1998), but are not embryonic lethal.  Although many cell types 
express Cx32, peripheral neuropathy appears to be the major clinical manifestation 
of mutations or loss of GJB1 and in light of the current study it should be noted that 
urinary tract defects do not appear to occur in these patients.  Interestingly, nor has 
an increase in tumour incidence been reported in these patients, although Cx32 
knock-out mice show increased susceptibility to hepatocarcinogenesis (Temme et 
al. 1997).  There is clear potential for partial functional redundancy in many tissues 
due to co-expression of other connexins which may explain these findings.  It is also 
unlikely that the wide range of mutations observed in CMTX patients is reflective of 
a complete Cx32 knock-out and the number of reported CMTX cases where Cx32 is 
deleted is likely too few for an increased incidence of cancers to be detectable 
(Gonzaga-Jauregui et al. 2010).   
There is substantial evidence both in vitro using cancer cell line models, as well in 
vivo to support a role for Cxs in tumour suppression (Trosko et al. 1998).  For 
example lack of Cx43 has been associated with breast tumours (Laird et al. 1999) 
and Cx32 knock-out mice show an increased incidence of hepatocarcinogenesis 
(Temme et al. 1997), although some findings suggest that some of the tumour 
suppressive effects of Cxs can be independent of gap junction formation and 
therefore communication (Moorby et al. 2001).   
1.2.4.4 Connexin Biosynthesis and Turnover 
Cxs are generally believed to have a very short half-life of approximately four hours 
and as a result cells are believed to be constantly cycling in Cx biosynthesis and 
degradation, however some Cxs have been demonstrated to develop more stable 
gap junction pools (Berthoud et al. 1999).  Rapid turnover of gap junctions is 
thought to promote the dynamic regulation of gap junctional communication and 
turnover rates have been demonstrated to vary according to Cx type and 
extracellular pH (Yamaguchi et al. 2003, Berthoud et al. 2004).   
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Cx43 is the most ubiquitously expressed vertebrate gap junction protein and as a 
result its life cycle has been studied intensively.  Cx43 proteins have been 
demonstrated to form connexon hemi-channels after exiting the ER in the trans-
Golgi network, which then move in vesicles for insertion into the plasma membrane 
and docking with compatible connexons on adjacent cells (Fig 1.3).  The second 
extracellular loop domain (E2) of connexins has been demonstrated to be essential 
for docking selectivity and the formation of functional gap junction channels (White 
et al. 1994, Gong et al. 2013). 
It is interesting to note that intracellular connexons are maintained as closed 
channels until insertion in the membrane, which is thought to prevent any 
biochemical unbalance from small molecular messengers entering the Golgi. For the 
same reason, it was originally believed that connexons would remain closed once 
inserted into the plasma membrane, until docking with a connexon on an adjacent 
cell.  However, an increasing body of research supports a role for the restricted 
opening of unpaired hemichannels, providing possible paracrine signalling 
pathways for ions such as Ca2+ and ATP  (Leybaert et al. 2003, Saez et al. 2005, 
Evans et al. 2006).  In addition it has been demonstrated that under specific 
conditions of stress such as ischaemia, hypoxia (Clarke et al. 2009), or osmotic 
stress (Quist et al. 2000), hemichannels may be induced to open, releasing small 
molecules and ions. 
Phosphorylation via mitogen-activated protein kinase activation is thought to play a 
key role in regulating assembly and function of Cx43 containing gap junctions, 
(Solan et al. 2007), including hemichannel functions (John et al. 2003).  The 
phosphorylation status of Cx43 can be observed by shifts in band mobility by gel 
electrophoresis and at least three phosphoforms have been identified: P0, P1 and 
P2, which can be attributed to key stages in the Cx43 life cycle; P0 being 
unphosphorylated and present mainly in the trans-Golgi network, P1 being 
phosphorylated and associated with Cx43 trafficking to the membrane and P2 being 
heavily phosphorylated and present in functional gap junctions (Solan et al. 2007, 
Sosinsky et al. 2007).   It has been reported that specific phosphorylation of Cx43 by 
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epidermal growth factor may result in degradation of gap junctions (Leithe et al. 
2004).  However, whilst phosphorylation may be a prerequisite for degradation of 
some Cxs, not all require phosphorylation for degradation, which can occur via both 
proteosomal and lysosomal mechanisms (Berthoud et al. 2004, Laird 2005, Falk et 
al. 2014) (Fig 1.3). 
 
 
Figure 1.3  Lifecycle of connexins 
 
1.2.4.5 Permselectivity of Gap Junction Channels 
The diverse expression patterns of connexins in different tissues may be due to 
functional differences, with evidence suggesting that gap junctions demonstrate 
selective permeability for different second messengers and metabolites, based on 
their connexin composition.  In HeLa cells, the G-protein-activated second 
messenger inositol 1,4,5-triphosphate (IP3), which is known to bind to membrane 
receptors in the endoplasmic reticulum to promote release of intracellular calcium, 
has been demonstrated to be more efficient at passing through channels composed 
of Cx32, than Cx26 (4-fold more efficient)  and Cx43 (2.5 fold more efficient) 
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(Niessen et al. 2000).  cAMP demonstrates preferential passage through Cx43 
channels, rather than Cx26, Cx32, Cx36, Cx45 and Cx47, which all demonstrate low 
cAMP permeability in transfected HeLa cells (Bedner et al. 2006).  In a layered 
culture system, transfer of radiolabelled metabolites from donor cells to receiver 
cells demonstrated a preference for AMP (8-fold), ADP (8-fold) and ATP (300-fold) 
to pass through Cx43 channels rather than Cx32, however adenosine passed 
through Cx32 channels 12-fold better than Cx43 channels (Goldberg et al. 2002), 
suggesting that addition of phosphate groups to adenosine can switch the relative 
permeability of this messenger molecule.  It is clear that different connexins are not 
simply selective for passage of a single messenger from cell-to-cell, rather they 
offer passage of signalling molecules with selective efficiency and transfer rates, 
often based on charge and size (Kanaporis et al. 2011). 
 
1.2.4.6 Connexin Interacting Proteins 
It has now been widely demonstrated that connexins have a wide range of 
functions beyond their role as a communication channel, involving interactions with 
other proteins at junctional complexes, sometimes referred to as the “junctional 
nexus” (Duffy et al. 2002).  It has been proposed that connexins can form the centre 
of a “junctional nexus”.  Cx32 and Cx43 have been demonstrated to influence the 
expression of over 300 genes, including transcription factors (Iacobas et al. 2007), 
suggesting that the role of connexins may extend beyond GJIC with influences 
major regulatory influences on gene transcription. 
In addition to influences on gene expression, connexins participate in a huge 
number of protein-protein interactions.  In the same way that tight junctions have 
been demonstrated to be positioned within the cell membrane anchored to the 
cytoskeleton, so too have GJ proteins, with several Cxs including Cx30, Cx31.9, 
Cx32, Cx43 and Cx45 reported to bind to the PDZ domain of ZO-1, thereby 
stabilising the GJ to the cytoskeleton, reviewed (Herve et al. 2012).   
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The majority of the literature regarding Cx interactions surrounds Cx43, since it is 
the most widely expressed connexin and is reported to interact with many proteins 
including P2 purinergic receptors (Fortes et al. 2004), N-Cadherin (Wei et al. 2005) , 
β-catenin (Ai et al. 2000), the tight junction proteins claudin 5 (Nagasawa et al. 
2006) and ZO-1 (Toyofuku et al. 1998) and calmodulin (Zhou et al. 2007).  Due to 
the close relationship between gap and tight junctional proteins it has been 
suggested that connexins may play a role in regulating expression of tight junction 
proteins (Koizumi et al. 2007), but the mechanism by which this occurs has not 
been identified and it is not clear whether gap junction intercellular communication 
(GJIC) is critical to tight junction assembly, reviewed in (Dbouk et al. 2009).  It does 
however seem plausible that some connexins may have a secondary role to 
function within multi-protein complexes for regulation of cell polarity, with 
influence on the assembly or maintenance of other intercellular junctions, in 
particular tight junctions.   
Interactions between gap junctions and other proteins can be influenced by post-
translational modification.  Most of the literature surrounding connexin post-
translational modifications surrounds Cx43, with at least 14 documented 
phosphorylation sites at serine or tyrosine residues present in the C-terminal tail 
(Lampe et al. 2004).  Cx32 has been demonstrated to be phosphorylated by PKA, 
PKC (Elvira et al. 1993), Ca2+/calmodulin-dependent kinase II (Saez et al. 1990) and 
EGFR (Diez et al. 1998).  Connexin phosphorylation events appear to mostly occur in 
the C-terminal tail with implications on channel gating (including channel closure 
mediated by a ball and chain mechanism), connexin proteolysis and influence on 
potential binding partners.  For example phosphorylation of Cx43 by Akt can 
influence its interactions with other proteins (Park et al. 2007).  
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1.2.4.7 Connexin Expression in the Bladder 
There are few studies reporting connexin expression in the bladder.  However, the 
expression of Cx43 has been demonstrated in the lamina propria in a sub-group of 
cells known as suburothelial myofibroblasts (Fry et al. 2007).   
There are a few studies linking connexin expression with urothelial carcinoma, for 
example high levels of Cx43 expression have been associated with poor prognosis 
of muscle invasive bladder tumours (Poyet et al. 2015).  An immunohistochemical 
study found that decreased expression of Cx26 was observed in bladder tumours 
(Gee et al. 2003).  Another report which combined experimental and publicly 
available microarray datasets, from bladder tumours and normal control tissues, 
identified GJB1 (Cx32) as being one of the most downregulated genes in bladder 
tumour samples (Zaravinos et al. 2011).  Some caution must be taken with 
interpretation of such data, since bladder tumours collected for microarray analysis 
can contain varying populations of urothelium, stroma and underlying muscle/fat 
tissue, therefore linking changes in expression to specific cell types can prove 
problematic.  There are no studies to date reporting the normal expression profile 
and physiological significance of connexins in human urothelium.  At present, there 
are no studies in which connexin mutations have been linked to urothelial 
carcinogenesis. 
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1.3 Wound-healing in epithelial tissues 
Differentiated epithelia, including the urothelium contain structural features to 
provide a specialised barrier.  However in order to maintain barrier function, 
epithelia must be able to rapidly repair when integrity is lost, for example upon 
mechanical injury and the urothelium has an impressive capacity for self-repair.  For 
this to occur, cells both adjacent to and remote from the wound site must be 
capable of responding to signals to allow coordinated proliferation and directed 
migration of healthy cells into the wound space to restore barrier function.  There 
are several key components of cellular behaviour which determine the ability and 
rate at which cells may migrate into a wound space, including actin cytoskeletal 
dynamics, cell-cell adhesion and cell-substrate adhesion. 
 
1.3.1 Urothelial regeneration 
The urothelium has a high capacity for regeneration following damage.  Urothelial 
destruction may be caused by a number of mechanisms including common bacterial 
infections, Interstitial Cystitis (IC), Ketamine-induced Cystitis, physical trauma 
following catheterisation or surgery for removal of urothelial carcinoma.  In each 
case the degree of severity can be variable, from sloughing of a few superficial cells 
which requires a small level of proliferation to maintain barrier function (Robino et 
al. 2014), to more acute full-thickness urothelial loss which necessitates rapid 
migration and proliferation to ensure barrier restoration (Kreft et al. 2005).  Whilst 
repair is extremely efficient, the mechanisms which support regeneration are not 
limitless.  The degree of damage can dictate the ability to regenerate and where 
damage is considerable, it would be extremely unlikely that a few urothelial cells 
could regenerate the urothelium to create an effective urinary barrier.  In IC 
patients there is strong correlation between the percentage of denuded bladder 
mucosa and patient pain, with the most denuded patients on average resulting in 
more total cystectomies (Leiby et al. 2007).   
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In vitro studies of NHU cells have shown that upon wounding, the initiating signal 
for repair is thought to be in the form of an ATP-driven calcium response, which 
propagates out from the wound edge immediately after damage (Shabir et al. 
2008).  The calcium wave was followed by increased migration of cells into the 
denuded space over a period of several hours, though details of the signalling 
pathways which are activated to drive the migration response to injury are not fully 
understood.  However, it has been demonstrated that TGFβ-receptor signalling is 
activated in response to wounding of differentiated NHU cultures (Fleming et al. 
2012) where it appears to play a key role in migration and repair.  Further details of 
TGFβ signalling in epithelial tissues are discussed in section 1.3.4.  
 
Animal models which mimic selective urothelial damage have provided some 
insight as to the processes by which barrier function is restored following injury.  
Damage caused by treatment of rat bladders with protamine sulphate, 
demonstrated that loss of superficial cells was repaired by a maturation of 
intermediate cells, which rapidly became terminally differentiated, expressing 
uroplakins and ZO-1-containing tight junctions (Lavelle et al. 2002).  The plasticity of 
basally-derived NHU cells to regenerate into all three layers of urothelium has 
recently been demonstrated (Wezel et al. 2014).  Superficial and full-thickness 
wounding of mouse bladder explant cultures confirmed that restoration of tight 
junctions is one of the earliest events in the bladder wound-healing process, 
occurring before expression of uroplakins (Kreft et al. 2005).  The same study 
concluded that the proliferative and migratory behaviour necessary to close 
wounds was mostly performed by basal cells.  It has since been demonstrated that 
immediately after isolation, basally-derived NHU cells have a higher capacity for 
proliferation than suprabasal-derived cells, but that the growth characteristics of 
both populations become indistinguishable after a short adaptation period in 
culture (Wezel et al. 2014).  A further study in mice demonstrated that urothelial 
injury induced by treatment with uropathogenic E. coli or protamine sulphate (a 
cationic peptide which increases urothelial permeability resulting in shedding of 
urothelial cells), caused a rapid increase in proliferation in the cytokeratin 5-positive 
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basal cell compartment (Shin et al. 2011).  This study also indicates that a paracrine 
signalling loop operates between the urothelium and stromal cells, in which sonic 
hedgehog protein is secreted  by basal cells following injury, inducing expression of 
Wnt signals from the underlying stroma, which thereby act upon urothelial cells to 
drive proliferation.   
It has been hypothesised that approximately 10% of rat bladder basal cells are a 
potential stem cell population, due to long term BrdU label retention (Kurzrock et 
al. 2008). However, separately isolated basal and intermediate/superficial cells can 
be sub-cultured and given the correct signalling cues, both populations retain the 
capacity to differentiate into a multi-layered organised urothelium expressing 
markers of basal, intermediate and superficial cells, implying that all urothelial cells 
retain a level of plasticity (Wezel et al. 2014).  There are no studies supporting 
pluripotency in urothelial cells and to date, no studies in which a marker is able to 
distinguish a subpopulation of urothelial stem cells from the remaining basal cell 
population.  It therefore remains controversial as to whether the urothelium 
maintains a population of stem cells which could support regeneration; however it 
would seem likely that the location of these cells would be in the cytokeratin-5 
expressing basal cell compartment, should they exist. 
 
1.3.2 The role of Connexins in epithelial wound healing 
Remodelling of GJs during wound migration has been frequently observed in skin 
where expression of up to ten Cxs has been described (Becker et al. 2012).  In 
human skin, the response to injury is thought to involve a rapid down regulation of 
Cx43 at the leading edge of the wound whilst at the same time a large induction of 
Cx30 and Cx26 is observed (Brandner et al. 2004).  These switches in Cx regulation 
correlate with a switch to a highly migratory phenotype in keratinocytes, implying 
that migration does not require a complete absence of cell-cell communication, but 
rather an absence of Cx43 expression and/or communication.  Connexin-mimetic 
peptides are short peptide sequences which mimetically match the extracellular 
loops of Cxs.  When applied to cells in vitro they are capable of blocking connexon 
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opening and thus intercellular communication, without interfering with Cx 
expression.  Due to similarities in the extracellular domains of connexins, relatively 
few mimetic peptides exist which are inhibitory to a single connexin; however 
Gap27 is a mimetic peptide believed to be specific to Cx43 in its effects.  Cx-mimetic 
peptides have been used in several in vitro studies to establish the contribution of 
GJIC, rather than just Cx expression in wound healing.  Addition of Gap27 peptide 
was found to increase the rate of migration in human fibroblasts and keratinocytes 
suggesting that it is perhaps Cx43-mediated GJIC, rather than just expression which 
acts to inhibit wound repair (Wright et al. 2009, Wright et al. 2013).   
 
The liver has a remarkable capacity for regeneration, with the dominant gap 
junction protein known to be Cx32, a commonly used differentiation marker for 
hepatocyte studies in vitro (Kojima et al. 1995).  Expression of a dominant-negative 
form of Cx32 in transgenic mice reduced the rate of liver regeneration, with 
reduced hepatocyte proliferation following partial hepatectomy (Dagli et al. 2004).  
However another in vivo study in rats indicated that Cx32 may be inhibitory to liver 
regeneration.  Cx32 protein expression, but not transcript, was markedly reduced 
for up to 30 days during regeneration, following chronic liver injury induced by 
treatment with hepatotoxic chemicals (Nakata et al. 1996).   
 
1.3.3 The Rho kinase pathway and epithelial wound healing 
The Rho family of small GTPases including Rho, Rac and Cdc42 are important signal 
transducers regulating actin dynamics, cell shape and movement (Fig 1.4 A).  During 
cell migration, slim cytoplasmic projections known as filopodia protrude beyond the 
leading edge of the cell across the ECM, under the control of cdc42 resulting in 
actin polymerisation mediated by VASP proteins. The lamellipodium contains an F-
actin mesh which acts to propel the cell across the ECM (or substrate) and occurs at 
the leading edge of motile cells under the control of Rac (Van Aelst et al. 2002). In 
MDCK cells it has been observed that lamellipodial crawling is dependent on Rac1 
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activity (Fenteany et al. 2000), where inhibition of Rac1 activity in the first three 
rows of the leading edge prevented formation of lamellipodia and subsequent 
wound healing.  Rho GTPases are inactive when bound to GDP, but when bound to 
GTP they activate ROCK, a key regulator of the actin cytoskeleton which has effects 
on multiple components of cytoskeletal reorganisation (Fig 1.4 A and B).  ROCK 
induces actin filament stabilisation via LIM kinase (LIMK) and also acts to inhibit 
myosin light chain (MLC) phosphatase, which results in an increase in 
phosphorylated MLC and the formation of contractile stress fibres.   Stress fibres 
enable dynamic focal adhesions, permitting movement of the cell away from the 
leading edge (Fig 1.4 A).  
In addition to supporting actin reorganisation, Rho GTPases are also though to 
regulate integrin dynamics as well as being regulated themselves by integrins 
(Schwartz et al. 2000) and Rho GTPases can also act at cell junctions where they 
also play a key role in the maintenance of adherens junctions (Watanabe et al. 
2009).  Cross-talk between the Rho kinase and several other signalling pathways has 
been identified, including the TGFβ receptor pathway, also known to be a key cell 
migration regulatory pathway (Clements et al. 2005).  Inhibition of TGFβ signalling 
in endothelial cells was demonstrated to result in a large reduction in Rho A gene 
expression (Tavares et al. 2006).  
  





Figure 1.4  Rho Kinase Pathway and Cell Migration 
A. Simplified diagram to demonstrate the roles of Rac, cdc42 and RhoA/ROCK in cell 
movement 
B. Simplified overview of the Rho-kinase pathway and regulation of actin dynamics. 
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1.3.4 TGFβ-receptor signalling and epithelial wound-healing 
1.3.4.1 TGFβ signalling mechanism 
TGFβ is a cytokine that exists in three isoforms; TGFβ1, TGFβ2 and TGFβ3, which are 
known to have autocrine, paracrine and endocrine regulatory functions in many cell 
types and implicated in tissue development and repair, proliferation, 
differentiation, homeostasis and pathogenesis.  As a member of the TGFβ 
superfamily of ligands, which includes bone morphogenic proteins and growth 
differentiation factors, TGFβ ligand binds to receptor complexes consisting of TGFβ 
receptors type I and II.  Both receptors have serine/threonine kinase activity and 
upon ligand binding, the type II receptor phosphorylates and activates the type I 
receptor, which hydrolyses ATP to directly phosphorylate receptor-regulated SMAD 
proteins, thus propagating the signal within the cell (Huse et al. 2001).  SMAD 
proteins translocate to the nucleus and act as signal transducers, to induce or 
repress transcriptional activity of a broad range of downstream genes, some of 
which are key to regenerative processes such as cell proliferation and migration.  
Loss of SMAD3 has been shown to delay liver regeneration through reduced 
hepatocyte proliferation (Kremer et al. 2014). 
 
1.3.4.2 TGFβ signalling in EMT 
The diversity of signalling effects brought about by TGFβ are complex and 
dependent on cell type and biological context.  A considerable body of evidence 
exists to suggest that signalling through TGFβ plays a major role in epithelial-to-
mesenchymal transitions (EMT) as reviewed in (Zavadil et al. 2005) and (Heldin et 
al. 2009). EMT is a process in which polarised epithelial cells adopt a more basic 
fibroblast-like phenotype and is associated with a loss of cell-cell adhesion, a loss of 
cell-matrix adhesion and cell migration.  EMT is a commonly recognised process 
associated with tumour metastasis and many developmental processes of which 
gastrulation is particularly well characterised (Thiery et al. 2009).  In some epithelia, 
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it is also believed that EMT may occur during healing in response to injury, for 
example during pulmonary fibrosis by alveolar epithelial cells (Kim et al. 2006).   
 
Whether EMT-like behaviour occurs during wound-healing of urothelium is not fully 
understood, however microarray studies demonstrate that TGFβR/SMAD3 
signalling is altered as a consequence of NHU cell differentiation.  Evidence suggests 
that regeneration of differentiated NHU cultures occurs in response to autocrine 
activation of TGFβR/SMAD3 pathway following wounding (Fleming et al. 2012), 
however the phenotype of wound-healing NHU cells was not considered in this 
study and therefore a specific EMT switch has not been identified and whilst 
TGFβR/SMAD3 signalling is known to participate in EMT-like behaviour, there are 
other recognised pathways implicated in tissue repair, for which TGFβR/SMAD3 
may be involved. 
 
1.3.4.3 cAMP and SMAD regulation 
It has been demonstrated in some cell types including fibroblasts and keratinocytes 
that SMAD-specific gene regulation occurs as a response to changes in intracellular 
cAMP (Schiller et al. 2003, Schiller et al. 2010).  cAMP-dependent activation of PKA 
induces the release of a catalytic subunit which diffuses into the nucleus where it is 
thought to phosphorylate cAMP-response element-binding protein (CREB) at serine 
133, thereby allowing it to bind with transcriptional coactivators, including P300 
and SMAD3 (summarised in figure 1.4).  This transcriptional complex binds to 
conserved cAMP-response elements found within a broad range of genes, including 
those involved in ECM destruction and synthesis.   
 
1.3.4.4 PPARγ and SMAD regulation 
A negative regulation of SMAD3 has been observed in several studies in response to 
activation of the nuclear hormone receptor PPARγ.  Treatment of rats with the 
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PPARγ agonist Rosiglitazone resulted in decreased levels of phosphorylated SMADS 
2 and 3 in subcutaneous adipose tissue (Beaudoin et al. 2014), whilst another 
PPARγ agonist Pioglitazone, inhibited TGFβ-induced EMT-like behaviour in retinal 
pigment epithelial cells (Hatanaka et al. 2012).  Mouse skin fibroblasts with deleted 
PPARγ showed an enhanced rate of dermal wound closure compared with wild-type 
mice (Sha et al. 2012) and PPARγ-null mouse embryonic fibroblasts show 
constitutive SMAD2/3 phosphorylation and interaction with its transcriptional co-
activator P300, with enhanced collagen biosynthesis, even in the absence of 
exogenous TGFβ (Ghosh et al. 2008).  A further study in aortic smooth muscle cells 
demonstrated a direct binding of PPARγ to SMAD3, resulting in abrogated ECM 
production and tissue growth following vascular injury (Fu et al. 2001). 
     
 
Figure 1.5  Overview of cAMP-dependent SMAD3/CREB gene transcription. 
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1.4 Thesis Hypothesis and Aims 
In order to maintain barrier function, the urothelium is able to switch to a highly 
migratory state in order to repair damage, which requires that urothelial cells are 
individually responsive to their environment and can behave in a coordinated 
manner to respond to regional damage.  Direct cell-cell communication is likely to 
play a key role in maintaining balanced homeostasis and also for generating the 
field effects necessary to drive a coordinated response to injury.  
 
Whilst the overall importance of gap junction intercellular communication in 
regulating tissue function and homeostasis is well documented, there is limited 
knowledge of the properties that specific Cxs offer to tissue function. Elucidating 
the function of a particular Cx in any given cell type is complex, since most cell types 
express multiple Cxs which are probably not selective for passage of a single 
messenger from cell-to-cell.  However Cxs do appear to have distinct permeability 
characteristics, with selective efficiencies and transfer rates and it is likely that their 
expression in any given tissue will offer permeability characteristics with significant 
physiological relevance.  It has been proposed that in addition to cell-cell 
communication, some Cxs offer alternative functions in cell signalling events and 
within large protein complexes for regulation of cell adherence and polarity by 
influencing the assembly or maintenance of tight/adherens junctions.  However, 
the current knowledge of the fundamental mechanisms underlying the spatial and 
temporal coincidence of gap and tight/adherens junction proteins is limited. 
 
Whilst the role of some Cxs (in particular Cx43) has been established to be closely 
linked to the migratory behaviour of cells and tissues during wound-healing, there 
are no reports which consider a potential role for Cxs in the wound-healing of 
human urothelium.  This may be of critical relevance to maintaining a tight barrier 
function.  In addition there is very little supporting evidence as to how some Cxs 
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enhance or inhibit wound migration and what migratory cell signalling events and 
pathways may be affected by the biology of specific Cxs.       
The working hypothesis for this project is that specific Cxs will be required for a) 
urothelial cell differentiation and barrier attainment and b) the ability for urothelial 
cells to regenerate in response to damage cues.    
The overall aims of this work were to use previously characterised in vitro systems 
to assess connexin expression in human urothelium and the contribution of gap 
junction-mediated intercellular communication to urothelial physiology, including 
barrier acquisition and wound repair.     
 
Specific objectives were to: 
 
 Characterise connexin family expression in human urothelium to identify 
connexins which may be closely associated with urothelial physiology and 
how expression of Cxs may be regulated during the development of a 
functional differentiated urothelium 
 
 Determine whether Cxs assemble into functional gap junctions in human 
urothelial cells 
 
 To examine whether specific connexins are involved in the generation of a 
differentiated urothelial phenotype, including the development of a 
functional urinary barrier 
 
 To study whether specific Cxs may contribute to the migratory and 
proliferative behaviour of human urothelial cells in response to wounding 





2. Materials and Methods 
2.1 General 
All experimental work was carried out in the Jack Birch Unit or Technology Facility 
in the Department of Biology, at the University of York.  TEM experiments were 
performed by Meg Stark and DNA plasmid sequencing by Celina Whalley, both in 
the Technology Facility, University of York.   
 
2.1.1 Suppliers 
Suppliers of reagents are indicated within this chapter, either at the first use of the 
reagent, or in table form for antibodies and drugs.  A full list of suppliers is detailed 
in Appendix 1.    
 
2.1.2 Lab Glassware, Plastic-ware and Accessories 
All glassware, glass Pasteur pipettes (Fisher Scientific), disposable microfuge tubes 
(Sarstedt), pipette tips (Starlab), metal dissection instruments (SLS) and glass 
multispot slides (C A Hendley) were sterilised by autoclaving at 121 oC for 
20 minutes.  Single use plastic-ware, Bijou tubes (Greiner), plastic Pasteur pipettes 
(SLS), Universal tubes and serological pipettes (Sarstedt) were supplied sterile for 
single use.  Coverslips used for all microscopy work were supplied by SLS (No. 1.5). 
 
2.1.3 Stock Solutions 
Recipes for all stock solutions are detailed in Appendix 2.  All chemicals were 
supplied by Fisher Scientific unless detailed otherwise.  General lab reagents were 
prepared using deionised water (dH2O), reagents for molecular and cell culture 
techniques were prepared using ultra-pure water from a Purelab (ELGA) ultraviolet 




for 20 minutes and non-heat stable solutions were sterilised by filtration through 
low-protein binding HT-Tuffryn syringe filters with 0.2 µm pore size (VWR). 
 
2.1.4 Antibodies 
All primary antibodies used (including source) are listed in Table 2.1.  For each 
application, primary antibodies were optimised by titration on known positive 
control samples to establish concentrations for use.  All antibodies were stored 
aliquotted at -80 oC to avoid freeze-thaw cycles and once thawed, aliquots were 
stored concentrated at 4 oC or diluted in TBS (Appendix 2) with 0.1 % (w/v) BSA as a 
protective protein and 0.1 % (w/v) sodium azide as a preservative.   
Secondary antibodies used (including relevant conjugate for detection and 
application purpose) are detailed in Table 2.2.  All secondary antibodies purchased 
were cross-adsorbed against human serum and human IgG.  Secondary antibodies 
were batch-tested using previously optimised primary antibody controls.  Neat 
stocks were stored in a light protective box at 4 oC and were diluted immediately 
before use.  Any background signal as a result of non-specific secondary antibody 
binding was assessed by exclusion of primary antibody from the reaction.            
 
2.1.5 Statistical Analysis 
All data represented by graphs in this thesis were produced using Microsoft Excel 
(2010).  Data are represented as a mean of all replicates ± standard deviation (SD) 
where appropriate.  Statistical tests performed throughout this thesis were 
performed using InStat software version 3 (GraphPad).  Data were confirmed to be 
drawn from normal distributions if appropriate.  Two-sample T-tests were used 
when comparing two sample means and one-way analysis of variance (ANOVA) 
tests were used when comparing more than two sample means (with appropriate 
post-tests selected).  Details of the number of replicates, statistical tests, p-values 










Connexin 32 5F9A9 M Life Technologies 32kD* 
Connexin 32 Ab59924 Rb Abcam 32kD* 
Occludin 71-1500 Rb Life Technologies 65kD 
E-Cadherin HECD-1 M Abcam 120kD 
ZO-1 1A12 M Life Technologies 220kD 
ZO-1α+ HP9044 Rb Hycult Biotech 225kD 
ZO-2 2874 Rb Cell Signaling 150kD 
ZO-3 D57G7 Rb Cell Signaling 140kD 
Claudin 4 3E2C1 M Life Technologies 22kD 
Claudin 5 4C3C2 M Life Technologies 24kD 
Claudin 7 ZMD.241 Rb Life Technologies 22kD 
β-actin AC-15 M Sigma 42kD 
CK7 OV-TL12/30 M Leica 51kD 
CK13 1C7 M Abcam 54kD 
Table 2.1  Primary Antibodies. 
M = Mouse  Rb = Rabbit *Note, connexion 32 dimeric bands were also 





Antigen Conjugate Host Supplier Supplier 
Ref. 
Application 
Mouse IgG biotin Rabbit DAKO E0354 IHC 
Rabbit IgG biotin Goat DAKO E0432 IHC 
Mouse IgG Alexa 488 Goat Life Technologies A11001 IF 
Mouse IgG Alexa 594 Goat Life Technologies A11005 IF 
Rabbit IgG Alexa 488 Goat Life Technologies A11008 IF 
Rabbit IgG Alexa 594 Goat Life Technologies A11012 IF 
Mouse IgG Alexa 680 Goat Life Technologies A21057 WB 
Rabbit IgG IR dye 
800 
Goat Tebu Bio 611-132-122 WB 
Table 2.2  Secondary Antibodies. 
IHC = Immunohistochemistry   IF = Immunofluoresence   WB = Western Blot 
 
2.1.6 Inhibitors, Agonists, Antagonists and Growth Factors 
Pharmacological reagents were prepared by reconstitution in fresh cell culture 
grade dimethyl sulphoxide (DMSO) or alternative vehicle (described in Table 2.3).  
Aliquots were stored in light protective boxes at -20 oC.  Drugs/growth factors 
which had previously been optimised for NHU cell treatment were used at 
published concentrations and previously untested treatments were tested over a 
concentration range to determine the effective dosage (see results chapters).  






Drug name Target Supplier Vehicle Working 
concentration 
Troglitazone PPARγ ligand R&D systems DMSO 1 µM 




DMSO 1 µM 
T0070907 PPARγ antagonist Cambridge 
Bioscience 
DMSO 1 µM 
Heptanol Uncouples gap 
junctions 








Sigma DMSO 5-50 µM 
SB431542 Inhibitor of TGFβRI Sigma DMSO 10 µM 
TGFβ1 
 
Cytokine/growth factor R&D systems 1 mg/ml 
BSA in 
4 mM HCl 
2 -4ng/ml 




2.2 Cell Culture 
2.2.1 General 
All cell culture work was performed using aseptic technique with work performed in 
class II laminar air flow safety cabinets with HEPA filters.  Work surfaces were 
cleaned with 70 % (v/v) ethanol before and after use.  Cultures were maintained in 
Heracell™ 240 Incubators (Heraeus®) at 37 oC in a humidified atmosphere of 5 % 
CO2 in air (for buffering of cells cultured in KSFMc) or 10 % CO2 in air (for all other 
media types).   
Culture medium was replaced on cell cultures every 2 or 3 days following vacuum 
aspiration of spent medium into a flask containing 10 % (w/v) Virkon® for 
decontamination.   
Centrifugation of cell suspensions was performed in a Sigma 2-6E compact 
centrifuge (SLS) at 400 x g for 5 minutes.  All cell counts were performed by 
pipetting 20 µl of a single cell suspension in to an “Improved Neubauer” 
haemocytometer (VWR).  Cells were counted in four grids (equivalent to 
0.0001cm3) and the mean cell count was multiplied by 104 to give an equivalent cell 
density per ml of medium.   
NHU cell cultures were maintained in Primaria® (BD Biosciences) or Cell+ plastic-
ware (Sarstedt), both of which have treated surfaces to promote attachment and 
growth of primary cells.   
Digital photomicrographs were generated by phase-contrast microscopy of cultures 





2.2.2 Primary Urothelial Cell Isolation and Sub-culture 
2.2.2.1 Tissue Samples 
Samples of normal human ureter, bladder and renal pelvis were collected following 
approval from the relevant local NHS Research Ethics Committee and the University 
of York Department of Biology Ethics committee.  Informed patient consent was 
obtained as required.  Samples were provided by surgeons at St. James’s University 
Hospital and Leeds General Infirmary (Leeds), Pinderfields Hospital (Wakefield), 
Castle Hill Hospital (Hull), and the Royal Hallamshire Hospital (Sheffield).  Patients 
were selected with no history of urothelial malignancy.  Biopsies were collected in 
15 ml sterile Transport Medium (Appendix 2) and were stored at 4 oC (or ambient 
temperature if delivered by post) until processed (see table 2.4 for details of tissue 
samples).  
 
2.2.2.2 Normal Human Urothelial (NHU) Cell isolation 
Previously described methods for urothelial cell isolation from patient biopsies 
were adopted to establish primary cultures (Southgate et al. 1994, Southgate J 
2002).  Samples were dissected in sterile Petri-dishes (Sterilin) using scissors and 
forceps to remove any excess fat and connective tissue.   A small representative 
sample was dissected with a scalpel and fixed for 24-48 hours in 10 % (v/v) formalin 
(Appendix 2) for histological assessment (section 2.5).  The remaining tissue was 
incubated in 10 ml Stripper Medium (Appendix 2) for 4 hours at 37 oC or for 16 
hours at 4 oC, before separation of the urothelial sheets from the underlying 
stromal tissue using sterile forceps.  Sheets were collected by centrifugation, 
resuspended in 400 units (in 2 ml) collagenase IV (Appendix 2) and incubated for 20 
minutes at 37 oC.  Cells were then triturated to encourage a single cell suspension, 
before centrifugation and seeding at 4x104 cells/cm2 in Keratinocyte Serum-free 
Medium (KSFM, Invitrogen), supplemented with 5 ng/ml recombinant human-EGF 




toxin (Sigma).  This complete KSFM (KSFMc) was used for all NHU cell culture work, 
unless detailed otherwise.    
 
2.2.2.3 Subculture of Normal Human Urothelial Cell Cultures   
At just confluence, NHU cell cultures were passaged by incubating in pre-warmed 
0.1 % (w/v) Ethylenediaminetetra-acetic acid (EDTA) in PBS for 3-5 minutes at 37 oC, 
until cell contacts were separated and cells began to round up.  The EDTA was then 
replaced with a 0.25 % (w/v) trypsin versene solution in Hank’s balanced salt 
solution (HBSS; Life Technologies) containing 0.02 % (w/v) EDTA.  Cultures were 
incubated at 37 oC until cells detached from the plastic (approximately 2-4 minutes) 
and were then collected into KSFMc containing 1.5 mg/ml trypsin inhibitor (from 
soybean), centrifuged and re-plated at the desired density.  NHU cultures were split 
at a ratio of 1:3 for routine maintenance.  For all experimental work, cultures were 
used between passage 1 and 5.  The independent NHU cell lines used in this thesis 




















































































Cell Line Tissue Derived Donor Age Donor Gender Surgical Procedure 
Y1057 Ureter Unknown Unknown Unknown 
Y1117 Ureter 64 Female Unknown 
Y1119 Ureter 65 Female Unknown 
Y1151 Ureter 31 Female Nephrectomy 
Y1185 Ureter 45 Female Unknown 
Y1247 Ureter 67 Female Nephrectomy 
Y1270 Ureter 76 Female Nephrectomy 
Y1277 Renal Pelvis 68 Female Pyeloplasty 
Y1284 Ureter 64 Female Nephrectomy 
Y1392 Ureter 60 Male Kidney Transplant 
Table 2.4b  Origin of NHU cell lines (Transduction studies). 
 
2.2.2.4 Culture of Transduced Human Urothelial Sublines 
NHU cells were transduced with retrovirus to genetically manipulate connexin-32 as 
described in section 2.9.  Transduced cultures were maintained in an identical 
manner to NHU cells, with the exception that the KSFMc contained a maintenance 
dose of antibiotic (0.025 mg/ml for G418 and 0.25 µg/ml for puromycin), to 





2.2.3 Differentiation of NHU cultures In Vitro  
2.2.3.1 Differentiation of NHU cultures by pharmacological activation of PPARγ 
and inhibition of EGFR signalling 
A previously described pharmacological treatment was used to induce 
cytodifferentiation of human urothelial cells (Varley et al. 2004a, Varley et al. 
2004b). NHU cultures were cultured to approximately 70-80 % confluence before 
replacing the growth medium with KSFMc containing the PPARγ agonist 
troglitazone at a final concentration of 1 µM and the EGFR inhibitor PD153035 at a 
final concentration of 1 µM.  The troglitazone/PD153035 treatment was maintained 
for 24h before replacing the growth medium with KSFMc containing 1 µM 
PD153035 alone and maintaining for a further 6 days, with a single medium change 
at day 3.  Vehicle control cultures were treated with an equivalent concentration of 
DMSO (without troglitazone or PD153035) to balance for any solvent-driven cellular 
effects.  See summary diagram (Fig 2.1). 
 
2.2.3.2 Differentiation of NHU cultures using 5% bovine serum and physiological 
calcium 
NHU cultures were functionally differentiated using a previously described method 
which induces a differentiated urothelial phenotype with tight barrier properties 
(Cross et al. 2005).  NHU cultures were grown to approximately 80 % confluence 
before replacing the growth medium with KSFMc containing 5 % (v/v) batch-tested 
Adult Bovine Serum (ABS; Harlan Sera-lab) for 4-5 days at 37 oC.   Cultures were 
then harvested and re-seeded onto Snapwell™ membranes at 5x105 cells per 1.1 
cm2 membrane (see section 2.8.1) or at a 1:2 ratio into fresh flasks (for protein or 
RNA lysates), 24-well plates (CA Hendley; time-lapse analysis) or 12-well multi-spot 
slides (immunocytochemistry) in KSFMc containing 5 % ABS.  After 24h, the growth 
medium was replaced with KSFMc containing 5 % ABS and 2 mM CaCl2 (final 
concentration).  Cultures were then maintained for a further 6 days (unless 




maintained in KSFMc alone, or treated with 2 mM calcium alone for a matched time 
period.   For summary diagram see Fig. 2.1. 
 
 
Figure 2.1  Summary of two methods used to induce differentiation of NHU cells in 
vitro. 
Summary of the two in vitro methods used to induce differentiation of NHU cultures as 
detailed in section 2.2.3.  Selected genes which are upregulated or down regulated in non-
differentiated and differentiated (both models) NHU cells are indicated (up and down 
arrows indicate up- or down-regulation respectively).   
TZ = the PPARγ agonist, troglitazone.  PD = the EGFR inhibitor, PD153035.  ABS = Adult 
bovine serum 
Note: The ABS/Ca2+ model was the preferred method of differentiation throughout this 
thesis, since this method supports barrier acquisition, which can be measured by TER.  
However, the factors in serum which induce differentiation are undefined. The TZ/PD 
model uses pharmacological activation of PPARγ to initiate the urothelial gene activation 
pathway in individual cells, however these cells do not self-organise into a multi-layered, 
barrier-forming epithelium.   The TZ/PD model was therefore only used in experiments 




2.2.4 Culture of Retropack™ PT67 Packaging Cells 
The 3T3 fibroblast-derived PT67 cell line (Clontech) has been genetically engineered 
to stably express the retroviral gag, pol and env genes necessary for retroviral 
particle production and replication.  PT67 cells were maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10 % (v/v) Fetal Bovine 
Serum (FBS; Harlan Sera-lab)) and 1 % (v/v) L-glutamine, in tissue culture flasks 
(Corning).  PT67 cultures were routinely passaged with a split ratio of 1:5, following 
the same method as for NHU cells (section 2.2.2.3), however the trypsin inhibitor 
step was not required due to the presence of serum in the growth medium. 
Before use for transfection, a stock of PT67 cells was subjected to “HAT” selection, 
as recommended by the manufacturer, by culture for 5 days in 100nM aminopterin, 
followed by 5 days in DMEM-HAT medium (30nM hypoxanthine, 1M aminopterin 
and 20mM thymidine) and then a further 5 days in DMEM-HT medium (30mM 
hypoxanthine and 20mM thymidine).  Following transfection, PT67 cells were 
continuously maintained in the relevant antibiotic at the selection concentration (as 
detailed in section 2.9.4).  
 
2.2.5 Cryopreservation and Thawing of Cells 
Just confluent cultures were harvested with EDTA and trypsin as described for cell 
passaging, however following centrifugation, cells were resuspended in cold 
“freeze-mix” which comprised 10 % (v/v) FBS and 10 % (v/v) DMSO, in the normal 
culture medium for the cell type.  Cells were aliquotted as a 1:3 split ratio into 
polypropylene cryovials (Sarstedt), with 1 ml freeze-mix used per vial.   Vials were 
placed in an isopropanol freezing chamber (Nalgene) at -80 oC for 16 h.  This allows 
cells to cool at a steady rate of -1 oC per minute.  The following day cryovials were 
transferred into a liquid nitrogen dewar for long-term storage.   
To thaw cells, cryovials were removed from liquid nitrogen and immediately placed 




growth medium before centrifugation, resuspension in fresh growth medium and 
plating at the desired density.   
 
2.2.6 Screening for Mycoplasma spp. 
Cultures were routinely checked for infection by Mycoplasma spp. using a DNA 
staining method to examine cells for extranuclear contamination.  Cells were 
seeded onto 12-well glass slides at a density of 1x105 cells/ml (50 µl/well) and left 
to attach for 4 h before flooding with medium and incubating overnight.  Slides 
were then washed twice in Phosphate Buffered Saline (PBS; Appendix 2), fixed for 
30 seconds in a 1:1 mixture of methanol:acetone and air dried.  Slides were 
incubated with 0.1 µg/ml Hoechst 33258 in PBS, for 5 minutes whilst protecting the 
slide from light with aluminium foil.  Slides were washed once in PBS, air dried and 
mounted in antifade (Appendix 2) before sealing the coverslip with clear nail polish.  
Cells were examined for extranuclear DNA, under epifluoresence illumination using 
an Olympus BX60 microscope.  
 
2.3 Cell Proliferation Assays 
The biomass of cell cultures was assessed using AlamarBlue®, a reagent that 
undergoes a colourimetric change in response to cell metabolism and which can be 
used to estimate changes in population mass (based on relative change) or number 
(following comparison against a standard curve).  The assay detects reduction of all 
elements of the electron transport chain and works on the assumption that 
mitochondrial activity is directly proportional to cell number.    
NHU cells were seeded at a density of 2x103 cells/well into Primaria® 96-well plates 
and allowed to attach for 18 hours overnight in the incubator.   The following day, 
one plate was assayed to establish initial seeding viability (day 0), whilst the growth 
medium in the remaining plates was replaced, either with fresh KSFMc, or 




determine the relative number of proliferating cells, growth medium was replaced 
with 200 µl of freshly prepared 10 % (v/v) AlamarBlue® reagent (diluted in pre-
warmed KSFMc) in six replicate wells, including empty (no cell) control wells,  
before returning to the incubator for exactly 4 hours.  The absorbance of samples 
was measured at 570 nm and 600 nm using a Multiskan Ascent 96-well plate 
spectrophotometer (Thermo Scientific).  The absorbance readings were directly 
proportional to the mitochondrial activity within the cells and were taken to be 
directly proportional to viable cell number.  The percentage reduction of 
AlamarBlue® was calculated from the absorbance values using the following 
equation: 
Percentage Reduction =  (O2 x A1) – (O1 x A2)    x100 
    (R1 x N2) – (R2 x N1) 
Where:  
O1 = molar extinction coefficient (E) of oxidized AlamarBlue® (Blue) at 570 nm, a 
constant value of 80586 
O2= E of oxidized AlamarBlue® at 630 nm, a constant value of 34798  
R1 = E of reduced AlamarBlue® at 570 nm, a constant value of 155677 
R2= E of reduced AlamarBlue® at 630 nm, a constant value of 5494 
A1 = absorbance of test wells at 570 nm  
A2 = absorbance of test wells at 630 nm  
N1 = absorbance of negative control well (medium plus AlamarBlue® but no cells) at 
570 nm 





2.4 Cell-Cell Communication Assays  
2.4.1 Lucifer Yellow / Rhodamine-Dextran method 
NHU cells were seeded at 4x104 cells/well (2 cm2) and cultured to confluence in 
Primaria® 24-well plates.  If required, cultures were treated with drugs or 
differentiated with troglitazone and PD153035.  For the dye-transfer assay, cultures 
were rinsed twice in PBS before applying 200 µl of KSFMc containing 1 mM lucifer 
yellow (LY; MW = 457.25 Da) and 0.5 mg/ml rhodamine dextran (RhoD; MW=3000 
Da) (both Life Technologies).  Both dyes are fixable to lysine residues within the cell 
and therefore dye-transfer is halted upon formalin fixation.  From this stage on, 
cells were protected from light using aluminium foil.   
A single horizontal scratch was performed across each well with a 21 gauge needle 
to temporarily perturb cell membranes along the scratch region and permit uptake 
of dye.  Cultures were then incubated for exactly 6 minutes in a 37 oC incubator to 
permit dye transfer.  Each culture was then washed twice with ice-cold PBS and 
fixed in 1 ml 10 % (v/v) formalin (Appendix 2) for 10 minutes at ambient 
temperature before rinsing in PBS.  Cells were then incubated with 0.1 µg/ml 
Hoechst 33258 in PBS, for 5 minutes, rinsed in PBS and stored in 1 ml fresh PBS for 
imaging.  LY, RhoD and Hoechst 33258 labelled cells were visualised along the 
scratch wound by epifluoresence on an Olympus IX81 motorized inverted 
microscope.  To evaluate the level of gap junctional intercellular communication 
(GJIC), dye-coupled cells on either side of the scrape line were counted from 
micrographs taken from 5-10 fields of view per well.  Fluorescent images were 
analysed using TissueQuest v4.0 software (TissueGnostics).  Individual cells were 
identified using the “nuclear mask” function which distinguishes cells based on the 
Hoechst 33258 stain.  The software was then used to perform counts to determine 
the number of RhoD positive cells (in red) and the number of LY positive cells (in 
green), after manual setting of a background threshold for each channel.   For each 
field of view the number of LY cells observed per initially-loaded RhoD cell was 
calculated.  Mean values were taken to be proportional to the gap-junction 




2.5 Histological Analysis 
2.5.1 Fixation 
Tissue specimens or cell sheets were immersed in 10 % (v/v) neutral-buffered 
formalin (Appendix 2) for 24-48 hrs or 16 h respectively, in 30 ml universal 
centrifuge tubes at ambient temperature before transferring to 70 % ethanol for 
storage.   
 
2.5.2 Embedding 
Fixed tissue samples or cell sheets were placed into labelled embedding cassettes 
(CellPath).  Very small biopsies or cell sheets were placed into a CellSafe mesh 
biopsy capsule (CellPath), within an embedding cassette to prevent tissue loss.  
Labelled cassettes were submerged in fresh 70 % (v/v) ethanol for 10 minutes on an 
orbital shaker, followed by 10-minute incubations on the orbital shaker with 100 % 
ethanol (repeated for a total of 3 washes), propan-2-ol (repeated for a total of 2 
washes) and finally xylene (repeated for a total of 4 washes), to clear tissues of 
alcohol and allow wax penetration into the tissue.  Tissues were then immersed in 
liquid paraffin wax (Thermo Scientific) at 60 oC for 15 minutes, followed by three 
further 15 minute incubations in fresh liquid paraffin wax, before orienting biopsies 
in embedding moulds filled with paraffin wax and setting on a cool plate (Raymond 
A Lamb) at -12 oC.  
 
2.5.3 Sectioning 
5 µM sections were cut using a Leica RM2135 rotary microtome.  Sections were 
floated onto water at 40 oC to remove creases, before collection onto charged 
Superfrost microscope slides (Fisher Scientific).  Slides were air-dried and stored for 
up to month at ambient temperature (or 6 months under vacuum), before use for 





2.5.4 Haematoxylin and Eosin Staining 
Tissue sections were de-waxed by incubation in fresh xylene for 1 minute, followed 
by three further xylene incubations for 1 minute each.  Tissues were then 
rehydrated by submersing in 100 % ethanol for three washes (one minute each), 75 
% ethanol for one minute followed by rinsing in gently running tap water for 1 
minute.  Tissues were then immersed in Mayer’s Haematoxylin (Appendix 2) for 2 
minutes, before rinsing in running tap water for 1 minute, incubating in Scott’s Tap 
Water (Appendix 2) for 1 minute and then briefly rinsing in tap water before 
staining tissues with 1 % Eosin solution (Raymond A Lamb) for 30 seconds.  Slides 
were rinsed thoroughly in tap water and then dehydrated in 70 % ethanol for 1 
minute, 100 % ethanol for 3 x 1 minute, before clearing in xylene for 2 x 1 minute.  
Sections were mounted in DPX mountant and a coverslip applied to each slide.  
Slides were examined by bright field microscopy using an Olympus BX60 
microscope. 
 
2.5.5 Transmission Electron Microscopy (TEM) 
All TEM analysis was performed by Meg Stark in the Technology Facility.  Cell sheets 
were grown on permeable Snapwell™ membranes and Transepithelial electrical 
resistance readings were taken (see section 2.8.1 for details).  Snapwell™ 
membranes were released from their detachable supports using a disposable 
scalpel before placing into a glass vial containing fixative comprising 2.5 % (v/v) 
glutaraldehyde, 4 % (v/v) formaldehyde in 100 mM phosphate buffer (pH 7.6) for 90 
minutes at ambient temperature.  Membranes were placed in a solution of 1 % 
(w/v) osmium tetroxide for 1 h on ice to preserve the lipid composition of the cells 
and enhance specimen contrast for TEM.  Membranes were dehydrated through a 
series of 25 %, 50 %, 70 %, 90 % and 100 % ethanol for 20 minutes each, followed 
by 20 minutes in neat 1,2-propylene oxide and then through a series of 1,2-
propylene oxide:epon araldite resin (Agar Scientific), at ratios of 25:75, 50:50, 75:25 
and finally 100 % resin, for 30 minutes each.  Membranes were orientated into 




Sections cut at 1 µm thickness for light microscopy and mounted onto glass slides 
and 70 nm for TEM and mounted onto square mesh TEM grids, using a Leica 
Ultracut UCT microtome.  For light microscopy, section were stained with a solution 
of 0.6 % (w/v) toluidine blue and 0.3 % (w/v) sodium carbonate and mounted in 
water before applying a coverslip and imaging on Olympus BX60 microscope.  For 
TEM, sections were stained with a saturated solution of uranyl acetate in 50 % (v/v) 
ethanol for 1 minute, rinsed in dH20 and stained with Reynold’s lead citrate for 30 





2.6 Analysis of gene expression 
2.6.1 General 
All RNA work was performed on a designated bench and RNAseZap® wipes 
(Ambion) were used to clean bench, pipettes & gloves before working.  
DNAse/RNAse-free filter pipette tips (Starlab) and 1.5 ml tubes (Ambion) were used 
for all RNA and DNA work.  For RNA extraction, 15 ml polypropylene tubes and caps 
(Sarstedt) were treated overnight with a solution of 0.1 % (v/v) diethyl 
polycarbonate (DEPC) at ambient temperature to remove RNAse activity, before 
autoclaving to destroy the DEPC and drying.   
 
2.6.2 RNA isolation 
Cultures were grown in 25 cm2 or 75 cm2 culture flasks or 10 cm (diameter) dishes 
as required.  Following treatments or at the desired confluence or time point, the 
culture medium was aspirated and cells were solubilised by addition of 2.5 ml (25 
cm2 flask) or 5 ml (75 cm2 flask or 10 cm dish) TRIzol® Reagent (Life Technologies).    
Plastic cell scrapers were used to remove any remaining cells from culture flasks 
and lysates were collected into 15 ml DEPC-treated polypropylene tubes and stored 
at -70oC.  Lysates were thawed on ice and then incubated at ambient temperature 
for 5 minutes to allow for complete dissociation of nucleoprotein complexes.  0.2 
ml of chloroform was added for each 1 ml of TRIzol® Reagent used and each tube 
was vortexed for 15 seconds followed by incubation at ambient temperature for 
3 minutes to allow phase solubilisation of RNA.  Tubes were centrifuged at 12,000 x 
g for 15 minutes at 4 oC to enable phase-separation and the RNA-containing 
aqueous phase was carefully collected into a fresh DEPC-treated polypropylene 
tube, avoiding any contamination from the white interphase (DNA containing) and 
the pink phenol-chloroform phase (protein and lipid containing).  RNA was 
precipitated by addition of 0.5 ml isopropanol for each 1 ml of TRIzol® Reagent used 
for lysis.   Tubes were gently shaken before incubating for 10 minutes at ambient 
temperature followed by centrifugation at 12,000 x g for 20 minutes at 4 oC.  The 




original lysis volume.  Tubes were vortexed to remove salt contaminants and 
centrifuged at 7,500 x g for 5 minutes at 4oC.  The ethanol was gently poured off 
and the RNA pellet air-dried before resuspending in 20 µl (from a 25 cm2 flask) or 
30 µl nuclease free water (from a 75 cm2 flask or 10 cm dish) and storing at -80 oC. 
 
2.6.3 DNAse treatment of RNA 
To remove any contaminating DNA from RNA samples, a DNase treatment was 
performed using the DNA-free™ kit (Ambion).  1 µl DNase enzyme and 0.1 volume 
of x10 DNase buffer was added to each sample before gently mixing and incubating 
at 37 oC for 30 minutes.  The “DNase inactivation reagent” was resuspended by 
vortexing for 1 minute before adding 5 µl to each RNA sample, which was then 
incubated for 2 minutes at ambient temperature before centrifugation at 10,000 x g 
for 1 minute.  The DNA-free supernatant was transferred to a new 1.5 ml tube and 
the RNA concentration and quality was determined using a NanoDrop™ UV 
spectrophotometer.  RNA samples were stored at -80 oC.   
 
2.6.4 cDNA synthesis 
DNAse-treated RNA was reverse transcribed using the SuperScript®II First-Strand 
Synthesis System (Life Technologies).  50 ng random hexamer primers were 
annealed to 1 µg RNA at 65 oC for 10 minutes, before placing on ice and adding a 
master mix which gave final concentrations of 2.5 mM MgCl2, 10 mM DTT, 1 mM 
dNTP mix and 1 x “RT buffer”.  Each reaction was then incubated at 25 oC for 2 
minutes before adding 50 units of SuperScript®II reverse transcriptase enzyme.  An 
enzyme-negative (“RT negative”) control was included for each sample to assess for 
DNA contamination.  Reactions were incubated for 50 minutes at 42 oC and then 
15 minutes at 70 oC to inactivate the reverse transcriptase.  The resulting cDNA was 





2.6.5 Reverse-transcription Polymerase Chain Reaction (RT-
PCR) 
2.6.5.1 Primer Design 
Transcripts for the genes of interest were identified using “Ensembl Genome 
Browser” and primers were designed to the selected mRNA sequences using 
Primer3 (v.0.4.0) software.  For each gene of interest, protein-coding splice variants 
were aligned using EMBL-EBI ClustalW2 sequence alignment programme, to select 
identical regions and primers were designed within these regions using Primer 3 
software. Each set of primers were subjected to a search using Primer BLAST 
software to ensure target specificity.  All primer sequences are detailed in Appendix 
3.  Since expression of some connexin transcripts are rare or tissue-specific, 
connexin primers were designed within exons to enable use of genomic DNA as a 
positive control.  Other primers were designed either within an exon or spanning 
two exons, based on optimal annealing predictions from Primer 3.   
 
2.6.5.2 RT-PCR  
All RT-PCR reactions were performed using a T100™ Thermal Cycler (Bio-Rad) and 
the GoTaq® Hot Start Polymerase system (Promega). In 0.2 ml PCR tubes (Star Lab), 
1 µl cDNA sample was added to 19 µl PCR master mix comprising 1 x GoTaq® Flexi 
Buffer, 2.5 mM MgCl2, 0.2 mM of each dNTP (Life Technologies), 10 µM forward 
and reverse primers and 0.5 units of GoTaq® Hot Start Polymerase enzyme, made 
up in nuclease-free dH2O.  PCR reactions were performed in the thermal cycler as 
follows: 5 minutes at 95 oC, followed by a suitable number of cycles at 95 oC for 30 
sec, optimum annealing temperature for 30 sec and a 72 oC extension for 30 sec.  A 
final extension step at 72 oC was performed for 10 minutes.  To determine the 
optimal annealing temperature of each primer set, a temperature gradient PCR 
reaction was performed using a positive control sample; cDNA from pooled human 
cell line total RNA (Ambion), where primers flanked intronic regions, or human 




temperature range of 55-62oC was tested for each primer pair (optimal annealing 
temperatures are detailed in Appendix 3).  RT-PCR reaction controls included were; 
an RT-negative for each cDNA sample, a non-template (cDNA negative) control and 
a positive control of genomic DNA or pooled total cDNA, as appropriate.  Primers 
which amplify the house-keeping genes GAPDH or β-actin were included to 
demonstrate equivalent loading and where necessary, primers which amplify 
differentiation-associated genes such as Uroplakin IIIa (UPK3a) were included to 
confirm successful in vitro differentiation of NHU cells.   
 
2.6.5.3 DNA Gel Electrophoresis 
Gels were prepared by boiling 0.75-4 % (w/v) agarose in a 1 x TBE buffer (Appendix 
2).  The percentage of agarose in each gel was selected to allow for best resolution 
based on amplicon length.  SYBR® Safe DNA gel stain (Life Technologies) was added 
to the liquid agarose at a dilution of 1:10,000 before pouring into a gel cast and 
removing any bubbles which collected using a pipette tip.  Gels were set at ambient 
temperature for at least 30 min before submerging in 1 x TBE in a gel 
electrophoresis tank.  In the first lane of each gel, 5 µl DNA ladder was loaded to 
allow estimation of amplicon size; using either Hyperladder™ 100 bp (Bioline) 
where amplicon length was less than 500 bp, or GeneRuler™ 1 kb (Thermo 
Scientific) for larger products.  10 µl PCR product was loaded in the remaining lanes 
and gels were run at 100 V for 1 h, before imaging on a GeneGenius gel imaging 
system with GeneSnap software (Syngene).  
 
2.6.6 Quantitative RT-PCR (qRT-PCR) 
Quantitative or real-time PCR measures the accumulation of PCR products as it 
occurs (i.e. in real time).  SYBR® Green I Dye binds only to double-stranded DNA 
(dsDNA), where it emits a fluorescent signal proportional to the accumulation of 
PCR product.  1 µl template cDNA was mixed with 300 nM of target gene forward 




Biosystems) which contained SYBR® Green I dye, AmpliTaq Gold® DNA polymerase, 
dNTPs and buffer components (including a passive reference ROX, which did not 
bind to DNA).  Each PCR reaction was loaded in triplicate into a clear optical 96-well 
reaction plate, which was sealed with an optical adhesive cover (both Applied 
Biosystems) before centrifugation.  Reactions were performed in an ABI Prism® 
7900HT Sequence Detection System and analysed with Sequence Detection System 
software v2.2 (both Applied Biosystems).  The thermal profile used was 95 oC for 10 
minutes, followed by 40 cycles of denaturation for 15 seconds at 95 oC and 
elongation for 1 minute at 60 oC. During each cycle the ABI Prism® detected 
fluorescence of the SYBR® Green I dye which was normalised against the ROX 
fluorophore to account for any changes in plate fluorescence which were not linked 
to product amplification.  To verify that single products were formed, a final stage 
“melt-curve” was included to examine the melting profiles of PCR products, which 
involved three incubations at 95 oC, 60 oC and finally 95 oC for 15 seconds each.  For 
each experiment, controls were performed in triplicate consisting of; an RT-
negative for each cDNA sample, a non-template (cDNA negative) control and a 
positive control of genomic DNA or pooled total cDNA, as appropriate.  Primers 
which amplified the house-keeping gene GAPDH or β-actin were included to check 
loading and where necessary, primers which amplify the early differentiation-
associated gene Aquaporin 3 (AQP3) were included to confirm successful in vitro 





2.7 Protein Analysis 
2.7.1 Immunohistochemistry on paraffin wax-embedded 
sections 
Formalin-fixed paraffin-wax embedded sections of tissues or cell sheets (see 2.5) 
were de-waxed at ambient temperature by incubating twice in fresh xylene for 10 
minutes each, followed by two further xylene incubations for 1 minute each.  
Tissues were then gradually rehydrated by submersing in 100 % ethanol for three 
washes (one minute each), 75 % ethanol for one minute followed by rinsing in 
gently running tap water for 1 minute.  
To quench endogenous peroxidase activity from red-blood cells, tissue biopsies 
were incubated in 3 % (v/v) hydrogen peroxide solution for 10 minutes at ambient 
temperature before gentle rinsing in running tap water for 10 minutes.  This step 
was omitted for labelling cell sheets due to the lack of endogenous peroxidase 
activity. 
Antigen retrieval was performed  by placing slides in a Pyrex® dish containing 350 
ml of citric acid buffer, pH 6.0, or 350 ml Tris-EDTA buffer, pH 9.0 (Appendix 2).  The 
Pyrex dish was covered in Saran™ food wrap to prevent evaporation and slides 
were microwaved for 13 minutes at 900 W (to allow for 10 minutes boiling time), 
before cooling on ice for 10 minutes.  Slides were inserted into Shandon Sequenza® 
slide racks using coverplates, which allowed for the application of reagents which 
are held over the specimen until displaced by the next reagent or wash buffer.  
Slides were washed twice in TBS (Appendix 2) wash buffer before applying 100 µl 
avidin blocking reagent for 10 minutes, followed by briefly washing in TBS and 
applying 100 µl biotin blocking reagent for 10 minutes (both Vector Labs), to block 
endogenous biotin-binding sites within the tissue.  After briefly rinsing in TBS, 100 
µl of 10 % (v/v) serum from the same species that the secondary antibody was 
generated in (see table 2.2), was applied to each slide for 5 minutes at ambient 
temperature.  Primary antibodies were diluted in TBS before applying 100 µl to 
each slide and incubating for 16 h at 4 oC.  For each experiment a negative (primary 




was used as a method control.  Primary and secondary antibodies were titrated on 
control tissues to optimise the signal to noise ratio and verify specific labelling.  
After two washes in TBS to remove primary antibody, biotinylated secondary 
antibodies (table 2.2) diluted in TBS were applied for 30 minutes at ambient 
temperature before washing twice in TBS.  100 µl of pre-mixed avidin/biotinylated-
HRP complex (Vector labs) was applied to each slide for 30 minutes, which was 
prepared by mixing 40 µl streptavidin, 40 µl biotinylated horseradish peroxidase in 
2.5 ml TBS.  Slides were washed once in TBS and once in dH2O, before preparing the 
3,3’-diaminobenzidine (DAB) substrate by dissolving Sigmafast™ DAB tablets in 5 ml 
dH2O.  200 µl DAB was added to each slide for 10 minutes, before washing in dH2O.  
Slides were removed from the Shandon Sequenza® slide rack and counterstaining in 
Mayer’s haematoxylin for 10 seconds (Appendix 2). Slides were then rinsed 
thoroughly in tap water and dehydrated in 70 % ethanol for 1 minute, 100 % 
ethanol for 3 x 1 minute, before clearing in xylene for 2 x 1 minute.  Sections were 
then mounted in DPX and coverslips applied.  Slides were examined by bright field 
microscopy on an Olympus BX60 microscope and digital micrographs were 
collected. 
 
2.7.2 Indirect Immunofluorescence Microscopy 
2.7.2.1. Slide Preparation 
Sterilised 12-well glass slides (C.A.Hendley Ltd, Essex) were placed in 4-slide 
quadriPERM® culture dishes (Sarstedt).  NHU cells were seeded at 5x103 cells per 
well (0.38 cm2) and left to attach at 37 oC for 4 hours before flooding with 5 ml 
KSFMc and left to grow at 37 oC overnight. Cells were cultured to the desired 
density before treating with differentiating or pharmacological agents (as explained 
in captions).  Cells were washed twice briefly in PBS, and fixed either by: 
a) Flooding slides for 30 seconds in a 1:1 mixture of methanol and acetone 
before air-drying.  Slides were either used immediately for immunolabelling or 





b) Flooding slides for 10 minutes in 10 % formalin in PBSc (Appendix 2).  
Formalin-fixed slides were washed twice in PBS for 5 minutes and used 
immediately for immunolabelling or stored in PBS at 4 oC for up to 1 week.  
Immediately prior to labelling, slides were permeabilised by incubation in 0.5 
% (w/v) Triton™ X-100 in PBS.   
Selection of fixative was based on choice of antibody, due to the susceptibility for 
damage or epitopes masking.  
 
2.7.2.2 Immunocytochemistry 
A grease pen (Cell Path) was used to outline each well of the 12-well slide to 
prevent antibodies from merging. Primary antibody was diluted in TBS containing 
0.1 % (w/v) BSA and 0.1 % sodium azide for preservation.  25 µl of primary antibody 
was applied to each well and incubated at 4 oC overnight in a humidified chamber.  
For each experiment a negative (antibody diluent) control was included and anti-
CK7 was used as a positive (method) control.  After washing 3 times for 5 minutes in 
PBS on an orbital shaker, slides were incubated with Alexa-488 or 594-conjugated 
Goat anti-Rabbit IgG or Goat anti-Mouse IgG secondary antibodies (Table 2.2) for 1 
hour at ambient temperature.  All slides were protected from light from this stage 
on using aluminium foil.  Slides were washed twice in PBS containing 0.25 % (w/v) 
Tween®20 for 5 minutes on an orbital shaker before counterstaining nuclei with 
PBS, containing 0.1 µg/ml Hoechst 33258 for 5 minutes.  Slides were then rinsed in 
PBS for 5 minutes and then in dH2O for 5 minutes before mounting in antifade 
mountant (Appendix 2).  Since the mountant was non-setting, coverslips were 
sealed with clear nail varnish.  Slides were examined by epifluorescent microscopy 






2.7.3.1 Protein extraction 
Cells were cultured in 25 cm2 flasks or 6 cm dishes according to the experimental 
plan. Cultures were briefly washed twice in ice-cold PBS before lysis under reducing 
conditions in 2 x SDS sample buffer, supplemented with 0.2 % DTT and 1 x protease 
inhibitor cocktail set III (Sigma). 100 µl lysis buffer was applied to each culture and 
lysates were harvested by scraping into ice-cold microfuge tubes using rubber cell 
scrapers (Sarstedt).  Lysates were sonicated on ice for two 10 second bursts, with a 
10 second rest on ice in-between, using a sonic probe at 25 W (Jencons) which was 
cleaned with 70 % ethanol between samples. Samples were incubated on ice for 
30 minutes before micro-centrifugation at 25,000 g for 30 minutes at 4 oC.  
Supernatants were aliquotted into clean, ice-cold microfuge tubes and either stored 
at -20 oC or immediately processed for protein quantification.   
 
2.7.3.2 Protein Quantification 
The protein concentration of lysates was measured using a Coomassie® protein 
assay kit (Pierce).  Samples were diluted in 1/12.5 in dH2O, and 10 µl of each diluted 
sample was added in duplicate to a 96-well plate.  10 µl aliquots of BSA of known 
protein concentrations were applied in duplicate to the 96-well plate to generate a 
standard curve from which unknown protein concentrations could be calculated 
(BSA supplied at 2 mg/ml from Pierce).  To each well, 200 µl of Coomassie reagent 
was added, taking care not to introduce air bubbles.  96-well plates were shaken for 
30 seconds in a Multiskan Ascent® plate reader (Thermo-scientific) and the 
absorbance of samples was measured at test and reference wavelengths of 570nm 
and 630 nm respectively against a blank H2O control.  The Ascent software (version 
2.6) was used to estimate the protein concentration of samples by comparison with 






2.7.3.3 Protein separation by SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE is a technique used to separate linear proteins in a gel on the basis of 
size.  Heating of samples in SDS (with addition of reducing agent) disrupts the 
tertiary structure of proteins (linearises) whilst coating the protein with a uniform 
negative charge, so that movement through the gel with current applied is based 
purely on size.  SDS protein lysates were prepared for gel separation under reducing 
conditions to maintain proteins in a reduced state.  15 µg of protein sample was 
added to 4 x NuPAGE® LDS sample buffer and 10 x NuPAGE® sample reducing agent 
(each to a final 1 x dilution), in 1.5 ml tubes with addition of dH2O as required to 
ensure loading volumes for each well were identical, before heating the mixtures to 
70 oC for 10 minutes to denature proteins and micro-centrifuging briefly to collect.  
NuPAGE® 4-12 % bis-Tris or 3-8 % Tris-acetate gels were selected for SDS-PAGE, 
depending on the molecular weight of the protein to be probed, with Tris-acetate 
gels used for larger proteins (>100 kD).  NuPAGE® pre-cast gels contain a “stacker” 
gel at the top to concentrate proteins to ensure that they collectively enter the 
running gel.  The running gel is manufactured as a gradient gel, to improve band 
resolution (by ensuring optimal band separation over a wide range of molecular 
weights).  Protein samples were loaded into the pre-cast wells at the top of each gel 
which was positioned into an XCell SureLock™ electrophoresis tank, containing 800 
ml of 1 x NuPAGE® MOPS or Tris-acetate running buffer, with 200 µl NuPAGE® 
antioxidant added to the inner chamber.  All NuPAGE® reagents and 
electrophoresis equipment was purchased from Life Technologies.  Electrophoresis 
was performed at 200 V (for bis-tris) or 150 V (for tris-acetate) to separate proteins 
by according to size, for 1 h at ambient temperature.  6 µl Precision Plus Protein™ 
ladder (BioRad) was added to the first well in each gel to allow for estimation of 
protein size.   
 
2.7.3.4 Western Blotting 
Immobilon®-FL PVDF membranes (Merck-Millipore) were trimmed to size before 




in western blot transfer buffer (Appendix 2).  A gel-membrane “sandwich” was 
assembled into an XCell II™ blot module (Life Technologies) with filter paper and 
blotting pads according to the manufacturer’s protocol, ensure that the gel and 
membrane were fully contacted and taking care not to introduce air bubbles.  The 
inner chamber of the blot module was filled with transfer buffer and the module 
was positioned in a tank containing tap water which was surrounded by an ice pack 
to prevent overheating during transfer.  Resolved proteins were electro-transferred 
from gel to membrane at 30 V for 3 h, after which membranes were briefly 
incubated in a solution of 0.5 % (w/v) Ponceau red in dH2O and rinsed thoroughly in 
dH2O, to enable visualisation of protein bands to check for successful transfer, 
equal loading and any air bubbles which may have interfered with transfer.   
 
2.7.3.5 Immunolabelling 
Non-specific binding by secondary antibodies was minimised by incubating 
membranes for 1 h at ambient temperature in blocking solution, with 50 % (v/v) 
Odyssey® blocking buffer (LI-COR) in TBS.  Membranes were probed with rabbit or 
mouse primary antibodies (table 2.1), diluted in 50 % (v/v) Odyssey® blocking buffer 
in TBS + 0.5 % Tween®20 and incubated for 16 h on an orbital shaker at 4 oC.  After 
washing in TBS for 4 x 5 minutes, primary antibodies were visualized by incubation 
with fluorescent dye-labelled secondary antibodies, AlexaFluor 680 goat anti-rabbit 
or IRDye800-conjugated goat anti-mouse IgG (Table 2.2), diluted in 50 % (v/v) 
Odyssey® blocking buffer in TBS + 0.5 % Tween®20 .  After briefly washing in TBS, 
membranes were scanned and fluorescent bands directly quantified using the 
Odyssey infrared imaging system and associated Odyssey software (v1.1; LI-COR).  
Band intensities were measured using the Odyssey software by drawing boxes 
around each protein band to calculate densitometry following background 
subtraction.  Densitometry of β-actin protein was measured on the same blot for 
use as a loading control to normalise protein loading in each lane.  Primary antibody 
dilutions were optimised by titration, using a known positive control lysate 




incubating with secondary antibody alone prior to the addition of any primary 
antibody to the membranes to ensure that no labelling was visible. 
 
2.7.3.6 Stripping and re-probing of membranes 
 If labelling of blots with multiple antibodies was necessary membranes were 
stripped by incubating for 30 minutes in high pH western blot recycling buffer 
(Source Bioscience), diluted 1:10 in dH2O.  After stripping, secondary antibody was 
applied and the membrane was scanned as above to confirm the removal of 
primary antibodies.   
 
2.7.4 Co-localisation studies by Proximity Ligation Assay 
(PLA). 
Co-localisation of proteins was detected using the Duolink® In Situ PLA assay kit 
(Olink Bioscience).  The assay utilises short complementary oligonucleotide probes 
attached to anti-mouse and rabbit secondary antibodies which, when in close 
proximity (<40 nm), can be ligated and form the basis of a rolling circle 
amplification reaction, into which fluorescent dNTP’s are incorporated. 
Cells were seeded and grown on glass slides and fixed as described in section 
2.7.2.1.  A grease pen was used to outline each well of the 12-well slide to prevent 
merging of antibodies from adjacent wells.  20 µl of primary antibodies (containing 
one primary antibody raised in mouse and one primary antibody raised in rabbit, 
table 2.1) were applied to each well, to assess co-localisation.  Incubations were 
carried out in 4-well quadriPERM® slide box (Sarstedt), for 16 hours at 4 oC in a 
humidified atmosphere, before carefully removing the antibodies by pipetting and 
washing slides three times for 5 minutes on an orbital shaker in Duolink® wash 
buffer A, at ambient temperature.  After tapping off excess wash buffer, anti-mouse 
IgG (minus) and anti-rabbit IgG (plus) PLA probes (each containing complementary 




diluent, before applying 20 µl to each well and incubating for 1 hour at 37 oC in a 
humidified atmosphere.  After removal of excess PLA probes, slides were washed 
twice for 5 minutes in Duolink® wash buffer A at ambient temperature.  PLA probes 
were ligated (when in close proximity) by addition of 20 µl of the Duolink® ligation 
solution to each well (containing 1/5 Duolink® ligation buffer and 1/40 Duolink® 
ligase enzyme diluted in molecular-grade water), which was incubated at 37 oC for 
30 minutes before washing twice for 2 minutes in Duolink® wash buffer A at 
ambient temperature and tapping off excess wash buffer.  To induce the rolling 
circle amplification reaction, duolink® amplification solution and polymerase were 
diluted 1/5 and 1/80 respectively in molecular-grade water and 20 µl was applied 
per well, for 100 minutes at 37 oC.  From this point the slides were protected from 
light using aluminium foil.  The polymerase solution was then removed and slides 
were washed on the orbital shaker in Duolink® wash buffer B for 10 minutes, 
counterstained by incubation in 0.1 µg/ml (w/v) Hoechst 33258, diluted in Duolink® 
wash buffer B for 10 minutes, followed by one wash in dH2O for 1 minute. Slides 
were mounted in antifade mountant (Appendix 2).  Epifluorescent microscopy was 
performed on an Olympus BX60 microscope and co-localisation was determined by 
the presence of fluorescent spots.  For each experiment a positive control reaction 
was included using antibodies raised against ZO-1 and ZO-1α+, since both antibodies 
bind to the α+ variant of ZO-1 and co-localise on the same protein.  Negative 
controls were included in which no primary antibodies were added, or in which 
primary antibodies for mouse anti-Cx32 and rabbit anti-Cx43 primary were 





2.8 Functional Studies 
2.8.1 TER measurements 
NHU cultures were seeded onto 0.45 µm permeable Snapwell™ membranes (Fisher 
Scientific), at 5x105 cells per 1.1 cm2 membrane (three to six replicate cultures per 
experimental condition).  Cultures were either differentiated with ABS/Ca2+ or 
cultured as non-difefrentiated controls as described in section 2.2.3.2.  For each 
membrane, 0.5 ml medium was added to the inner chamber and 3 ml to the outer 
chamber.  At 24 hrs post-seeding the growth medium was replaced and maintained 
for 7-14 days with the growth medium changed every other day.  Transepithelial 
electrical resistance (TER) was measured at various time points over the time 
course, using an EVOM™ voltohmeter (World Precision Instruments).  The TER 
probe was sterilised in Cidex Plus®, 3.4 % (v/v) gluteraldehyde solution (Civco 
Medical Solutions), for 20 minutes and equilibrated in 7.5 ml growth medium (as 
used to culture the cells) for 2 x 5 minutes before readings were taken. The 
electrical resistance of a blank (no cells) membrane was measured and subtracted 
from the experimental readings to give a resistance reading generated by the cell 
sheet alone. 
 
2.8.2 Measuring barrier recovery after wounding  
Cells seeded onto Snapwell™ membranes and maintained for 7-14 days as 
described in section 2.8.1.  TER measurements were taken immediately prior to 
wounding NHU cultures (3-6 replicate cultures).  To wound, a single horizontal 
scratch was created across the full width of the Snapwell™ membrane, using a 100 
µl sterile pipette tip to generate a scratch approximately 500-750 µm wide.  TER 
measurements of the wounded cultures were recorded immediately post-scratch, 
before returning cultures to the incubator.  TER measurements of each culture 





2.8.3 Analysis of wound-healing in differentiated cultures 
using time-lapse microscopy  
 Cultures grown on 24-well plates were wounded with a single horizontal scratch 
across the full width of the well, using a 100 µl sterile pipette tip to generate a 
wound approximately 750-1000 µm wide.  24-well plates were placed into an 
environmental chamber (Solent Scientific) at 37 oC with 5 % CO2 (in air) feed for 
buffering of medium.  Wound-repair was monitored in each well by phase-contrast 
microscopy using an Olymous IX81 motorised microscope.  Images were captured 
every 2 h over a time-course of 36-48 h using CellM image capture software 
(Olympus).  The image analysis software was then used to measure the initial 
wound area and serial wound-areas during repair to calculate the percentage 
wound-closure at various time points.  Three to six replicate cultures were 
measured for each experimental condition and the mean percentage wound 





2.9 Development of Cx32 knock-down and Cx32 
overexpressing Wild-type and Dominant Negative 
(T134A) Human Urothelial Cells 
Cx32 shRNA knock-down cultures and Cx32 overexpressing cultures were generated 
by retroviral transduction of NHU cells with retroviral particles. For overexpressing 
cultures, two different transductants were generated.  Wild-type Cx32 (Cx32WT), for 
which the coding sequence was cloned from differentiated NHU cells, as well as a 
dominant negative mutant form, in which a single base substitution generated a 
“closed-channel” phenotype (Beahm et al. 2006).  The dominant negative Cx32 
(Cx32T134A) was generated by site-directed mutagenesis as described below.     
 
2.9.1 Generation of Cx32 shRNA retroviral vectors 
Three different short-hairpin RNA (shRNA) sequences were designed to target the 
Cx32 transcript for degradation.  For gene silencing, shRNA sequences were ligated 
into the pSIREN-RetroQ retroviral vector (Clontech).  Included in the pSIREN retro-Q 
vector are the following features (figure 2.2): 
 5’ and 3’ LTRs necessary for transcription 
 The RNA packaging signal ψ+ 
 A puromycin resistance cassette for selection in eukaryotic cells 
 E-coli Ampr gene for propagation and selection in bacteria 
 A site for insertion of shRNA oligonucleotides, flanked by BamHI and EcoRI 






Figure 2.2  Schematic of the pSIREN-RetroQ retroviral vector.  
(Image from http://www.clontech.com/images/pt/PT3739-1.pdf)  
 
2.9.1.1 shRNA Oligonucleotide sequence Design 
A 269 base pair sequence common to all four human Cx32 transcript variants was 
used for shRNA design.  Two shRNA software packages were used to select three 
20-21 base pair target sequences; siRNA target finder (Applied Biosystems) and 
BLOCK-iT™ RNAi Designer (Life Technologies).  shRNA sequence designer software 
(Clontech) was used to convert the target sequences into short hairpin sequences 
by addition of the hairpin loop sequence TTCAAGAGA, BamH I and EcoR I restriction 
site overhangs for directional vector insertion, RNA Pol III terminator sequence (a 
run of 6 thymidine residues) and an additional Mlu1 restriction site immediately 
downstream of the terminator sequence to confirm the presence of the cloned 
insert.  Target sense and antisense sequences are detailed in table 2.5 and were 



















Table 2.5  shRNA oligonucleotides.  
Specific Cx32 target sequences are underlined 
 
2.9.1.2 Annealing shRNA Oligonucleotides 
Each shRNA oligonucleotide sequence was resuspended in nuclease-free water to a 
concentration of 100 µM.  Top and bottom strands were mixed in a 1:1 ratio (to 
give a 50 µM concentration of double stranded oligonucleotide) and heated in a 
thermal cycler for 30 seconds at 95 oC (to remove secondary structure) followed by 
annealing (hybridisation) for 2 minutes at 72 oC, 2 minutes at 37 oC and finally 2 
minutes at 25 oC before storing on ice. 
 
2.9.1.3 Ligation of double-stranded Oligonucleotides into pSIREN-RetroQ 
Annealed oligos were ligated into RNAi-Ready pSIREN-RetroQ vectors by incubation 




1 µl diluted, annealed oligonucleotide (0.5 µM) or nuclease-free water (negative 
control), 2 µl linearised pSIREN-RetroQ vector (25 ng/µl), 1.5 µl 10x T4 DNA ligase 
buffer (Promega), 1 µl T4 DNA ligase (3 U/µl; Promega) and 9.5 µl nuclease-free 
water. 
 
2.9.1.4 Transformation of Chemically Competent E-coli  
2 µl of ligated vector mixture was added to 50 µl XL-1 Blue (Escerichia Coli) 
chemically competent cells (Stratagene) in Falcon 2059 polypropylene tubes.  Vials 
were tapped gently to evenly distribute and incubated for 30 minutes on ice.  A 
negative cell-only control was included.  Cells were transformed by heat-shock for 
30 seconds in a water bath at 42 oC before immediately returning to ice.  250 µl SOC 
medium (Life Technologies) was added to promote membrane repair and the 
mixture was shaken at 250 rpm for 60 minutes at 37 oC.  5-50 µl from each 
transformation was plated onto LB-agar plates (Appendix 2) containing 100 µg/ml 
ampicillin, for 16 hours at 37 oC. 
 
2.9.1.5 Amplification of Plasmid DNA  
Five single, isolated colonies were selected from each plate and used to inoculate 5 
ml LB-liquid cultures (Appendix 2) containing 100 µg/ml ampicillin, for 16 hours at 
37 oC with shaking at 250 rpm. 
 
2.9.1.6 Glycerol Stocks 
For long-term storage of transformed bacteria, glycerol stocks were prepared by 
mixing 750 µl cell suspension (section 2.9.1.5), with 250 µl sterile 80 % (v/v) glycerol 
in dH2O into a cryovial (Sarstedt) and storing at -80 
oC.  To recover cells from a 




plates containing 100 µg/ml ampicillin and plates were incubated at 37 oC 
overnight, before amplifying plasmid DNA as described in section 2.9.1.5.   
 
2.9.1.7 Purification of Plasmid DNA 
Plasmid DNA was purified using a spin-column system which captures plasmid DNA 
on a spin column, following bacterial cell lysis.  Bacterial cells were pelleted from 5 
ml liquid cultures (section 2.9.1.5) by centrifugation at 1100 x g for 10 minutes and 
the supernatant was discarded.   Plasmid DNA was extracted and purified using the 
“QIAprep® Spin Miniprep Kit” according to manufacturer’s recommendations 
(Qiagen).  Bacterial cells were resuspended in 250 µl of buffer “P1” (resuspension 
solution) containing RNase A (to remove RNA) and transferred into a 
microcentrifuge tube.  250 µl of lysis buffer “P2” was added and the reaction which 
contains SDS to induce cell lysis.  The reaction mixture was gently mixed by 
inverting the tubes several times over a 5 minute period (at ambient temperature).   
350 µl neutralisation solution buffer “N3” was added and cell debris/chromosomal 
DNA was pelleted by centrifugation at 9500 x g for 10 minutes.  The clear 
supernatant was added to the QIAprep® spin column and centrifuged at 9500 x g 
for 60 s to bind plasmid DNA to the column.  After a wash step in 750 µl “buffer PE” 
the purified plasmid was eluted in a clean 1.5 ml microcentrifuge tube by addition 
of 50 µl nuclease-free water followed by centrifugation at 9500 x g for 1 minute.  
The plasmid DNA concentration was determined using a NanoDrop™ UV 
spectrophotometer.   
 
2.9.1.8 Screening plasmid DNA for shRNA insertion 
Purified plasmid DNA was tested for successful shRNA insertion by restriction 
analysis of the Mlu1 restriction site, positioned downstream of the terminator 
sequence in the shRNA.  Each restriction digest was set up in nuclease-free 1.5 ml 
microcentrifuge tubes, containing: 1 µl Mlu1 enzyme (10 units) and 2 µl 10x 




DNA and 12 µl nuclease-free water.  In control digests restriction enzyme was 
replaced with nuclease-free water.   Digests were incubated at 37 oC for 3 hours 
before running on a 1 % (w/v) agarose gel (section 2.6.5.3).   
The pSIREN-RetroQ vector does not contain an internal Mlu1 restriction site, 
therefore successful shRNA insertion was confirmed in plasmid DNA from the 
difference in migration into the gel between the faster migrating uncut plasmid 
DNA (control digest) and the slower migrating linear cut DNA (Mlu1 digest).     
 
2.9.2 Generation of Cx32WT overexpression vector 
For overexpression studies the full-length coding sequence of Cx32 was cloned from 
differentiated NHU cells and ligated into the multiple cloning site of the pLXSN 
retroviral overexpression vector (Clontech).  Included in the pLXSN vector are the 
following features (figure 2.3):  
 5’ and 3’ LTRs necessary for transcription 
 The RNA packaging signal ψ+ 
 A neomycin (G418) resistance cassette for selection in eukaryotic cells 
 E-coli Ampr gene for propagation and selection in bacteria 





                   
Figure 2.3  Schematic of the pLXSN retroviral vector. 
(Image from www.clontech.com/products/cat/HTML/1076.shtml). 
 
2.9.2.1 Primer design for Cx32 cloning 
Primers were designed to flank the full length protein coding sequence of Cx32, 
with the forward primer containing the first 24 nucleotides of Cx32 and the reverse 
the last 21 nucleotides, since this gave a very similar annealing temperatures for 
the two primers.  An EcoRI restriction site was added to the forward primer and a 
BamHI site to the reverse, to enable directional cloning into pLXSN and it was 
verified that neither restriction sites were present within the Cx32 coding sequence 
using restriction digest prediction software (RestrictionMapper v3.0).  To aid 
initiation of translation, a Kozak sequence (ACC) was inserted to the forward primer 
immediately prior to the start codon and to preserve the restriction sites, 6 extra 
bases (all A’s) were added to the primers upstream of the restriction site.  The 




sequences (restriction sites are underlined, Cx32 cloning components are in capital 
letters): 
Fwd 5’-3’:   aaa aaa gaa ttc acc ATG AAC TGG ACA GGT TTG TAC ACC 
Rev 5’-3’:  aaa aaa gga tcc TCA GCA GGC CGA GCA GCG GTC; 
 
2.9.2.2 PCR amplification of Cx32 cDNA  
Cx32 was amplified from cDNA extracted from Y1151 NHU cells, following 
differentiation with 5 % ABS and 2 mM Ca2+.   The “Expand High Fidelity PCR 
System” was used (Roche), in which the polymerase has proofreading activity to 
ensure high fidelity.  Each PCR reaction contained 0.3 µM forward and reverse 
primers, 0.2 mM of each dNTP (Life Technologies), 5 % DMSO, 1 X Expand PCR 
buffer, 0.375 µl Expand Taq polymerase and 1 µl cDNA diluted in nuclease-free 
water to a final reaction volume of 25 µl.  Duplicate PCR reactions were performed 
in the thermal cycler as follows: 2 minutes initial denaturation at 94 oC, followed by 
35 cycles of denaturation at 94 oC for 30 sec, 61 oC annealing for 30 sec and a 72 oC 
extension for 60 sec.  A final extension step at 72 oC was performed for 7 minutes.  
One of the completed PCR reactions was examined in a 1 % agarose gel as 
described in section 2.6.5.3, to verify a single band product of 852 base pairs, once 
verified, the remaining reaction was processed for purification. 
 
2.9.2.3 Purification of PCR products 
Amplicon was purified from the PCR reactions (section 2.9.2.2) using a QIAquick® 
PCR purification kit (Qiagen), which purifies and concentrates PCR products up to 
1 kb in size.  The 25 µl PCR reaction mixture was combined with 125 µl buffer PB 
and loaded on to a QIAquick column which was centrifuged for 60 seconds at 9500 
x g, in a table-top microcentrifuge to bind DNA.  To wash, 750 µl of PE wash buffer 
was added to the column and centrifuged for 60 seconds at 9500 x g, before 
discarding the flow through and centrifuging again for 30 seconds at 13,000 rpm to 




microcentrifuge tubes and the DNA eluted by adding 50 µl nuclease free water to 
the column and centrifuging for 1 minute at 13,000 rpm.  The DNA concentration 
was determined using a NanoDrop™ UV spectrophotometer. 
 
2.9.2.4 TA cloning into the expression vector pGEM®T Easy 
The pGEM®T Easy expression vector was used for sub-cloning of the Cx32 PCR 
product.  The vector contains the following features (see figure 2.4):   
 T7 and SP6 RNA polymerase transcription initiation sites  
 Ampicillin-resistance gene for colony selection  
 3’ Thymidine overhangs for TA-cloning of PCR products 
Cx32 PCR product was ligated into the pGEM®T Easy cloning vector by incubation of 
the following ligation mixture at 4 oC for 16 h; 3 µl PCR product (or nuclease-free 
water background control), 1 µl pGEM®T Easy vector (50 ng), 5 µl 2x rapid T4 DNA 
ligase Buffer (Promega), 1 µl T4 DNA ligase (3 U/µl; Promega).   
E-coli were transformed with the Cx32-pGEM®T Easy ligation mixture and plasmid 







Figure 2.4  pGEM®T Easy Vector Map. 
 (Image from:  http://www.promega.com) 
 
2.9.2.5 Screening Plasmid DNA for Insertion of Cx32 by sequencing 
To assess the presence and sequence fidelity of Cx32 in pGEM®-T easy following 
ligation, 300 ng purified plasmid DNA was sequenced using an Applied Biosystems 
3130XL Genetic Analyser, with sequencing primers specific to regions within the T7 
and SP6 RNA polymerase binding sites found up- and downstream of the multiple 
cloning site in pGEM®-T easy (fig 2.4).  Sequencing was performed by Celina 
Whalley in the Technology Facility.  The resulting sequencing data was analysed 
using Chromas software (v1.45), comparing both sense and antisense strands with 





2.9.2.6 Restriction Digests for Subcloning of Cx32 into the pLXSN Overexpression 
Vector 
Restriction digests were set up to cut Cx32 from the pGEM®-T Easy vector and to 
linearise the pLXSN vector for subcloning.  5 µl purified plasmid DNA (either pLXSN 
or pGEM®-T Easy-Cx32) was combined with 0.5 µl EcoRI restriction enzyme, 2 µl 10x 
EcoRI buffer, 0.2 µl BSA (all Promega) and 12.3 µl nuclease-free H2O in 1.5 ml 
microcentrifuge tubes and incubated for 3 h at 37 oC.  Digest reactions were 
“cleaned” to remove digest enzyme and buffers as detailed in section 2.9.2.3.  DNA 
was eluted in 17 µl nuclease-free H2O and a second digest was performed by adding 
0.5 µl BamHI enzyme, 2 µl 10 x BamHI buffer and 0.2 µl BSA (all Promega) to the 
eluate and incubating for 3 h at 37 oC.  Digested pLXSN and pGEM®-T Easy-Cx32 
products were loaded into a 0.75 % agarose gel and electrophoresis was performed 
at 90 V for 1 h to separate bands (as described in section 2.6.5.3), using a wide gel 
comb to enable all DNA to be loaded onto the gel.  Linearised pLXSN and Cx32 
bands were then excised during brief viewing on a UV transilluminator, using a 
clean disposable scalpel for each band.   
 
2.9.2.7 DNA Purification by Gel Extraction 
Excised bands were placed into a 1.5 ml nuclease-free microfuge tube and weighed.  
DNA was purified from gel fragments using a QIAquick® Gel extraction Kit (Qiagen).  
300 µl buffer QG was added to each tube per 100 mg gel present and the gel slices 
were dissolved by incubation at 50 oC for 10 minutes.  The resulting solution was 
then diluted 1:1 with isopropanol and mixed, before loading onto a QIAquick spin 
column and centrifuging for 1 minute at 13,000 rpm in a bench-top centrifuge to 
bind DNA to the column.  The flow-through was discarded and the DNA was washed 
by adding 750 µl Buffer PE to the column and centrifuging again for 1 minute, 
before discarding the flow through.  Elution of DNA was performed by placing the 
column into a clean microfuge tube and adding 20 µl nuclease-free water, before 
centrifuging for 1 minute.   The final DNA concentrations were determined using a 




2.9.2.8 Subcloning of Cx32 into the pLXSN Overexpression Vector 
The Cx32 coding sequence was ligated into pLXSN by combining 30 ng purified, 
linearised pLXSN plasmid with 13 ng purified Cx32 DNA with 1.5 µl 10 x T4 DNA 
ligase buffer and 0.5 µl T4 DNA ligase (both Promega), in a total volume of 15 µl and 
incubating for 16 h at 4 oC.  pLXSN-Cx32 plasmid DNA was amplified and purified as 
described in sections 2.9.1.4 to 2.9.1.7.  Insertion of the correct Cx32 sequence and 
orientation was verified by sequencing as described in section 2.9.2.5. 
 
2.9.3 Generation of the Dominant Negative Cx32T134A 
overexpression vector 
In addition to generating the Cx32-pLXSN overexpression vector, a second mutant 
overexpression vector was generated, Cx32T134A-pLXSN.  This dominant-negative 
form of Cx32 is non-functional with a channel-closed phenotype, but retains the 
ability to be correctly synthesised and trafficked into Cx32 gap junctions (Beahm et 
al. 2006).  A single base-pair mutation was performed, altering the Threonine in 
position 134 to an Alanine (T134A mutant) to generate the desired mutant.  To 
achieve this, site directed mutagenesis (SDM) was performed using a Single-Primer 
Reactions In Parallel (SPRINP) technique described below, in a technique adapted 
from a previous study (Edelheit et al. 2009), see figure 2.6. 
 
2.9.3.1. SDM Primer design 
Primers were designed using Primer X software (www.bioinformatics.org/primerx) 
to produce a single base-pair substitution, in which the bases to be mutated were in 
the centre of both primers (highlighted below).  The T134A mutation was 
performed by converting the sense sequence from ACC to GCC (underlined below).  
Primers were ordered from MWG Eurofins.   
Fwd (5’-3’)  GGACACTGTGGTGGGCCTATGTCATCAGC 






Figure 2.5  Flow chart of the single-primer site-directed mutagenesis method. 
Image adapted from Edelheit et al. (2009).  The parental plasmid is shown in grey and the 
two PCR synthesised strands are shown in blue and purple.  The letter x marks the position 





2.9.3.2. Site-directed mutagenesis 
Wild-type Cx32 cDNA was cloned into the pGEM®-T Easy expression plasmid as 
described in 2.9.2.  Purified plasmid DNA was isolated from XL1-Blue cells 
(Stratagene), which have a dam+ (wild-type) genotype encoding Dam methylase.  
This was necessary since the method requires methylated parental DNA to provide 
a distinction between parental and newly synthesised (mutant) DNA strands.     
Forward and reverse primer reactions were set up in parallel (separate tubes) to 
prevent binding of the forward and reverse primers which would otherwise reduce 
the yield of successful transformants.  PCR reactions were set up using Expand High 
Fidelity PCR system (Roche) as described in table 2.6 using a Biorad T100™ thermal 
cycler.  After an initial denaturation step of 94 oC for 2 minutes, PCR was performed 
for 30 cycles with a denaturation step of at 94 oC for 40 s, primer annealing at 65 oC 
for 40 s and template extension phase at 72 oC for 4 minutes. A final 10 minute 
extension phase was included at 72 oC.   
Reaction products were then combined to give a total reaction volume of 50 µl and 
the reaction was heated to 95 oC for 5 minutes in the thermal cycler to separate the 
PCR products from the template strands, followed by slow cooling to 37 oC (1 min at 
90 oC, 1 min at 80 oC, 30 s at 70 oC, 30 s at 60 oC, 30 s at 50 oC, 30 s at 40 oC and held 





Component Reaction 1 Reaction 2 
Cx32-pGem®T plasmid DNA 500 ng 500 ng 
Forward primer 300 nM - 
Reverse Primer - 300 nM 
dNTPs 200 nM 200 nM 
Expand High Fidelity Buffer (10x) with 
15 mM MgCl2  
1X 1X 
Expand High Fidelity Enzyme  1.3 Units 1.3 Units 
Nuclease-free water 19.875 µl 19.875 µl 
Reaction Volume         25 µl             25 µl 
Table 2.6  Site-directed mutagenesis PCR reaction components. 
Forward and reverse reactions were set up in parallel separate tubes (Reactions 1 and 2) 
and PCR performed with forward and reverse primers which incorporate the mutated base.  
 
2.9.3.3. Digestion of Parental DNA strands 
The combined reaction mixture was divided between two PCR tubes (25 µl per 
tube) and a restriction digest was performed on one of the 25 µl aliquots to digest 
methylated parental strands by addition of 15 units DpnI enzyme, 0.1 µg/ml 
acetylated BSA and 1X DpnI restriction enzyme buffer (all Promega) for 16 h at 37 
oC.  The second aliquot was also set up as a non-digested control (by replacing the 
DpnI enzyme with nuclease-free water).  The resulting DNA fragments were purified 
using a PCR clean-up column (section 2.9.2.3) to remove digested nucleotides and 
enzyme reagents, before running on a 1 % gel by electrophoresis (section 2.6.5.3) to 





2.9.3.4 Plasmid Transformation and isolation 
Mutated plasmid DNA was transformed into E.coli for amplification and nick-repair, 
before purification (sections 2.9.1.4 to 2.9.1.7).   Sequencing in both forward and 
reverse directions (as described in 2.9.2.5), was performed to confirm whether the 
cDNA carried the desired mutation and to check that the cDNA did not carry any 
other mutation.  The digested Cx32T134A fragment was subcloned into the pLXSN 
overexpression vector (sections 2.9.2.6 - 2.9.2.8).  
 
2.9.4 Transfection of Retroviral Vectors into the RetroPack™ 
PT67 Packaging Cell Line 
All retroviral work (transfections and transductions) was performed in a Biosafety 
Level 2 safety cabinet with containment level 2 working practices.   
Viral gag, pol and env genes necessary for particle formation and replication are 
stably integrated into the genome of RetroPack™ PT67 cells (Clontech) and are 
maintained by HAT selection (section 2.2.4).  When transfected with a retroviral 
vector, PT67 cells produce high-titre replication-incompetent viruses, which may be 
collected and used to infect target cells.   
PT67 cells were maintained in T25 culture flasks in DMEM (GIBCO) supplemented 
with 10 % FBS and 1 % L-glutamine in a humidified atmosphere at 37 oC and 10 % 
CO2 in air.  All tranfections were performed using Effectene® reagent (Qiagen).  
Transfection medium was generated by adding 5 µg plasmid DNA to 150 µl buffer 
EC and 40 µl enhancer and incubating for 5 minutes at ambient temperature.  50 µl 
of Effectene® transfection reagent was added and the mixture was vortexed briefly 
before incubating for 10 minutes at ambient temperature.  This mixture was then 
added to 5 ml growth medium and used to transfect packaging cells.  At 
approximately 60 % confluence, medium was aspirated from the PT67 packaging 
cells and replaced with the transfection mixture before returning the culture to the 
incubator for 16 hours.  The transfection mixture was removed from the cells and 




split ratio of 1:3 and subjected to antibiotic selection in growth medium containing 
0.5 mg/ml G418 (for pLXSN vector) or 4 µg/ml puromycin (for pSIREN-RetroQ 
vector).  Mock-transfected cells (lacking retroviral vectors) were generated as 
control cultures for antibiotic selection.  Empty-vector pLXSN and control shRNA- 
pSIREN-RetroQ (Clontech) were transfected as vector controls. Following 
transfection, packaging cells were maintained in growth medium containing 
antibiotic at a reduced maintenance concentration of 0.05 mg/ml G418 or 0.25 
µg/ml puromycin (as appropriate) to retain selection pressure.     
 
2.9.5 Retroviral Transduction of NHU Cells 
The growth medium was aspirated from T75 flasks containing 100 % confluent 
cultures of PT67 cells transfected with empty or recombinant plasmids and 
replaced with 10 ml of antibiotic-free medium consisting of equal volumes of 
DMEM:RPMI with 5 % FBS and 1 % L-glutamine for 16 hours.  Virus was harvested 
by removing the culture medium from the packaging cells and passing through a 
0.45 µM Acrodisc® syringe filter to remove cell debris.  To enhance retroviral 
infection the virus-containing medium was supplemented with 8 µg/ml Polybrene 
(hexadimethrine bromide, Sigma).  Growth medium was removed from 50-60 % 
confluent NHU cultures and replaced with the virus-containing medium before 
returning the cultures to the incubator for 6 hours, before replacing medium with 
KSFMc.  48 hours post-infection, NHU cells were passaged 1:3 and subjected to 
antibiotic selection in growth medium containing 0.1 mg/ml G418 (for pLXSN 
vector) or 0.5 µg/ml puromycin (for pSIREN-RetroQ vector).  Mock-transduced 
cultures (lacking retroviral vectors) were generated as control cultures for antibiotic 
selection.  Following transduction, cells were maintained in growth medium 
containing the relevant antibiotic to prevent out-growth from non-transfected cells.   
One to two weeks post-transduction, the growth medium was replaced with 
antibiotic-free complete medium.  After an overnight incubation, this medium was 
harvested and used to infect NHU cells using the above transduction protocol and 




NHU cells were then returned to level 1 containment and routinely cultured in the 





3. Characterisation of Connexin Expression and 
Distribution in Human Urothelial Cells In vitro and 
In vivo 
 
The biological requirements of different tissues will likely necessitate differences in 
the capacity of GJIC and connexin expression.  Distribution of connexins is 
extremely variable amongst epithelia and further, compartmentalisation of 
expression is observed within stratified epithelia (for example in skin and gut), 
suggesting that selective compartments for communication are set up.  An 
assessment of Cx expression in human urothelium has not previously been 
reported. 
3.1. Aims 
The overall aims of this chapter were to use previously characterised in vitro 
systems to assess connexin expression in human urothelium.  More specifically: 
 To define the connexin genes expressed by normal human urothelial cells in 
vitro using well characterised culture systems to replicate non-differentiated 
and differentiated cell phenotypes (section 3.3) 
 To determine the expression of specific connexin genes in human 
urothelium in situ (section 3.3)  
 To examine the expression of specific connexin proteins whose function 
may contribute to a differentiated urothelial phenotype using two in vitro 
models to mimic urothelial differentiation (section 3.4)  
 To examine the distribution of specific connexin proteins of interest in 
native urothelium (section 3.5) 
 To predict potential transcriptional regulators of connexin expression 
following differentiation in vitro (section 3.6)  
 To determine if expressed connexins assemble into functional gap junctions 




3.2. Experimental Approach 
RT-PCR was used to assess transcript expression of each of the known human 
connexin genes in non-differentiated NHU cells (grown in KSFMc) and NHU cells 
differentiated using the two methods: ABS/Ca2+ and TZ/PD described in detail in 
section 2.2.3).  Differentiation was verified by expression of uroplakin 3a (UPK3a) or 
aquaporin 3 (AQP3) transcripts.  Transcript expression of specific connexins of 
interest was also studied in freshly isolated (P0) urothelium. 
 
On the basis of this data, the spatio-temporal regulation of Cx32 expression during 
NHU cytodifferentiation in vitro was examined by quantitative RT-PCR (RTqPCR), 
immunocytochemistry and western blot analyses of NHU cells differentiated using 
both methods.  Western blot and immunocytochemistry analysis of Cx32 was 
performed using a monoclonal antibody which recognises the C-terminal domain of 
both monomeric and dimeric Cx32 products. 
 
The PPARγ-dependency of Cx32 gene and protein expression was studied using 
T0070907, a specific and potent inhibitor of PPARγ which binds covalently to the 
ligand binding region (at cysteine 313), inducing a conformational change which 
irreversibly blocks the recruitment of transcriptional cofactors.  The dose of 
T0070907 selected for use was previously titrated in our laboratory and was 
demonstrated to specifically block expression of PPARγ-driven genes in NHU cells in 
a dose dependent manner (Varley et al. 2006).  For quantitative RT-PCR studies, 
AQP3 gene expression was used to confirm induction of differentiation (Rubenwolf 
et al. 2012) and for immunoblot analysis, the tight junction protein claudin 5 was 





Immunohistochemistry of Cx32 in native human bladder and ureter was performed 
to establish whether distribution of Cx32 within the multi-layered urothelium was 
associated with differentiation stage in situ. 
 
A transcription factor prediction binding database (JASPAR) was used to predict 
potential regulators of Cx32 expression during NHU cell differentiation, with search 
parameters limited to transcription factors that have been previously demonstrated 
to promote urothelial cytodifferentiation in human and mouse (Varley et al. 2004b, 
Varley et al. 2009, Bell et al. 2011, Bӧck et al. 2014). 
 
Finally, the functionality of gap junctions in non-differentiated and differentiated 
NHU cultures was examined using a method to examine intercellular 
communication by transfer of labelled dyes between cells, known as the Scrape-
Load Dye-Transfer (SLDT) method. 
 
SLDT method 
This technique provides a useful screening tool for determining the 
presence/absence of functional gap junctions.  A membrane-impermeable low-
molecular weight dye (such as lucifer yellow, MW=457.2 Da) is added to the culture 
medium before scratching a confluent cell culture with a scalpel.  The membranes 
of cells along the scratch wound are temporarily damaged, but rapidly reseal, 
thereby introducing dye into the cells.  If cells are communication competent, the 
dye will be transferred to neighbouring cells.  Concurrent loading with a high 
molecular weight dye (rhodamine-dextran, MW=4 kDa) is used to verify that dye-
transfer of lucifer yellow is via gap junctions; as rhodamine-dextran is unable to 
pass through the relatively narrow channels (Fig 3.1).  Dye transfer occurs within 
minutes and both dyes are lysine fixable which allows the assay to be terminated at 







Figure 3.1  Schematic to demonstrate theory of scrape-load dye-transfer. 
Cell monolayers are scraped in the presence of lucifer yellow (shown in green, gap junction 
permeable) and rhodamine-dextran (shown in red, gap junction impermeable).   
 
 
SLDT was optimised for NHU cells by adapting a basic method as detailed in 
methods section 2.4 (el-Fouly et al. 1987).  Assessment of ABS/Ca2+-differentiated 
cultures by SLDT was not performed due to the technically challenging nature of 
performing cell counts with highly stratified cultures; therefore the TZ/PD method 
of differentiation was selected for SLDT studies, since they retain a monolayer 






3.3 Expression of Connexin Genes in Normal Human 
Urothelial Cells in vitro and In Situ 
3.3.1 RT-PCR Screen to Assess Expression of Connexin Genes 
in Proliferating and Differentiated NHU Cell Cultures 
An RT-PCR screen of two independent ureteric NHU cell lines harvested in 
proliferating (non-differentiated) and differentiated (using the ABS/Ca2+ method) 
states, confirmed that of nineteen human connexin genes assessed, eight were 
expressed by cultured NHU cells (Fig 3.2).  Those expressed were: Cx26, Cx30, 
Cx30.3, Cx31.1, Cx31.9 Cx32, Cx43, and Cx45.   
 
Cx25, Cx30.2, Cx31, Cx36, Cx37, Cx40, Cx40.1, Cx47, Cx50, Cx59 and Cx62 were not 
expressed.  Successful attainment of differentiation was confirmed by an increase 
in the expression of UPK3a transcript.  Cx32 and Cx31.9 transcripts were 
upregulated in response to differentiation.  Five of the eight connexins expressed 















Figure 3.2  RT-PCR Screen to Assess Connexin Expression in Proliferating and 
Differentiated NHU cell cultures.  RNA was extracted from ureteric-derived Y778 and 
Y779 NHU cells cultured in KSFMc (Prolif) or following differentiation in 5% ABS and 2 mM 
Ca2+ (Diff).  RT-PCR was performed to amplify 19 human connexin gene products.  For 
presentation the connexin genes are split into α, β, C and D subclasses.  Reaction controls 
included an RT-negative for each RNA sample (RT-), a no-template water control (NTC), a β-
actin loading control and a Uroplakin IIIa (UPK3a) control to confirm urothelial 
differentiation status. Human genomic DNA was used as a positive control since all primers 
(with the exception of β-actin) were designed to amplify gene products confined within an 





3.3.2 RT-PCR Screen to Assess Expression of Connexin Genes 
In Vitro and In Situ 
To characterise the expression of the eight connexins with identified expression in 
NHU cells, RT-PCR was performed to study transcript expression in freshly isolated 
urothelium (P0), as well as in cultured NHU cells isolated from a donor bladder 
sample (Y930).  Phase contrast micrographs of Y930 NHU cultures taken 
immediately before harvesting for RNA extraction showed that when grown in 
KSFMc, cells grew as a monolayer culture with a pavement-like morphology and 
phase-bright cell borders typical of an epithelial culture, which was retained as cells 
reached confluence (Fig 3.3A).  Growth in 2 mM [Ca2+] induced stratification and an 
apparent alignment of more cuboidal cells within the culture, whilst differentiation 
by culture in 5% ABS and 2 mM [Ca2+] resulted in a complex heterogeneous 
population of spindly and stratified cells.  Concurrent activation of PPARγ with TZ 
and inhibition of EGFR signalling by PD153035 resulted in a culture containing 
compact, tear-shaped cells with occasional organisation into rosette structures (Fig 
3.3A arrow).  Both methods used to induce differentiation (ABS/Ca2+ and TZ/PD) 
resulted in an induction of UPK3a gene expression,  which was weakly expressed in 
freshly isolated NHU cells and not detected in stratified or non-differentiated 
cultures, irrespective of degree of confluence (Fig 3.3B).    
 
Expression of connexin genes is summarised in table 3.1.  An increase in the 
confluence of non-differentiated cultures did not appear to have an impact on 






Results of particular interest were:  
 Cx26 and Cx31.1 appeared to be expressed as a result of cell culture, 
whereas they were minimally expressed in freshly isolated urothelium. 
 Cx45 was expressed in proliferating and stratified cultures, but expression 
was non-detectable in freshly-isolated (P0) urothelium and minimally 
detected in both sets of differentiated cultures (ABS/Ca2+ and TZ/PD). 
 Cx26, Cx30 and Cx43 were constitutively expressed in freshly isolated 
urothelium and in NHU cultures regardless of growth conditions.   
 Cx31.9 expression was weakly associated with a differentiated NHU cell 
phenotype, being minimally expressed in P0 and ABS/Ca2+-differentiated 
cultures only 
 Cx32 expression was associated with a differentiated phenotype, with 
expression observed in cultures differentiated by both methods, as well as 










Figure 3.3  RT-PCR to Assess Connexin Expression in NHU Cell Cultures and Freshly 
Isolated Urothelium.   
(A) - RNA was collected from bladder-derived Y930 NHU cell cultures (P4), following growth 
in KSFMc to low (<50%), medium  (60-70%) and high  (90-100%) confluence, in medium with 
2 mM [Ca2+] for 5 days or following induction of differentiation in either 5% ABS with 2 mM 
[Ca2+]or TZ/PD.  Phase contrast images were taken from each culture immediately prior to 
lysis (A).  Arrow indicates the presence of rosette structures in cultures differentiated with 
TZ and PD153035.  Scale bar = 200 µm   
(B) - RT-PCR was performed to amplify gene products from eight connexins of interest 
(Cx26, 30, 30.3, 31.1, 31.9, 32, 43 and 45) in these cultures as well as from Y1043 (ureteric) 




induction of differentiation and β-actin was included as a loading control. PCR controls 




   
 




Cx26 + +++ +++ +++ +++ +++ +++ 
Cx30 +++ +++ +++ +++ +++ +++ +++ 
Cx30.3 + + + + + + + 
Cx31.1 - +++ +++ +++ +++ +++ +++ 
Cx31.9 + - - - - + - 
Cx32 ++ - - - + ++ ++ 
Cx43 +++ +++ +++ +++ +++ +++ +++ 
Cx45 - ++ ++ ++ ++ + + 
 
Figure 3.1 Summary Table of Connexin Transcript Expression  
Expression of connexion transcripts by freshly isolated NHU Cells (P0), non-differentiated 
NHU cultures (of low, medium and high confluence), stratified NHU cultures (grown in 2 
mM [Ca2+]) and NHU cultures differentiated using  ABS/Ca2+ and TZ/PD methods are 








3.3.3 Assessment of Cx32 Gene Expression in Response to 
NHU Cell Differentiation In Vitro 
RTqPCR analysis of three independent donor NHU cell lines (Y930, Y1054 and 
Y1108) confirmed the previous finding that Cx32 expression was significantly 
induced following a 6 day induction of differentiation in vitro. When compared to 
non-differentiated cultures (grown in KSFMc), mean Cx32 expression was 14-fold 
higher when cells were differentiated by ABS/Ca2+ and 58-fold higher by TZ/PD (Fig 
3.4A).  Increased AQP3 expression confirmed successful induction of differentiation 
(Fig 3.4B).   
 
To verify that differentiation-induced Cx32 expression was PPARγ-dependent in the, 
NHU cells (Y1153) were cultured in TZ/PD in the presence of the PPARγ antagonist, 
T0070907 for up to 72h.  At each time-point assessed, Cx32 expression was plotted 
as fold-change relative to the 6 h vehicle control cultures (to enable the increase in 
Cx32 during the differentiation time-period to be assessed, see Fig 3.4C).  In TZ/PD 
cultures, mean Cx32 gene expression was increased by 24-fold at 24 hours and 174-
fold by 72 hours.  A small induction of Cx32 (3.5 fold) was observed at 6h in cultures 
containing TZ/PD suggesting induction of Cx32 is initiated early following PPARγ 
activation.   
 
T0070907 inhibited TZ/PD-induced Cx32 gene expression by 85% and 57% at 48 and 
72 hours, respectively.  Throughout the 72 h experiment, the expression of Cx32 
was found to be significantly higher in TZ/PD cultures, than in parallel cultures with 
T0070907 or vehicle-only controls.  However, expression in both vehicle control and 
T0070907-treated cultures did increase during the time course. At each time point 
assessed, Cx32 expression in TZ/PD cultures with T0070907 was not significantly 
different to vehicle control cultures, suggesting that the PPARγ antagonist 







Figure 3.4  RT-qPCR analysis of Cx32 expression in non-differentiated and 
differentiated NHU cultures.  RNA was extracted from NHU cell lines grown in KSFMc for 
6 days (Non-diff) or differentiated following the ABS/Ca2+ or TZ/PD methods for 6 days.  
Quantitative analysis of Cx32 transcript (A) was assessed alongside AQP3 (B) to confirm 
differentiation status. Mean expression is plotted as fold-change relative to non-
differentiated cultures, after normalisation to GAPDH.  In (C), NHU cells were pre-treated 
with the PPARγ antagonist T0070907 (5 µM) or vehicle for 3 h, before supplementing with 
1 µM troglitazone (TZ) and 1 µM PD153035.  RNA was collected for analysis at 6 h, 24 h, 
48 h and 72 h post-treatment. At each time point a DMSO vehicle control was included.   
Cx32 quantitative RT-PCR was performed and expression was normalised to the 
housekeeping gene GAPDH.  Values represent Cx32 expression fold-change relative to the 
6 h vehicle control.  One way ANOVA tests were performed with a Tukey-Kramer multiple 
comparisons post-test. NS = not significant, *** = P<0.001 ** = P<0.01 * = P<0.1 
Data for A & B are pooled mean values from three independent donor NHU cell lines (Y930, 
Y1054 and Y1108); Data in C are three technical replicates from a single donor cell line 




3.4 Protein Expression of Connexin 32 in Normal 
Human Urothelial Cells In Vitro 
3.4.1 Cx32 Protein Expression following NHU 
Cytodifferentiation using ABS/Ca2+ and TZ/PD Methods   
Cx32 immunoblotting revealed the presence of two clear bands in NHU cell cultures 
differentiated with both TZ/PD and ABS/Ca2+ methods, one at the estimated 
molecular weight of 32kD and a second dimeric product, at approximately 50kD (Fig 
3.5A).  The weaker band at 32kD was present in non-differentiated cells and was 
not further induced following differentiation. 
 
A large induction of dimeric Cx32 was observed in cultures differentiated with 
TZ/PD. In cells cultured in TZ alone or PD alone, expression levels of the dimer were 
weak compared to the combined treatment.  Claudin 5 protein expression was used 
to confirm differentiation and was found to be enhanced when cells were cultured 
in both TZ and PD, with low level expression in the solo treatments and no 
observable protein expression in vehicle control cells.        
 
Dimeric Cx32 was induced upon differentiation with 5% ABS and 2 mM [Ca2+], with 
no expression of the 50 kD band in proliferating cultures (grown in KSFMc).  
Induction of claudin 5 protein expression confirmed differentiation.   
 
By indirect immunofluorescence, Cx32 protein expression was extremely weak in 
non-differentiated cells and DMSO control cells, with expression confined to 
perinuclear regions within the cytoplasm of cells (possibly ER/Golgi associated), 
with no evidence of localisation at intercellular junctions (Fig 3.5B).   When cells 
were cultured in TZ/PD for 6 days, Cx32 expression was heterogeneous across the 




intense and localised to cell junctions (Fig 3.5B).  In cultures differentiated in 
ABS/Ca2+, expression was observed throughout the entire culture with distinctive 






Figure 3.5  Immunoblot and Immunofluoresence Analysis of Cx32 Expression in 
Differentiated and Non-differentiated NHU cultures.  (A) Cx32 immunoblotting from 
two NHU cell lines.  Y1064 cells were treated with 1 µM troglitazone (TZ) and 1 µM 
PD153035 (PD), either as combined or solo treatments for a period of 6 days with a parallel 
vehicle control culture (Ctrl).  Y1119 cells were grown in 5% ABS and 2 mM Ca2+ to induce 
differentiation for 6 days.  A parallel culture of non-differentiated (confluent) was harvested 
before addition of serum as a control (Non-diff).   Western blot membranes were also 
probed with antibodies against claudin 5 (CLDN5), to confirm differentiation and β-actin to 




fluorescent channel.   (B) Cx32 immunofluorescence labelling of non-differentiated and 
differentiated NHU cells using both the TZ/PD and ABS/Ca2+ culture systems.  Parallel 
cultures as described in (A) were set up on glass slides and fixed for indirect 
immunofluorescence after 6 days.  Nuclei were counterstained (blue) with Hoechst 33258.    
Scale bar = 50 µm 
Note: Red and green immunolabelling are the consequence of using secondary antibodies 
conjugated to different fluorochromes. 
 
3.4.2 Defining the Specific Effects of PPARγ activation on 
Cx32 Protein Expression in NHU Cultures. 
To verify that the induction of Cx32 protein expression was PPARγ-dependent, NHU 
cultures (Y1153) were treated with troglitazone and PD153035 in the presence of 
the PPARγ antagonist T0070907 for up to 72 h.  Cx32 immunoblotting confirmed 
the presence of a weak band at 32kD in all cultures regardless of treatment, in 
keeping with previous findings (section 3.2.1); however in this cell line the 32kD 
band appeared as a weak doublet (Fig 3.6A).   The presence of Cx32 at 50kD was 
first observed in TZ/PD cultures at 48 h post-treatment and was also observed at 72 
h, however when TZ/PD cultures were supplemented with the PPARγ antagonist 
T0070907, dimeric Cx32 expression was absent and equivalent to vehicle control 
cultures.  In TZ/PD treated cultures, claudin 5 expression confirmed induction of 
differentiation and was first observed weakly at 24 h, with a more striking 
expression at 48 h and 72 h.  The PPARγ antagonist T0070907 attenuated the 
induction of claudin 5 observed in TZ/PD cultures.   
 
Cx32 protein was immunolocalised to patchy islands of cells in cultures treated for 
72 h with TZ/PD, where it was localised to cell borders (Fig 3.6B).  Cell junction 
immunolabelling of Cx32 was not seen where cultures contained T0070907, where 





Figure 3.6  Immunoblot and Immunofluoresence Labelling of Cx32 in Response to 
PPARγ Activation or Inhibition.  Y1153 (P3) NHU cells were pre-treated with the PPARγ 
antagonist T0070907 (5 µM) (T007) or DMSO vehicle control for 3 h before supplementing 
with 1 µM Troglitazone (TZ) and 1 µM PD153035 (PD).  (A) Whole cell lysates were collected 
for analysis at 6 h, 24 h, 48 h and 72 h post-treatment. A DMSO vehicle control was included 
at each time point.   The same membranes were also probed with antibodies against 
claudin 5 (CLDN5) to assess differentiation and β-actin to verify equivalent loading.  The 
protein ladder image was extracted from a different fluorescent channel.   (B) Y1153 (P3) 
NHU cells grown on glass slides were treated with 1 µM TZ and 1 µM PD153035, in the 
presence of the PPARγ antagonist T0070907 (5 µM) or vehicle control.  Cultures were fixed 
72 h post-treatment and Cx32 indirect immunofluorescence was performed.  Nuclei were 




3.4.3 Characterisation of Cx32 Protein Localisation during 
NHU Cell Differentiation with ABS/Ca2+ 
Protein expression of Cx32 was examined over the 11 day process of differentiation 
following the ABS/Ca2+ procedure (indicated in Fig 3.7A).  In cultures grown only in 
KSFMc (day 0), a weak, cytoplasmic distribution was observed throughout all cells, 
with no Cx32 labelling at cell junctions (Fig 3.7B).  Pre-treatment of cultures with 5% 
ABS for 3 days resulted in an increase in Cx32 expression with heterogeneous 
patches of membrane labelling for Cx32.  When cultured in growth medium 
containing both 5% serum and 2 mM [Ca2+], bright membrane labelling was 
observed for Cx32 throughout the culture with large amounts of cytoplasmic 
labelling. At the final time point assessed for differentiation, i.e. following 6 days 
culture in ABS/Ca2+, the Cx32 protein localisation was mostly visible at the cell 
membranes, with reduced cytoplasmic labelling compared to earlier time points.  
The pattern of expression of Cx32 at cell junctions was very similar to that of the 
differentiation-associated tight junction protein claudin 5 during the differentiation 
time course, which was detected at tight junctions after 3 days growth in 5% ABS 
and expression was further enhanced at tight junctions and within the cytoplasm of 
cells following the switch to ABS/Ca2+.  Expression of the structural tight junction 
protein ZO-1 was extremely patchy after 3 days in ABS, but after calcium 
supplementation was observed very clearly at cell-cell junctions throughout the 





Figure 3.7  Immunofluoresence Analysis of Cx32 Expression During Differentiation of 
NHU Cells following the ABS/Ca2+ method.  Y1191 (P3) NHU cells were grown to just 
confluence on glass slides in KSFMc and fixed at the time points indicated in A 
during the ABS/Ca2+ differentiation process.  Slides were immunolabelled with primary 
antibodies against Cx32, and the tight junction proteins claudin 5 (CLDN5) and ZO-1 (B).  




3.5 Protein Expression of Connexin 32 in Native 
Human Urothelium 
Immunohistochemical labelling of Cx32 in normal human bladder and ureter, 
demonstrated that labelling was reproducibly distinct between the superficial and 
intermediate/basal cell layers of human urothelium (Fig 3.8).  In the basal and 
intermediate cell compartments, Cx32 labelling was weakly cytoplasmic and 
membrane-associated, whilst intense Cx32 expression was observed in the 
basolateral membrane underlying the most-specialised superficial cells.   
 
Figure 3.8  Immunohistochemical Labelling of Cx32 in Normal Human Urothelium. 
Antibody labelling of Cx32 in normal human ureter (Y1216 and Y1221) and bladder (Y1186).  
Note: Rat liver was used as a positive control to optimise the primary antibody (as 
recommended by the antibody manufacturer), since the epitope for which the antibody was 
raised is identical in rat Cx32.  Note islands of membrane labelling within the rat liver 





3.6 Identification of Potential Transcription Factor 
Binding Sites within the Cx32 Promoter Region 
A bioinformatics analysis of predicted transcription factor binding motifs in the 
5000 bp sequence upstream of the Cx32 (GJB1) transcriptional start site (using 
JASPAR datasets), revealed the presence of potential high affinity binding sites for 
FOXA1 and KLF5 (see table 3.2).  Transcription factors with the highest predicted 
scores from those searched (relative score of greater than 0.95), were FOXA1, with 
and KLF5; the closest predicted binding site to the start codon was KLF5 which was 
found to be immediately adjacent to the start codon.   
 
Predicted binding domains for IRF-1, GATA3 and PPARγ were also sought as part of 
the analysis.  A PPAR-response element (PPRE) was not identified within the region 
selected for analysis; nor was predicted transcriptional start sites for IRF-1 or 
GATA3.  The search was limited to predict binding sites for transcription factors 
implicated in the urothelial differentiation, however multiple high-affinity predicted 
binding sites for the transcription factors SP1 and SOX10 were also identified (three 
predictions for SP1 and 12 for SOX10).  This was included as a control search, since 
both SP1 and SOX10 have previously been implicated in Cx32 transcriptional 





Model Name Relative 
Score 
Start (bp) End (bp) Predicted site 
sequence 
KLF5 0.97 3128 3137 CCCCCACCCA 
FOXA1 0.95 4186 4200 TCTCTGTTTACCTTA 
KLF5 0.96 4990 4999 GTCCCTCCCC 
 
Table 3.2  Potential KLF5 and FOXA1 binding sites identified within the 5000 bp 
sequence upstream of the Cx32 start codon.  The 5000 bp sequence immediately 
upstream of the Cx32 (GJB1) start codon was used to perform a motif search in the JASPAR 
database for predicted TF binding sites.  The profile score threshold was set to 95% to 
ensure only extremely high sensitivity predictions were generated.  The search included 
selected transcription factors implicated in urothelial development and differentiation 
(PPARγ, FOXA1, IRF-1, KLF5 and GATA3; the predictive tool did not contain algorithms for 
GRHL3 and ELF3).  Note: only KLF5 and FOXA1 gave matches, as indicated by the similarity 






3.7 Functional Assessment of Gap Junctional 
Communication in NHU Cultures  
Gap junction dye-transfer of Lucifer-yellow (LY, mw = 457 Da) in NHU cell cultures 
demonstrated that both non-differentiated cultures (Fig 3.9A) and those 
differentiated using the TZ/PD method to induce differentiation (Fig 3.9B) were 
capable of dye-transfer via gap junctions.  Cell counts revealed that for every cell 
initially loaded with dye following scratching (assessed by uptake of rhodamine-
dextran), the mean number of cells which were subsequently positive for LY after 6 
minutes was 8 and 6 (to the nearest whole number), for non-differentiated and 
differentiated cultures respectively (Fig 3.9C).  Pre-treatment of cultures with the 
gap junction inhibitors heptanol or 18α-glycyrrhetinic acid, resulted in a reduction 
in dye-transfer capacity of both non-differentiated and differentiated cultures.  This 
reduction was not statistically-significant with heptanol treatment; however 
addition of 18α-glycyrrhetinic acid resulted in a highly significant reduction in the 






Figure 3.9A  Gap Junction Mediated Dye-Transfer in control NHU Cultures.  
Y1268 (P3) NHU cells were cultured for 6 days prior to pre-treatment for 30 minutes with 
the gap junction inhibitors heptanol (1 mM) or 18α-glycyrrhetinic acid (18αGA; 5 µM), or 
DMSO (vehicle control). Cultures were scrape-loaded in the presence of the gap junction 
permeable Lucifer-yellow dye (green) and the gap junction impermeable rhodamine-dextran 
fluorescent dye (red).  After 6 minutes, the dye-transfer was halted by formalin fixation and 
dyes were visualised by fluorescent microscopy to determine the extent of GJIC.  
Representative images are shown (one region from five).  Merged overlaid images are also 
shown.  White lines indicate the approximate scratch boundaries.   








Figure 3.9B  Gap Junction Mediated Dye-Transfer in TZ/PD differentiated NHU 
Cultures.  
Y1268 (P3) NHU cells were cultured for 6 days in TZ/PD prior to pre-treatment for 30 
minutes with the gap junction inhibitors heptanol (1 mM) or 18α-glycyrrhetinic acid 
(18αGA; 5 µM), or DMSO (vehicle control). Cultures were scrape-loaded in the presence of 
the gap junction permeable Lucifer-yellow dye (green) and the gap junction impermeable 
rhodamine-dextran fluorescent dye (red).  After 6 minutes, the dye-transfer was halted by 
formalin fixation and dyes were visualised by fluorescent microscopy to determine the 
extent of GJIC.  Representative images are shown (one region from five).  Merged overlaid 
images are also shown.  White lines indicate the approximate scratch boundaries.   








Figure 3.9C Assessment of Gap Junction Mediated Dye-Transfer in NHU Cultures. 
Y1268 (P3) NHU cells were treated for 6 days with DMSO (A) or TZ/PD (B). Cultures were 
pre-treated for 30 minutes with the gap junction inhibitors heptanol (1 mM) or 18α-
glycyrrhetinic acid (18αGA; 5 µM), or DMSO control. Cultures were scrape-loaded in the 
presence of Lucifer-yellow and rhodamine-dextran fluorescent dyes.  After 6 minutes, the 
dye-transfer was halted by formalin fixation and visualised by fluorescent microscopy and 
cell counts performed.  The number of cells containing the gap junction permeable dye 
Lucifer yellow, were normalised to the number of initially loaded (rhodamine-dextran) cells 
to give a mean number of LY dye-transmitted cells (per initially loaded cell), at 5 contiguous 
areas across each scratch. 
*** P value <0.001 considered extremely significant 






This data has revealed the expression of multiple connexin genes in human 
urothelium and NHU cell cultures.  Whilst several of these connexins (Cx26, Cx30, 
Cx30.3 and Cx43) are constitutively expressed both in situ and in vitro regardless of 
differentiation status, others (Cx31.9 and Cx32) appear to be distinctly associated 
with a differentiated NHU cell phenotype.  Due to the close association with 
urothelial differentiation using both ABS/Ca2+ and TZ/PD models, Cx32 was selected 
for follow up studies for this research project.  However, this is not to discount the 
clear potential interest for studying other connexins in the urothelium, including 
those not linked to a differentiated state such as Cx26, Cx30, Cx30.3 and Cx43. 
Whilst the non-differentiated and differentiated NHU cell lines where used as a 
screening tool to select candidate connexins worthy of further study here, the gene 
expression of all connexins in freshly isolated urothelium was not performed here.  
There may be other connexins expressed in situ for which the differentiation 
models lack expression which would be useful to include for future studies.  A 
summary of this gene expression data, along with other representative tissues and 
cell types which express each connexin is summarised in table 3.3. 
 
Cx31.9 may be extremely relevant to the differentiated phenotype of urothelium, 
especially given that expression was only observed with the ABS/Ca2+ model of 
differentiation (in which tissue stratification and barrier function is observable), but 
not the TZ/PD model.  In situ expression was also observed in freshly isolated, 
uncultured NHU cells (P0), which is of particular interest since Cx31.9 is rarely 
expressed in other tissues (and not in other epithelia).   
 
Cx45 was the only connexin where expression appeared to be associated with loss 
of differentiated phenotype.  Cx45 knock-out mice are embryonically lethal; 
possibly because Cx45 is essential for the early stages of cardiogenesis (Kumai et al. 




human keratinocytes (Di et al. 2001) and corneal epithelium (Yuan et al. 2009), 
there is little evidence to support a functional role for Cx45 in epithelial tissues, or 
to indicate why Cx45 expression may be reduced in response to differentiation cues 
in urothelium.   
 
There are very few studies describing connexin expression in the urothelium 
however previous studies have shown expression of two of the most frequently 
studied human connexins; Cx26 and Cx43.  In studies of cultured human urothelial 
cells, expression of Cx26 and Cx43 mRNA was detected and loss of Cx26 expression 
was observed in human bladder cancer cell lines (Grossman et al. 1994) and bladder 
tumour tissue biopsies (Gee et al. 2003).  In rat bladder, Cx26 and Cx43 were found 
to be expressed in the urothelium in a punctate labelling pattern (Sunagawa et al. 
2015) and in mouse urothelium, Cx26 was described as restricted to the basal cell 
compartment (Lorentz et al. 2012).     
 
This is the first systematic characterisation of connexin family expression in 
urothelium and demonstrates that urothelial cells alter their connexin expression 
upon differentiation to produce specific channels.  Dye-transfer studies indicated 
that functional channels exist in both non-differentiated (confluent) and 
differentiated NHU cultures. 
 
It should be noted however that RT-PCR was selected as a gene expression 
screening tool for the connexins, for which there are technical caveats due to it 
being a fixed end-point method, such as limiting reagent concentrations after the 
exponential phase of the reaction.  Therefore subtle changes in abundance cannot 
be presumed accurate and although useful as a crude screening tool, quantitation 










Representative tissues and cell 
types*  
Cx25 no nd  
Cx26 Yes – ND and D Yes (P0) Breast, cochlea, placenta, 
hepatocytes, skin, pancreas, 
kidney, intestine 
Cx30 Yes – ND and D Yes (P0) Brain, cochlea, skin 
Cx30.2 no nd Brain, spinal cord, Schwann cells 
Cx30.3 Yes – ND and D Yes (P0) Skin, Kidney 
Cx31 no nd Cochlea, placenta, skin 
Cx31.1 Yes – ND and D no Skin 
Cx31.9 Yes – D only Yes (P0) Vascular smooth muscle 
Cx32 Yes – D only Yes (P0) Hepatocytes, Schwann cells 
Cx36 no nd Neurons, pancreatic β-cells 
Cx37 no nd Endothelium, granulosa cells, 
lung, skin 
Cx40 no nd Endothelium, lung, myocardium, 
skin 
Cx40.1 no nd Heart, Kidney, Liver, Pancreas 
Cx43 Yes – ND and D Yes (P0) Bone, cartilage, colon 
myocardium, skin, spleen, thyroid, 
tonsil (among many others) 
Cx45 Yes – ND and D no Myocardium, neurons, skin, 
smooth muscle cells 
Cx47 no nd Brain, spinal cord 
Cx50 no nd Lens 
Cx59 no nd Retinal cells 
Cx62 no nd Retinal cells 
 
Table 3.3  Connexin genes and their expression in human cells and organs.   
Data in red are summarised from the present study, all other data is derived from previous 
studies* with major sites of expression selected.  ND = non-differentiated urothelial 
cultures.  D = urothelial cultures differentiated by adaptation of culture conditions (Varley et 
al. 2004b, Cross et al. 2005).  P0 = freshly isolated (uncultured) urothelial cells from human 
bladder.  nd = no data (Gene expression was not examined in these freshly isolated samples 
due to lack of expression in urothelial cultures). 
*data derived from multiple sources (Di et al. 2001, Nielsen et al. 2003, Sohl et al. 2003, 





Since it is understood that different connexins form selective channels offering 
distinct permeability characteristics (Goldberg et al. 2004), it is a possible that in 
urothelium, expression of multiple connexins may support a range of physiological 
functions, some of which may or may not be overlapping.  It has been proposed 
that several connexins have alternative roles within multi-protein complexes for 
regulation of cell polarity, with influence on the assembly or maintenance of 
tight/adherens junctions (Herve et al. 2012).  It is therefore possible that although 
some urothelial connexins may be involved in cell-cell communication, other 
connexins may have an alternative communication-independent role.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 
The unique differentiation-restricted expression of Cx32 transcript in both freshly-
isolated NHU cells, as well as in NHU cultures differentiated using two independent 
cell culture methods, suggests that Cx32 may play a prominent functional role 
during urothelial cytodifferentiation or in the homeostasis of the mature 
urothelium.  However, data presented in this chapter does not identify a potential 
role, nor allow for speculation as to whether the role of Cx32 in urothelium might 
be dependent or independent of Cx32-mediated cell-cell communication.   
 
Patients with X-linked Charcot-Marie-Tooth disease (CMTX) demonstrate that 
partial or total loss of Cx32 channel function is not lethal, but does lead to 
progressive peripheral nerve neuropathy linked to a highly specific role of Cx32 in 
Scwann cells (Patel et al. 1994, Scherer et al. 1999, Kleopa 2011).  Moreover, there 
are no apparent urinary tract defects reported in these patients as may be 
predicted in light of the present study, nor are there reports of liver dysfunction or 
enhanced hepatocarcinogenesis as might be predicted since Cx32 is a major liver 
gap junction and a marker of hepatocyte differentiation (Piechocki et al. 2000).  This 
suggests that the function of Cx32 in liver and bladder is either non-essential for 
tissue function or there may be potential for redundancy from other connexins.  It 
is likely a complex situation since CMTX patients are found with a huge degree of 




loss.  The number of patients with total Cx32 gene deletion appears to be very few 
and therefore liver and/or urinary tract symptoms may not be reported as 
significant (Gonzaga-Jauregui et al. 2010).  There is added complexity in that 
transcriptional regulation of Cx32 differs between Schwann cells and liver 
(Piechocki et al. 2000, Murphy et al. 2011), each being expressed from separate 
Cx32 splice variants (differing only in the 5’ UTR’s).  Although, given that the 
majority of CMTX patients have mutations in the coding sequence for Cx32 (rather 
than in the UTR), there is little evidence to suggest that this should explain the lack 
of liver and/or bladder pathologies in these individuals.   
Specific PPARγ antagonism blocked the inducibility of Cx32 during TZ/PD 
differentiation of NHU cells in vitro.  This suggests that it is highly likely that Cx32 
expression in human urothelium is regulated under the influence of PPARγ, as is the 
case with a range of other proteins identified as “markers” of urothelial 
cytodifferentiation (see section 1.1.6.4).  Specific PPARγ antagonism was not 
considered in cultures differentiated using the ABS/Ca2+ method and therefore 
regulation of Cx32 expression by PPARγ using this method of differentiation cannot 
be supported.  As with the PPARγ-regulated aquaporin 3, induction of Cx32 
expression was more effective in cultures differentiated with TZ/PD than those 
differentiated following the ABS/Ca2+ method, thus further providing evidence for a 
strong influence of PPARγ on the expression of Cx32.  It should be noted from 
immunoblotting data that it is a requirement that EGFR signalling is inhibited for 
maximal PPARγ-driven Cx32 expression.  Inhibition of EGFR-signalling in the 
absence of differentiation did induce a small amount of dimeric Cx32 expression, 
however not to the same extent as when PPARγ was activated.  This in itself is of 
potential interest, since a study in rat hepatocytes has reported that EGFR can 
phosphorylate Cx32 at tyrosine residues (Diez et al. 1998).  However the biological 
significance of this finding is not known, although Diez et al. speculate that it may 
play a role in assembled channel stoichiometry and thus channel function.  Since 
little is known about the exact mechanism by which bovine serum induces 
urothelial cytodifferentiation in vitro, it is not possible to determine the relative 




ABS/Ca2+ method of differentiation, when compared with using troglitazone to 
directly ligand-activate PPARγ.  Future studies using a specific PPARγ antagonist in 
ABS/Ca2+ differentiated cultures may provide further understanding. 
 
Sequence analysis did not identify a high-affinity PPRE within the promoter region 
of Cx32, increasing the likelihood that the PPARγ-mediated induction of Cx32 is 
indirect.  Although caution must be taken not to over-interpret the findings of 
transcription factor binding predictor tools, the predicted presence of a high-affinity 
FOXA1 binding site 800bp upstream of the Cx32 start codon might be an 
encouraging starting candidate in unravelling the mechanisms of Cx32 regulation in 
urothelial cells.  The promoter region of FOXA1 does contain a high-affinity PPRE 
and FOXA1 has previously been shown to act downstream of PPARγ, as an 
intermediary transcription factor driving expression of other markers of urothelial 
cytodifferentiation, including UPK2 (Varley et al. 2009).  However, FOXA1 has not 
previously been described as a regulator of Cx32 gene expression.  The 
transcription factor SOX10 has been shown to directly regulate human Cx32 in 
Schwann cells of peripheral nervous system and mutations in the SOX10 binding 
region of the Cx32 promoter (position -526bp), have been identified in a subset of 
patients with the Cx32-linked form of Charcot-Marie-Tooth disease (Bondurand et 
al. 2001, Houlden et al. 2004).  Cx32 is the predominant gap junction protein 
expressed in liver and is a commonly used marker of hepatocyte differentiation, as 
well as being a key mediator of cell-cell communication throughout the liver (Patel 
et al. 2012). Studies in rat hepatoma cells have identified Sp1 and two putative 
HNF-1 binding regions (at -187 and -736), within the Cx32 promoter region as being 
crucial to Cx32 expression (Piechocki et al. 2000). 
 
Observation of monomeric and dimeric Cx32 products was observed by 
immunoblotting, which is consistent with the theory that Cx32 is commonly 
resolved in monomeric and dimeric form by SDS-PAGE  (Green et al. 1988, VanSlyke 




independent Cx32 antibodies for immunoblotting in Cx32 wild-type and knock-out 
mice neatly demonstrated this phenomenon (Nagy et al. 2003).  Three monoclonal 
and two polyclonal Cx32 antibodies were used; raised to epitopes present in both 
the cytoplasmic loop and the C-termianl domain of Cx32.  Nagy et al. demonstrated 
two Cx32 products at approximately 30-32 kD and 50-52 kD in Cx32 wild-type mice, 
which were absent in knock-out mice; this was a consistent finding with all five 
antibodies (including the antibody used in the present study).  A third band at 
approximately 90 kD was observed with four of the five antibodies tested, however 
this was not lost in Cx32 knock-out mice and therefore was presumed to be non-
specific.  An additional study demonstrated dimeric Cx32 products with multiple 
Cx32 antibodies which were absent in Cx32 K/O mice (Nagy et al. 2003).  There are 
possible explanations for why Cx32 may resolve in monomeric and dimeric forms 
and one study reports a shift in immunoreactivity to only a monomeric form when 
samples are reduced in 50 mM DTT (Tang et al. 2009).  These are more stringent 
conditions than followed in standard protein preparation methods for SDS-PAGE, 
where DTT concentrations are commonly in the 1-10 mM range (2 mM used in the 
current study), suggesting that disulphide bonds formed when connexins dimerise 
require strong reducing conditions for separation.  It has been demonstrated that 
Cx32 GJ channel assembly involves dimeric and tetrameric intermediates (Ahmad et 
al. 2001) and therefore with specific SDS-PAGE conditions it tetramers may also be 
present, however these were not detected in the conditions used in the current 
project.  Given that Cx32 GJ assembly involves dimeric intermediates, it seems 
unlikely that the observation of the Cx32 immunoreactive 50-52 kD band is the 
product of a strong interaction between Cx32 interacting and another protein of 
similar size (although not impossible).  Therefore given the supporting literature the 
term “dimeric” was used throughout in the present study.    
 
In differentiated NHU cultures two specific bands at approximately 32kD and 50 kD 
were observed, however the dimeric band was not observed in non-differentiated 
cultures.  The presence of dimeric Cx32 bands following induction of differentiation 




dimeric band observed on immunoblots represents assembled Cx32 junctional 
complexes at the membrane, or partially assembled connexons prior to membrane 
insertion.  Under differentiating conditions, inhibition of PPARγ blocked both the 
expression of Cx32 dimeric products and also membrane-associated Cx32; 
suggesting that PPAR activation not only regulates overall Cx32 expression, but also 
induces the development of membrane-associated Cx32 channels.  The presence of 
monomeric Cx32 products in non-differentiated cultures along with a small amount 
of cytoplasmic Cx32 labelling suggests a likely low level basal Cx32 expression is 
expressed by NHU cells even in the absence of differentiation.  This is supported by 
the quantitative RT-PCR data which demonstrated some increase in Cx32 
expression over time in non-differentiating growth conditions (treated with DMSO 
as a vehicle control), although to a much lesser extent than when differentiation 
was induced with TZ/PD.  It is highly possible that this increase in Cx32 expression 
over time is due to an increased culture confluence, however non-quantitative RT-
PCR analysis of non-differentiated NHU cultures of increasing cell density (in the 
absence of DMSO as a vehicle control), did not result in an apparent upregulation of 
Cx32.  This may be due to the threshold of sensitivity associated with viewing 
RT-PCR amplicon products by gel-electrophoresis, although an alternative 
explanation may implicate DMSO treatment with enhanced Cx32 gene expression, 
since DMSO has been previously recognised as a differentiation-enhancing agent 
(Chetty et al. 2013).   
 
In situ, urothelium is organised into basal, intermediate and superficial cell layers, 
with each compartment expressing specialist proteins appropriate for function.  
The superficial cells are often described as terminally-differentiated, based on their 
high degree of specialisation towards barrier function, such as the expression of the 
uroplakins, which generate a transcellular barrier to urine (Hu et al. 2002) and  
terminal tight junctions which support barrier function (Varley et al. 2006, Smith NJ 
et al. 2015).  Since PPARγ plays a key role in driving expression of many proteins 
expressed superficially in the urothelium, it was noteworthy to find that Cx32 




superficial cell layer of urothelial cells in situ.  The positioning of membrane-bound 
Cx32 within the basolateral membrane of superficial cells may infer a potential role 
in allowing passage of specific signalling molecules between the superficial cell zone 
and the intermediate/basal cell layers, or a potential role in the final stages of 
differentiation or repair following loss of superficial cells (for example due to 
infection). 
 
In NHU cultures differentiated following the ABS/Ca2+ method, a tight barrier (as 
measured by TER) is known to develop following supplementation of ABS pre-
treated cultures with near-physiological concentrations of calcium (Cross et al. 
2005).   The timing of Cx32 protein expression at the cell membrane was observed 
to be approximately coincidental with that of the tight junction proteins claudin 5 
and ZO-1.  Some assembly was observed in cultures treated with bovine serum 
alone; however expression was enhanced and more consistent across the entire 
culture after calcium concentrations were increased.  This indicates that Cx32 
expression is temporally and spatially similar to the development of urothelial tight 
junctions during the process of barrier development.    
 
In summary, data presented here indicates that several connexins are expressed in 
human urothelium; singled out to be of particular interest was Cx32, due to its close 
correlation with terminal differentiation of this tissue under the influence of the 
nuclear receptor and transcriptional regulator PPARγ.  It remains to be determined 
whether functional Cx32 gap junctions are essential to the physiology of human 
urothelium.  Work presented in the final two chapters will address the hypothesis 
that Cx32 plays a critical role in the balance between generation of a tight urothelial 







4. Defining the Role of Cx32 in Urothelial 
Differentiation 
 
Previous studies have linked specific connexin expression to tissue differentiation, 
in some cases with implications on cell polarity and development of tight junctions.  
Data presented in results chapters 3 has identified Cx32 as a gap junction protein 
which is highly up-regulated during urothelial cell differentiation, indicating 
potential relevance to the differentiated urothelial cell phenotype.  This chapter will 
focus on the specific role of Cx32 and its associated cell-cell communication, in one 
particular aspect of urothelial biology: the generation of a tight epithelial barrier.    
4.1 Aims 
Specific objectives were to: 
 generate Cx32 knock-down and Cx32 overexpressing (wild-type and pore-
closed dominant-negative) human urothelial sub-lines (section 4.3) 
 characterise the morphology, growth rates and gap junction-mediated 
communication of Cx32 knock-down and Cx32 overexpressing (wild-type 
and dominant-negative) transduced cells  (section 4.4) 
 assess the differentiation capacity and barrier function of Cx32 knock-down 
and Cx32 overexpressing (wild-type and dominant negative) NHU cells 
following induction of differentiation using the ABS/Ca2+ method (Section 
4.5) 
 assess the histology and tight junction ultrastructure of differentiated 
urothelial constructs in Cx32 knock-down and Cx32 overexpressing (wild-
type and dominant negative) NHU cells, compared with control cultures 
(section 4.6) 
 evaluate the potential physical association of Cx32 with the urothelial tight 





4.2 Experimental Approach 
Cx32 shRNA knock-down, Cx32 (wild-type) overexpressing and Cx32 (dominant 
negative) overexpressing sub-lines were developed from NHU cells, using retroviral 
gene transfer technology.  Full-length Cx32 cDNA was cloned from differentiated 
NHU cells and was used to generate the dominant-negative mutant by site-directed 
mutagenesis.  Full method details of retroviral vector preparation and transfection 
into packaging cells are detailed in chapter 2.9.4.   
 
The dominant-negative form of Cx32 was generated by a single point mutation 
which eliminates functionality without interfering with gap junction formation, as 
described by Beahm et al. (2006), see figure 4.1.  The mutated channel (Cx32T134A) is 
reported to be correctly synthesised, trafficked and inserted into the plasma 
membrane where it is able to dock with partner connexons on adjacent cells; 
however passage of signalling molecules through the channel is disabled, enabling 
the identification of cellular behaviours which are entirely communication-
dependent, rather than just dependent on physical expression. 
 
Retroviral particles were collected from the growth medium of the transfected 
PT67 packaging cell line and used to transduce proliferating NHU cells before 
subjecting the cells to antibiotic selection.  Immunoblotting and 
immunocytochemistry techniques were used to confirm Cx32 knock-down or 
overexpression, using an antibody which recognises the C-terminus of Cx32; 
identical in both wild-type and mutated Cx32T134A.   RT-PCR was performed to 






Figure 4.1  Schematic of Cx32 Pore-closed Mutant. 
A single point mutation in a threonine (position 134) at the cytoplasmic end of the third 
transmembrane helix (approximate location is indicated by the star symbol), is described to 
eliminate functionality without interference with gap junction formation (Beahm et al. 
2006).  This threonine is strictly conserved among the α- and β-connexin subgroups.  
 
Transduced NHU sub-lines were observed by phase-contrast microscopy for 
morphological changes before and after differentiation with ABS/Ca2+.  Growth 
capacities of all transduced cultures were assessed in cultures grown in KSFMc 
using an AlamarBlue® assay, to determine the effects of Cx32 expression and 
associated cell-cell communication on NHU cell proliferation. 
 
Dye-transfer techniques were used to determine the effects of Cx32 gene silencing 
and overexpression of wild-type (Cx32WT) and dominant negative Cx32 (Cx32T134A) 
on functional gap junction mediated cell-cell communication.  This was particularly 
important since no antibody specific to the mutated T134A Cx32 was available, 
therefore dye-transfer studies served to confirm dominant negative function. In all 
dye-transfer studies, transduced cells were cultured in troglitazone and PD153035, 
to induce a differentiated phenotype (and Cx32 expression) in a monolayer, to 





TER measurements were recorded to determine the functional role of Cx32 for 
barrier attainment in transduced NHU cultures.  To determine the effects of Cx32 
manipulation on differentiation capacity, western blot analysis of each transductant 
during differentiation with ABS/Ca2+ was performed, to study the expression of 
other differentiation-associated markers such as tight junction proteins, CK13 and 
E-cadherin.  Transmission electron microscopy (TEM) was performed on 
differentiated NHU constructs to assess the tight junction integrity in Cx32 knock-
down and overexpressing Cx32WT and Cx32T134A transductants.   
 
A flow diagram to summarise the experiments performed with Cx32 modified sub-
lines is shown in figure 4.2 and the individual sub-lines generated are summarised 
in table 4.1. 
 
A proximity ligation assay was performed on differentiated (non-transduced) NHU 
cells, to assess potential direct tight junction protein interactions with Cx32.  The 
assay involves use of two primary antibodies raised in different host-species to label 
two proteins for which an interaction is unknown.  Ligation of labelled 
oligonucleotides attached to specific secondary antibodies occurs when the 
proteins of interest are in close proximity (<40 nm) resulting in a fluorescent signal.  
The technique allows for localised detection of interacting protein pairs (Soderberg 




















Y1185 Ureter 45/F Cx32 shRNA (1,2,3) and control shRNA 
Y1117 Ureter 64/F Cx32 shRNA (1) and control shRNA 
Y1057 Ureter unknown Cx32 shRNA (1) and control shRNA 
Y1119 Ureter 65/F Cx32 shRNA (1) and control shRNA 
Y1151 Ureter 31/F Cx32 shRNA (1) and control shRNA 
Y1270 Ureter 76/F pLXSN (empty, Cx32-WT and Cx32-T134A) 
Y1284 Ureter 64/F pLXSN (empty, Cx32-WT and Cx32-T134A) 
Y1277 Renal Pelvis 68/F pLXSN (empty, Cx32-WT and Cx32-T134A) 
Y1247 Ureter 67/F pLXSN (empty, Cx32-WT and Cx32-T134A) 
 







4.3 Generation of Cx32 Knock-down and 
Overexpressing Human Urothelial Sub-lines 
4.3.1 Generation of Cx32 shRNA and Cx32WT and Cx32T134A 
overexpressing vectors 
A Mlu1 restriction digest on purified plasmid DNA confirmed that the three 
independent Cx32 shRNA sequences were successfully ligated into the retroviral 
vector pSIREN-RetroQ (Fig 4.2).  shRNA reactions containing the Mlu1 enzyme ran 
more slowly through the gel than control reactions without Mlu1 enzyme, 
indicating linearization.  Control empty pSIREN-RetroQ vector was not linearised by 
Mlu1. 
 
Generation of the Cx32WT-pLXSN overexpression vector was confirmed by 
sequencing.  After mutating the wild-type Cx32 coding sequence by site-directed 
mutagenesis, a Dpn1 digest confirmed the presence of newly synthesised plasmid 
DNA (Fig 4.3 A) and sequencing results confirmed that 1 out of the 4 single bacterial 
colonies from which plasmid was purified, successfully contained the T134A 
mutation (Fig 4.3 B). 
 
Full plasmid map details for pSIREN-RetroQ and pLXSN are provided in the methods 






Figure 4.2  Schematic of shRNA Vectors and Mlu1 Restriction Digest to Verify Cx32 
shRNA Inserts. 
To verify that the pSIREN-RetroQ vector contained Cx32 shRNA inserts, a Mlu1 restriction 
digest was performed on purified plasmid DNA.  The three shRNAs were designed to be 
inserted directionally between BamHI and EcoRI restriction sites (A).  Each shRNA contained 
a Mlu1 restriction site downstream of the hairpin loop (not found in the vector backbone).  
shRNA digests containing the Mlu1 enzyme resulted in a product that was retarded on the 






Figure 4.3  Sequence Confirmation for DNA Plasmids following Site-directed 
Mutagenesis. 
(A) Cx32 (wild-type plasmid) was subjected to site-directed mutagenesis using primers 
to incorporate the single base change.  The resulting plasmid DNA PCR products 
were incubated with DpnI restriction enzyme to digest methylated parental (non-
mutated) plasmid to leave only mutated plasmid, as illustrated by reduced intensity 
of band at 4 kb(*).  Following Dpn1 digest, additional smaller DNA fragments were 
observed (**).  These are predicted to be incomplete PCR products from the site-
directed mutagenesis, or partially DpnI-digested parental plasmid according to 
Edelheit et al. 2009.  
(B) Purified plasmids containing “mutated” Cx32 DNA were sequenced following 
bacterial expansion to identify successful site-directed mutagenesis.  Of four 
sequenced plasmids, one contained the desired T134A mutation as circled in red 
(ACC mutated to GCC at nucleotide position 400).  
 
4.3.2 Generation of retroviral transfected PT67 packaging cell 
lines 
Following transfection of the PT67 packaging cells with the pSIREN-RetroQ shRNA 
or pLXSN overexpression vectors, antibiotic selection was effective in removing 
non-transfected cells from the cultures.   Phase contrast micrographs of packaging 




and 4.5 respectively.  Mock-transfected control cultures were killed by the 
antibiotic selection within 3 days for shRNA-transfected cells grown in puromycin 
and 5 days for pLXSN-transfected cells grown in G418.   
 
 
Figure 4.4  Phase Contrast Micrographs of Cx32 shRNA Transfected PT67 Cells 
Following Antibiotic Selection. 
PT67 cells were transfected with pSIREN-RetroQ vector containing Cx32 shRNAs 1, 2 
and 3 (B-D respectively) and selected in puromycin.  A mock-transfected control was 
included to demonstrate the effectiveness of the antibiotic on non-transfected cells 
(A).  Images were taken 3 days after growth in 4 µg/ml puromycin.   






Figure 4.5  Phase Contrast Micrographs of pLXSN Transfected PT67 Cells Following 
Antibiotic Selection. 
PT67 cells were transfected with pLXSNempty (B), pLXSN-Cx32WT (C) and pLXSN-Cx32T134A and 
then selected in 0.5 mg/ml G418.  A mock-transfected control was included to demonstrate 
the effectiveness of the antibiotic on non-transfected cells (A).  Images were taken after 5 
days growth in antibiotic.   
Scale bar = 200 µM 
 
4.3.3 Generation of stable Cx32 shRNA knock-down sub-lines 
Following retroviral transduction complete death of mock-transduced NHU cells 
occurred after 5 days in puromycin, whilst the successfully transduced NHU cells 
were actively proliferating indicating successful antibiotic selection (Fig 4.6).  The 
transduction efficiency was estimated to be similar for control and Cx32 shRNA 
cells; however transduction efficiencies between three independent NHU cell lines 




70%.  The appearance of Cx32 shRNA cells grown in KSFMc was morphologically 
indistinguishable from control shRNA cultures; cells grew as a monolayer with an 






Figure 4.6  Phase Contrast Micrographs of Representative Cx32 shRNA Transduced 
NHU Cells Following Antibiotic Selection. 
Y1185 (P1) NHU cells were transduced with retroviral particles containing control shRNA (B) 
and Cx32 shRNAs 1, 2 and 3 (C-E respectively) and then selected in 1 µg/ml puromycin.  A 
mock-transfected control was included to demonstrate the effectiveness of the antibiotic on 
non-transfected cells (A).  Images were taken 5 days after antibiotic treatment.   





4.3.4 Verification of Cx32 shRNA knock-down in NHU 
transductants 
RT-PCR analysis of Cx32 transcript demonstrated an observable knock-down in 
expression in Cx32 shRNA cells grown in either 5% serum or cells differentiated in 
ABS/Ca2+, compared to control shRNA cells (Fig 4.7 A).  Expression of Cx32 was not 
detected by RT-PCR in control or Cx32 shRNA cells grown in either KSFMc 
(undifferentiated) or 2mM [Ca2+] (stratified).   
 
Cx32 protein expression in differentiating cultures was analysed by immunoblotting 
to verify successful protein knock-down (Fig 4.7 B).  Following 5% ABS pre-
treatment, the calcium concentration in cultures was increased to 2mM and protein 
lysates of control shRNA and Cx32 shRNA (1), (2) and (3), were collected after 3 or 6 
days.  Bands were analysed by densitometry following normalisation to the loading 
control β-actin, which revealed that after 3 days the expression of the dimeric 
product of Cx32 was reduced by 58%, 31% and 41% in each of the three shRNA 
transductants respectively, compared to the scrambled control shRNA cells.  By day 
6 post differentiation, protein knock-down was less pronounced, with expression of 
dimeric Cx32 product knocked down by 34% in Cx32-shRNA (1) cell lysates and in 
shRNAs (2) and (3), expression was 2% or 9% higher (respectively) than scrambled 
control cells.   
 
Monomeric Cx32 product was knocked-down to a lesser extent than dimeric, with a 
reduction of 36%, 15% and 25% in shRNA (1), (2) and (3) respectively after 3 days 
compared with control shRNA cells.  By 6 days post-differentiation, monomeric 
Cx32 product was reduced by only 12% in shRNA (1) compared with control shRNA 
cells, however there was a 53% increase in Cx32 shRNA (2) and no change in Cx32 





An additional band at approximately 100 kD was observed in these blots; previous 
studies with Cx32 knock-out mice using the same antibody suggest that it is non-
specific since the same band was observed in lysates from Cx32 knock-out mice 
(Nagy et al. 2003).  It was therefore not analysed in this study.  
Cx32 shRNA (1) gave the most effective knock-down of Cx32 protein and was 







Figure 4.7  Verification of Cx32 Knock-down in Retroviral Transduced NHU Cultures. 
(A) Expression of Cx32 transcript was examined in Y1185 Cx32 shRNA-1 transduced NHU 
(k/d) and control shRNA (Ctrl) cell cultures, grown for 5 days in KSFMc, 2 mM [Ca2+] or 
5% ABS, or differentiated following the ABS/Ca2+ method for 6 days.  Cx32 expression 
was analysed by RT-PCR and β-actin was included as a normalisation control.  A 
negative control β-actin PCR was performed in which the reverse transcriptase was 
omitted.  
(B) Cx32 protein expression in Y1185 NHU cells transduced with control shRNA (Ctrl) or 
three independent Cx32 shRNAs (1-3) after 3 or 6 days grown in differentiating 
conditions following the ABS/Ca2+ method.  Whole cell lysates were processed for 
western blotting and labelled with antibodies against Cx32 or β-actin as a loading 
control.  Cx32 monomeric and dimeric products are indicated.  Both bands were 
assessed by densitometry after normalisation to β-actin and expression of each band is 





4.3.5 Subcellular localisation of Cx32 in control shRNA and 
Cx32 shRNA transduced NHU cultures 
Expression of Cx32 in ABS/Ca2+ differentiated NHU control shRNA cultures was 
cytoplasmic with clean continuous Cx32-labelling observed along the intercellular 
cell membranes of the majority of cells (Fig 4.8).  In Cx32 shRNA knock-down cells, 
membrane labelling was sparse when compared to control shRNA cells although 
the majority of cells contained some cytoplasmic labelling.   
 
Figure 4.8  Cx32 Immunocytochemistry in Cx32 shRNA Transduced NHU Cultures. 
Cx32 immunolabelling in Y1185 ABS/Ca2+ differentiated NHU cells transduced with either 
control shRNA (A) or Cx32 shRNA 1  (B).  Arrows indicate membrane labelling.   
C = negative control, D-F = Corresponding Hoechst 33258 images.  





4.3.6 Generation of Cx32-overexpressing wild-type and 
T134A dominant-negative mutant sub-lines 
After harvesting viral particles from the packaging cells, NHU cells were retrovirally 
transduced with pLXSNempty, pLXSN-Cx32WT or pLXSN-Cx32T134A and selected with 
G418 to kill any non-transduced cells.  Mock transduced NHU cultures were 
included to verify the effectiveness of the G418 selection.  Complete death of the 
mock-transduced cells occurred after 4 days in G418, whilst the successfully 
transduced NHU cells were growing back (Fig 4.9).  The effectiveness of each 
transduction varied between experiments, with estimated efficiencies between 40 
and 60% based on the population of cells which survived antibiotic treatment.  
 
Figure 4.9  Phase Contrast Micrographs of Representative pLXSN Transduced NHU 
Cultures following Antibiotic Selection. 
Y1270 NHU cells were transduced with pLXSNempty (B), pLXSN-Cx32WT (C) and pLXSN-
Cx32T134A (D) and then selected in 0.1 mg/ml G418.  A mock-transfected control was 
included to demonstrate the effectiveness of the antibiotic on non-transduced cells (A).  
Images were taken 4 days after antibiotic treatment.   




4.3.7 Verification of Cx32WT and Cx32T134A overexpression in 
transduced NHU cultures 
In control (pLXSNempty) cells, expression of dimeric Cx32 was induced following 
differentiation using the ABS/Ca2+ method, with very little monomeric Cx32 protein 
observed regardless of culture conditions (Fig 4.10 A).  Expression of monomeric 
and dimeric Cx32 bands were strongly upregulated in both wild-type and mutant 
Cx32 overexpressing cells.  In overexpressing cells, Cx32 protein expression was 
substantially increased as differentiation progressed.  Densitometry analysis of 
Cx32 bands after 6 days culture in ABS/Ca2+ revealed an increase in monomeric 
Cx32 by 40- and 29-fold in CxWT and Cx32T134A cells respectively, and dimeric Cx32 
by 10-fold in both Cx32WT and Cx32T134A (Fig 4.10 B).   
 
In addition to monomeric and dimeric protein products, immunoblotting with 
Cx32WT and Cx32T134A cell lysates demonstrated expression of many additional 
bands and some band smearing was observed.  The extra protein products were 
associated with Cx32 overexpression, increased in intensity during cell 
differentiation and were not observed in control (pLXSNempty) cells.  This included a 
13kD product which is the size of the C-terminal tail recognised by the Cx32 
antibody. The 13kD product was particularly abundant in non-differentiated cells 
and cells treated with 5% ABS, with a small amount observed in differentiated cells.   
 
4.3.8 Subcellular localisation of Cx32 in overexpressing 
Cx32WT and Cx32T134A transduced NHU cells 
Intensity of Cx32 by immunocytochemistry was increased in Cx32WT and Cx32T134A 
transductants when compared to pLXSN empty vector control cells (Fig 4.11).  In 
Cx32WT and Cx32T134A overexpressing cells, strong punctate Cx32 expression was 
observed in large cytoplasm vesicles, whereas cytoplasmic Cx32 expression was 




Areas of continuous membrane labelling were observed in all cells, however large 
patches of cells in both Cx32WT and Cx32T134A overexpressing cultures contained 
thick brightly labelled plaques of Cx32 which appeared to be membrane-associated 
and were not observed in control cells (Fig 4.11 D).   
 
Figure 4.10  Western blot analysis of pLXSN transduced Y1270 NHU cells.   
NHU cells were transduced with pLXSNempty, pLXSN-Cx32WT and pLXSN-Cx32T134A and 
differentiated using the ABS/Ca2+method.  Whole cell lysates were collected during the 
differentiation time course (in KSFMc, after 5 days in 5% ABS and after 6 days in ABS/Ca2+) 
and 12 µg protein was processed for immunoblotting.  Monomeric, dimeric and breakdown 
products are indicated on the western blot image (A).   Densitometry analysis was 
performed and after normalisation to β-actin, expression of monomeric and dimeric Cx32 





Figure 4.11  Immunocytochemistry of Cx32 in pLXSN-transduced NHU Cultures 
following Differentiation in ABS/Ca2+. 
pLXSN-transduced Y1270 NHU cells were seeded onto glass slides and differentiated 
following the ABS/Ca2+method prior to fixation.  Immunofluoresence of Cx32 
immunolabelling in pLXSNempty (A), pLXSN-Cx32WT (B) and pLXSN-Cx32T134A (C & D) cells is 
shown.  Continuous membrane labelling (white arrows, A to C) and large membrane 
plaques (green arrows, D) are indicated.  Large membrane plaques were observed in both 
Cx32WT and Cx32T134A cultures, but not pLXSNempty transduced cells. 





4.4 Assessment of Growth and Morphology of Cx32 
Knock-down and Overexpressing Human Urothelial 
Cell Lines 
4.4.1 Assessment of growth in Cx32 shRNA Knock-down NHU 
cells.  
Growth rates in Cx32 and control shRNA transduced NHU cells grown in KSFMc (3 
independent cell lines, Y1057, Y1119 and Y1185) were determined by Alamar Blue® 
assay (Fig 4.12).  Cx32 shRNA cells were growth-inhibited compared with control 
shRNA cells, but this effect was variable between cell lines and most pronounced 
early in the exponential growth phase (approximately 4-5 days post-seeding) where 
the percentage reduction of Alamar Blue® was significantly different in all three cell 
lines.  However, overall growth trends over the 11 day time period were 
comparable between Y1057 control and Cx32 shRNA cells (Fig 4.12 A), whereas 
Cx32 shRNA cells demonstrated reduced growth rates compared to control shRNA 
cells in both Y1119 and Y1185 cell lines (Fig 4.12 B & C). 
 
4.4.2 Assessment of growth in Cx32WT and Cx32T134A 
overexpressing transduced NHU cells 
The biomass of pLXSN-transduced (empty vector, Cx32WT and Cx32T134A) NHU sub-
line cultures was determined by Alamar Blue® assay which was performed up to 9 
days after seeding in KSFMc (Fig 4.13).  Cultures displayed normal growth patterns 
regardless of plasmid insert, with exponential growth occurring between days 3 and 







Figure 4.12  Assessment of Growth in Cx32 shRNA Knock-down NHU Cultures. 
Alamar Blue® assays were performed on Y1057 (A), Y1119 (B) and Y1185 (C) NHU cell lines, 
transduced with control shRNA or Cx32 shRNA retroviral vectors.  Percentage reduction of 
Alamar Blue® over a 10 or 11 day period was plotted to demonstrate growth of cells grown 
in KSFMc.  Each data point is the average of six replicates ± SD.   






Figure 4.13  Assessment of Growth in Cx32 Wild-type and Dominant Negative Cells. 
Alamar Blue ® assays were performed on Y1247 NHU cells transduced with pLXSN-empty 
vector, pLXSN-Cx32WT and pLXSN-Cx32T134A retroviral overexpression vectors.  Percentage 
reduction of Alamar Blue® was plotted over a 9 day period to demonstrate growth of cells 





4.4.3 Assessment of morphology of Cx32 knock-down and 
overexpressing Cx32WT and Cx32T134A cells following 
differentiation in ABS/Ca2+ 
Examination of Cx32 shRNA cells after differentiation in ABS/Ca2+ for 6 days 
revealed that they were similar in appearance to control cells, with a 
heterogeneous population of spindly and stratified cells characteristic of a 
differentiated phenotype (Fig 4.14 A-C).  Some cells contained phase-bright 
borders.  Cx32 overexpressing cells (Cx32WT and Cx32T134A) were very similar in 
morphology to empty-vector control cells (Fig 4.14 D-F).  All pLXSN-transduced 
cultures exhibited heterogeneous morphologies with large numbers of spindly cells, 
some containing large vacuoles and a number of small rounded cells with phase-
bright borders. 
 
Figure 4.14  Phase Contrast Micrographs of Cx32 shRNA Knock-down, Cx32WT and 
Cx32T134A. 
Overexpressing NHU Cultures following Differentiation in ABS/Ca2+ Phase contrast 
micrographs of mock (A), control shRNA (B) and Cx32 shRNA (C) transduced NHU cells 
(Y1185 at P4) and Y1270 NHU cells transduced with pLXSN-Empty Vector (D), pLXSN-Cx32WT 
(E) and pLXSN-Cx32T134A (F) at P4.  Following transduction and successful selection of NHU 
cultures, cells were differentiated according to the ABS/Ca2+ protocol.   




4.4.4 Effects of Cx32 knock-down and overexpression on gap 
junction mediated intercellular communication    
Quantitative assessment of Lucifer yellow dye-transfer was performed in Cx32 
shRNA knock-down and in Cx32WT and Cx32T134A overexpressing cells, following 
differentiation with the TZ/PD method to study the extent of functional GJIC in each 
transduced cell line. 
 
In Cx32 shRNA cells, Lucifer yellow dye-transfer was significantly reduced when 
compared with control shRNA cells (Fig 4.15).  In shRNA control cells the mean 
number of lucifer yellow containing cells was 8.8 ± 2.6 (sd) for every cell initially 
scratch loaded (as observed by Rhodamine dextran), whereas the mean number of 
Lucifer yellow containing cells in Cx32 shRNA cultures was 4.5 ± 1.5 (sd).    
 
Quantitative assessment of Cx32WT overexpressing cells revealed that there was a 
highly significant increase in the number of dye-receiving cells following scratching, 
when compared to pLXSN empty vector control cells and Cx32T134A dominant 
negative cells (Fig 4.16).  There was also a significant reduction in dye-transfer in 
Cx32T134A dominant negative cells, compared to empty vector and Cx32WT cells 
suggesting inhibition of GJIC when the mutant channel was over expressed, 
indicative of a dominant negative influence.  In Cx32WT overexpressing cells, the 
mean number of Lucifer yellow dye-transmitted cells was 10.1 ± 3.5 (sd) for every 
cell initially loaded with Rhodamine dextran, whereas the mean number of Lucifer 
yellow containing cells in  Cx32T134A overexpressing cells was 1.1 ± 0.2 (sd) and in 






Figure 4.15  Lucifer Yellow Scrape-load Dye-transfer in Cx32 Knock-down Cultures. 
Y1117 Cx32 shRNA and control shRNA transduced NHU cultures were differentiated 
following the TZ/PD method for 6 days.  Cultures were scratched in the presence of Lucifer 
yellow and Rhodamine-dextran fluorescent dyes to load cells during temporary membrane 
perturbation.  The number of cells containing the gap junction-permeable dye Lucifer 
yellow, were normalised to the number of initially loaded (rhodamine dextran) cells at 10 
continuous areas across each scratch.  White lines indicate the approximate scratch 
boundaries.  Scale bar = 50 µm 





Figure 4.16  Lucifer Yellow Scrape-load Dye-transfer in Cx32WT and Cx32T134A 
Transduced Cultures. 
pLXSN-empty, Cx32WT and Cx32T134A transduced NHU cultures (Y1270) were differentiated 
following the TZ/PD method for 6 days, before scratching to load cells in the presence of 
fluorescent dyes.  The number of cells containing Lucifer yellow were normalised to the 
number of initially loaded (Rhodamine dextran) cells at 10 regions of interest across each 
scratch.  White lines indicate the approximate scratch boundaries.  Scale bar = 50 µm 
*** P value <0.001 considered extremely significant   **P<0.01 considered very 




4.5 Assessment of Barrier Function and Differentiation 
Capacity of Cx32 Knock-down and Overexpressing 
Human Urothelial Cell Lines 
4.5.1 Assessment of barrier function in Cx32 shRNA knock-
down cultures 
In Cx32 shRNA transduced cells, barrier development as measured by TER was 
delayed following differentiation with ABS/Ca2+, when compared to control shRNA 
transduced cells or mock-transduced NHU cells (Fig 4.17 A).  The effect was 
apparent with all three Cx32 shRNA sequences.  After 6 days in differentiating 
conditions the mean TER values of mock-transduced and control shRNA cultures 
were 2500 Ω.cm2 ± 75 (sd) and 2490 Ω.cm2 ± 437 (sd) respectively, compared with 
Cx32 knock-down cultures for which the mean TER values were 212 Ω.cm2 ± 4 (sd), 
168 Ω.cm2 ± 6 (sd), and 186 Ω.cm2 ± 10 (sd) for Cx32 shRNA (1), (2) and (3) 
respectively.  However, a tight barrier did eventually develop in all Cx32 shRNA cells 
between days 10 and 13 after induction of differentiation.    
 
Although the rates of barrier development during differentiation of independent 
donor samples was variable, the compromised barrier development following Cx32 
gene silencing was reproducible in three independent cell lines transduced with 
control shRNA and Cx32 shRNA (Fig 4.17 B).  After 6 days in differentiating 
conditions, all three cell lines examined had significantly lower TER values following 





4.5.2 Assessment of barrier function in Cx32WT and Cx32T134A 
transduced NHU cultures 
To examine the relationship between Cx32-mediated cell-cell communication and 
barrier development, TER was examined in wild-type and mutant Cx32 
overexpressing cell lines during differentiation in ABS/Ca2+.  Transduced cell lines 
from three independent donors were investigated (Fig 4.18 A).  Although there 
were some significant TER differences between empty vector, Cx32WT and Cx32T134A 
transductants, particularly in the Y1277 cell line, there were no clear and consistent 
differences in TER which could be confirmed across multiple cell lines at both 3 and 
6 days during differentiation.  
 
Variability in barrier development was clear between the three cell lines, one of the 
cell lines tested (Y1270) gave a tight barrier which exceeded 1500 Ω.cm2 after 3 
days in differentiating conditions, whilst the other two cell lines (Y1284 and Y1277) 
were still below 500 Ω.cm2 at a comparable time point during differentiation, 
confirming that barrier attainment across different donor cell lines occurs at a 
variable rate. 
 
The relationship between gap junction-mediated intercellular communication and 
barrier development of NHU cells was further examined in non-transduced NHU 
cells, undergoing differentiation in the presence of the generic gap junction 
communication inhibitor 18α-glycyrrhetinic acid (Fig 4.18 B).   
 
Barrier development (as measured by TER) was not compromised by the addition of 
18α-GA.  3 days after seeding cells in ABS/Ca2+, the mean TER of NHU cells treated 
with 5 µM or 50 µM 18α-GA was 1937 Ω.cm2 and 2223 Ω.cm2 respectively (n=6), 




>3900 Ω.cm2 by day 6 and no significant difference was observed between 18α-GA 
treated and control cultures. 
 
 




(A) Barrier function of Cx32 shRNA knock-down NHU cells (Y1185, P4) was 
determined by measurement of TER in ABS/Ca2+ differentiating conditions at 3, 6, 10 
and 13 days following addition of 2 mM calcium.  Mean TER values of control shRNA 
and mock-transduced NHU cells are represented by solid lines, whilst the TER of 
three Cx32 shRNA transductants (three independent Cx32 shRNA sequences) are 
represented by dashed lines.  Data show the mean of four replicate cultures ± SD 
(***P<0.001 T-test comparing the mean TER for the Control shRNA with the mean 
value TER of Cx32 shRNA at day 6 post addition of Ca2+). 
(B) Barrier function as measured by TER in three independent cell lines (Y1185, 
Y1151 and Y1057), transduced with control or Cx32 shRNA retroviral vectors and 
grown on permeable Snapwell™ membranes.  Mean TER values are plotted after 3 
or 6 days culture in ABS/Ca2+ differentiating conditions.  Data show the mean of 4-6 
replicate cultures ±SD (*** P<0.001 *P<0.05 NS = not significant (P>0.1).  T-test 






Figure 4.18 Effect of Cx32-mediated GJIC on the Barrier Development of 
Differentiated NHU Cultures. 
(A) Barrier function of Y1270, Y1284 and Y1277 NHU cells overexpressing wild-type 
or pore-closed mutant Cx32, determined by measurement of TER in cells grown in 
ABS/Ca2+ on permeable Snapwell™ membranes.  Mean TER values (±SD) are plotted 




pLXSN-Cx32WT cells (dashed bar) and pLXSN-Cx32T134A cells (white bar).  Data 
show the mean TER of 3 to 6 replicate cultures ± SD (One way ANOVA P values of 
***=P<0.001, **=P<0.01 and *=P<0.1 indicate significance with Tukey-Kramer post-
test.  Where a P-value is not indicated, data was considered not significant). 
(B) Barrier function as measured on by TER plotted on days 3 and 6 during 
differentiation of Y1335 NHU cultures in ABS/Ca2+.  Cells were grown on permeable 
Snapwell™ membranes and treated with 5µM or 50µM 18α-glycyrrhetinic acid (18α-
GA) or DMSO vehicle control for the duration of the experiment.  Data show the 
mean TER of 6 replicate cultures ±SD (One-way ANOVA P values of >0.3 at day 3 and 
>0.5 at day 6, considered not significant). 
 
4.5.3 Phenotypic Assessment of Cx32 shRNA knock-down 
cells during differentiation. 
Control and Cx32 shRNA cells were seeded at equivalent cell densities and 
differentiated following the ABS/Ca2+ method. Whole cell lysates were collected 
during the differentiation time course; from cultures before addition of serum 
(untreated), after culture in serum for 1 or 3 days and at days 1, 3 and 6 after 
increasing the calcium concentration to [2 mM] (as summarised in 4.19A).  This 
allowed for a time-dependent assessment of proteins associated with urothelial 
differentiation and tight barrier development such as claudins and Zonula 
Occludens proteins.   
 
Cx32 shRNA expression in NHU cells resulted in Cx32 protein knock-down (Fig 4.19 
B), however as observed previously (see Fig 4.7), the knock-down in protein 
became less pronounced as differentiation proceeded.  Monomeric Cx32 was 
expressed throughout the differentiation procedure, with knock-down in 
expression observed at early time-points (day 0 and after 1 day in ABS).   Dimeric 
Cx32 protein was upregulated following the switch to ABS/Ca2+, with knock-down 




shRNA knock-down on expression of selected markers of urothelial differentiation 
are summarised below. 
 
Claudin 4  
Claudin 4 was expressed following treatment of cells with 5% ABS and the 
expression of both proteins increased as differentiation progressed. Claudin 4 
expression was reduced in Cx32 knock-down cells when compared to control shRNA 
cells, this was particularly apparent before the addition of calcium but continued 
throughout (Fig 4.19 B-D).       
 
Claudin 5 
A large decrease in Claudin 5 expression was observed in Cx32 shRNA cells, 
compared to control shRNA cells throughout the full 6 day differentiation period, 
with expression knocked down by approximately 75% after 1 day in ABS and 50% 
after 6 days in ABS/Ca2+.   
 
Claudin 7 
Claudin 7 was expressed in non-differentiated cells, although expression did 
increase during differentiation.  The effects of Cx32 knock-down on claudin 7 were 
not consistent, since at day 0 a slight increase in expression was observed in Cx32 
shRNA cells; this was reduced compared to control cells after 1 day in ABS but for 
the remainder of the differentiation time-course claudin 7 expression was 







E-cadherin was first observed after the addition of ABS to the cultures and 
expression was increased after the switch to ABS/Ca2+.  In Cx32 shRNA cells, E-
cadherin expression was reduced compared to control cells, until after 3 days in 
ABS/Ca2+ when levels became comparable between control and Cx32 shRNA cells.   
 
Cytokeratin 13 
CK13 expression was increased during differentiation with very little/no expression 
in non-differentiated cultures, however expression levels were highest in control 
cells at day 1 in ABS/Ca2+, after which expression declined during the latter part of 
the time course.  Expression of CK13 was reduced in Cx32 shRNA cells until 1 day in 
ABS/Ca2+, after which the expression of CK13 was found to be higher in Cx32 knock-
down cells than control cultures. 
 
ZO-1 
Both ZO-1α- and ZO-1α+ splice variants of ZO-1 were expressed in differentiating 
NHU cells as indicated by the double band recognised by the ZO-1 antibody.  In 
Cx32 knock-down cells a decrease in ZO-1α- was observed early in the 
differentiation time course compared to control cells, however by day 6 in ABS/Ca2+ 
there was more ZO-1α- observed in Cx32 shRNA cells than control cells.  Expression 
of the ZO-1α+ splice variant was reduced in Cx32 knock-down cells throughout the 
differentiation experiment.   
 
ZO-2 
ZO-2 expression was observed throughout the differentiation time-course with 
some induction of expression after 1 day and 3 days in ABS.  This induction of ZO-2 




but after this time point the expression of ZO-2 was comparable between the two 
transduced cell lines. 
ZO-3  
ZO-3 expression was not induced in cells until growth conditions were switched to 
ABS/Ca2+.  The induction of ZO-3 expression was delayed in Cx32 shRNA cells, as 
observed by reduced ZO-3 expression after 1 day in ABS/Ca2+ compared to control 
shRNA cells.    
 
Occludin 
Occludin expression was upregulated during differentiation of control shRNA cells 
and was found to be reduced in Cx32 shRNA cells after 1 day in ABS, but 
comparable to control shRNA cells at later time points.  Overall, occludin expression 
was highest after 1 day in ABS/Ca2+ and a decline in expression was observed after 
6 days culture in ABS/Ca2+.   
 
4.5.4 Localisation of selected tight junction proteins in Cx32 
shRNA cells 
Expression of ZO-1 and ZO-3 were examined by immunocytochemistry in Cx32 
shRNA cultures after differentiation in ABS/Ca2+ for 6 days.  In control shRNA cells 
both ZO-1 and ZO-3 were expressed at cell borders in most cells across the culture 
where expression highlighted a largely intact network of tight junctions (fig 4.20).  
In Cx32 shRNA cells, expression of both ZO-1 and ZO-3 were observed, however 
distribution at cell borders was patchy and sparse.  Cytoplasmic labelling for both 
ZO-1 and ZO-3 was at a similar intensity in Cx32 shRNA cultures and control shRNA 





4.5.5 Phenotypic assessment of wild-type and mutant Cx32 
overexpressing cells following differentiation. 
 
Cx32WT, Cx32T134A and pLXSN-empty vector control cells were seeded at comparable 
cell densities and whole cell lysates were collected from non-differentiated cultures 
grown in KSFMc, after culture in 5% serum for 5 days and in differentiated cultures 
grown according to the ABS/Ca2+ method.   
 
Forced expression of wild-type and mutant Cx32 resulted in the overexpression of 
monomeric and dimeric Cx32 protein products (Fig 4.21).  The increase in Cx32 
protein products was more apparent in differentiated cultures for all three 
transductants, compared with non-differentiated cultures; however in this cell line 
(Y1270), very little monomeric Cx32 was expressed in control pLXSNempty cells.  The 
overexpression of Cx32 did not appear to impact on the protein expression levels of 
claudins 4 and 5 or occludin, all of which were upregulated following addition of 











Y1151 NHU cells expressing either Cx32 shRNA (k/d) or control shRNA (Ctrl) were 
seeded and pre-treated with 5% serum for 5 days, followed by 5% ABS and 2 mM 
Ca2+ for 6 days, as summarised in (A).  Whole cell lysates were harvested before 
treatment (day 0) and after 1 or 3 days in ABS or 1, 3 or 6 days in ABS/Ca2+ and 
processed for immunoblotting with anti-Cx32, Claudin 4, Claudin 5, Claudin 7, E-
cadherin, Cytokeratin 13 (CK13), ZO-1, ZO-2, ZO-3, Occludin and β-actin (loading 
control) antibodies (B).  For ZO-1, the upper band represents the ZO-1α+ variant and 
the lower band the ZO-1α- variant.  Parallel cultures were seeded on permeable 
Snapwell™ membranes after 5 days ABS pre-treatment.  Mean TER values of 6 
replicate cultures are indicated in brackets below.   
Densitometry analysis of each band formed and (after normalisation to β-actin) was 
plotted as fold-change relative to control shRNA from cultures after 1 day grown in 






Figure 4.20  Immunocytochemistry of ZO-1 and ZO-3 in Cx32 shRNA Transduced 
Cultures following Differentiation in ABS/Ca2+. 
Y1185 transduced cells were seeded onto glass slides and differentiated with 5% 
ABS and 2mM Ca2+ for 6 days prior to fixation.  Immunofluoresence of ZO-1 and 
ZO-3 immunolabelling in control and Cx32 shRNA cells is shown.  Cell nuclei were 






Figure 4.21  Immunoblot Analysis of Cx32 Overexpressing Cultures During 
Differentiation in ABS/Ca2+. 
Y1270 NHU cells transduced with overexpressing pLXSN-Cx32WT, Cx32T134A or control 
pLXSN-empty vector control plasmid were seeded and grown to 80% confluence.  
Whole cell lysates were harvested from non-differentiated (KSFMc) cells, cells grown 
in 5% ABS for 5 days or cells differentiated according to the ABS/Ca2+ method and 
processed for immunoblotting with anti-Cx32, Claudin 4, Claudin 5, Occludin and 





4.6 Assessment of Histology and Ultrastructure of 
Cx32 Knock-down and Overexpressing Differentiated 
Human Urothelial Cell Lines 
4.6.1 Analysis of histology and ultrastructure of Cx32 shRNA 
cell sheets after differentiation in ABS/Ca2+ 
The barrier function of transduced NHU cells (Y1117) was assessed by TER, before 
fixation and processing for transmission electron microscopy. TER measurements 
for control shRNA and Cx32 shRNA cells were 2000 Ω.cm2 and 533 Ω.cm2 
respectively, at day 6 post-differentiation in ABS/Ca2+.  The histological appearance 
of toluidine blue-stained control and Cx32 shRNA cell sheets grown on permeable 
membranes were similar (Fig 4.22 A and B).  Each membrane was overlaid with an 
intact sheet of cells approximately 3 cells thick with occasional vacuoles observed 
between cells.   
 
Apical tight junctions were observed in all electron micrographs of control shRNA 
cells which reproducibly appeared as protein dense (dark), clearly-defined tight 
junction strands, aligned between the apical-most aspect of cell contact (Fig 4.22 C-
K).  The particle distance across the width of the tight junction strands was 
measured to be approximately 15 nm.   
 
Tight junction-regions in Cx32 shRNA transduced cells were extremely variable (Fig 
4.22 L-T).  Some areas of apical cell-cell contact did not contain defined protein-
dense strands, but rather wider, indistinct areas of protein with a blurred 
appearance (Fig 4.22 L, M, O, R).  Other regions contained apparent tight junction 
strands which were distinct, but shorter than those observed in control shRNA cells 
(Fig 4.22 N and O).  Some tight junction strands were comparable to those observed 
in control shRNA cells (Fig 4.22 P and S), whilst other areas completely lacked a 




4.6.2 Analysis of histology and ultrastructure of wild-type and 
mutant Cx32 overexpressing cell sheets after 
differentiation in ABS/Ca2+ 
The barrier function of pLXSN transduced NHU cell cultures (Y1284) were assessed 
by TER before fixation and processing for TEM analysis; measurements were 
1500 Ω.cm2, 1450 Ω.cm2 and 1430 Ω.cm2 for control empty-vector, Cx32WT and 
Cx32T134A overexpressing cells respectively at day 6 post-differentiation in ABS/Ca2+.  
The histological appearance of toluidine blue-stained cell sheets grown on 
permeable membranes was similar between all three transductants (Fig 4.23 A-C).  
Each cell sheet was approximately 3 cells thick with occasional vacuoles observed 
between cells.  In Cx32T134A cells, toluidine blue uptake was variable and many 
purple spots were observed within the cytoplasm of cells.   
 
Apical tight junctions were observed in electron micrographs of all transductants 
with some variability in protein density surrounding tight junction regions; however 
the overall majority of tight junction strands were clearly-defined and protein dense 






Figure 4.22  Transmission Electron Micrographs of Terminal Tight Junctions in Cx32 
shRNA Differentiated Cell Constructs.    
Light microscopy images of resin embedded ultrathin (0.1 µm) sections of control shRNA (A) 




differentiating on permeable Snapwell™ membranes for 6 days following the ABS/Ca2+ 
method.  TER values for each construct are indicated.  Six replicate cultures were 
differentiated; the cell sheet with the TER reading closest to the mean was selected for 
transmission electron microscopy analysis.  Thick ruckled areas can be observed in the resin 
sections.  Transmission electron micrographs were taken of the apical-most tight junctions 
in control shRNA (C-K) and Cx32 shRNA (L-T) differentiated cells.  Yellow arrow indicates a 
well-defined tight junction strand (D) and the white arrow indicates a non-developed 
junction between two apical cells (M).   Note: all apical tight junctions assessed in control 
shRNA cells contained well defined tight junction strands (C-K), whereas tight junction 
regions in Cx32 shRNA cells were either less defined (L, N, O, P, Q, R, S), or non-developed 
(M and T).   
Light microscopy scale bar (black) = 50 µm  







Figure 4.23  Transmission Electron Micrographs of Terminal Tight Junctions in Cx32 
Overexpressing Wild-type and T134A Mutant NHU Constructs.    
Light microscopy images of resin embedded ultrathin (0.1 µm) sections of control empty-
vector pLXSN (A) pLXSN-Cx32WT (B) and pLXSN-Cx32T134A (C) transduced NHU cell sheets 
(Y1284), stained with Toluidine Blue after differentiation on permeable Snapwell™ 
membranes for 6 days following the ABS/Ca2+ method.  TER values for each construct are 
indicated.  Four replicate cultures were differentiated; the cell sheet with the TER reading 
closest to the mean was selected for transmission electron microscopy analysis.  Thick 
ruckled areas can be observed in the resin sections.  Transmission electron micrographs 
were taken of tight junctions regions in pLXSN-empty (D & G), pLXSN-Cx32WT (E & H) and 
pLXSN-Cx32T134A (F and I) differentiated cells.  Well defined tight junction strands were 
observed in apical tight junction regions for all three transductants.   
Light microscopy scale bar = 50 µm 




4.7 The Association of Cx32 with Urothelial Tight 
Junction Proteins 
4.7.1 Assessment of Cx32 interaction with tight junction 
proteins 
Cx32 protein interactions were examined in ABS/Ca2+ differentiated urothelial 
constructs using a Proximity Ligation Assay (PLA).  Areas with fluorescent spots 
were observed throughout the cell sheets when antibody combinations for 
Cx32/Occludin and Cx32/ZO-2 were applied to cell sheets indicating a potential 
interaction between Cx32 and these two tight junction proteins (Fig 4.24).  Cx32 did 
not appear to co-localise with ZO-3, since distinct fluorescent spots were not 
observed.  As a positive control, primary antibodies for the known interacting tight 
junction proteins ZO-1 and ZO-3 were applied to human ureter and bright areas of 








Figure 4.24  Proximity Ligation Assay to Evaluate Cx32 Co-localisation with Tight 
Junction Proteins in Differentiated Urothelial Constructs. 
Y1151 (non-transduced) NHU cells were differentiated according to the ABS/Ca2+ 
method for 6 days on Snapwell™ permeable membranes, prior to fixation in 10% 
formalin and paraffin-embedding.  A fluorescent proximity-ligation assay (Duolink®) 
was performed on de-waxed 5 µM sections with primary antibody combinations as 
indicated on each image.  Cells were counterstained in Hoechst 33258.  White spots 
indicate areas of antibody interactions (arrows).  The known interaction of ZO-1 and 
ZO-3 was used as a positive control on a section of human ureter (Y1216).   











 Cx32 knock-down cultures were generated which gave 
functional reduction in gap junction-mediated intercellular 
communication 
 Cx32 expression was knocked-down in these cultures, but the 
reduction in protein expression became less pronounced as 
differentiation proceeded over time 
 Morphologically, Cx32 knock-down cells were similar to 
controls with a minor reduction in growth rate of non-
differentiated cells 
 Normal barrier development of differentiated NHU cells was 
inhibited as a consequence of Cx32 shRNA knock-down 
 Tight junction protein expression was affected by Cx32 knock-








 Cx32 overexpressing cultures were generated.  A functional 
reduction in gap junction-mediated intercellular 
communication was observed when the pore-closed mutant 
was expressed and an increase in functional communication 
was observed in wild-type overexpressing cultures.   
 Cx32 protein was overexpressed successfully in 
undifferentiated and differentiated cells.   
 Morphologically Cx32 overexpressing cultures were similar in 
appearance to control cells with similar growth rates 
 Overexpression of wild-type and mutant forms of Cx32 did not 
affect barrier function.    
 Tight junction expression and ultrastructure appeared normal 
in all overexpressing cells 
 
NHU cells 
 Treatment of NHU cells with a general gap junction inhibitor 
did not affect barrier development 
 In differentiated cells, Cx32 potentially co-localised with 
Occludin and ZO-2, but not ZO-3  





The primary function of the urothelium is to line the urinary tract and prevent 
toxins from re-entering the body after urine production by the kidneys; therefore a 
tight barrier function is essential to bladder physiology.  It is considered that the 
urothelium serves as the tightest barrier epithelium in the human body (Negrete et 
al. 1996); with terminal tight junctions, the most apical components of intercellular 
junctional complexes, playing a fundamental role in barrier attainment (Anderson 
et al. 2009). 
 
In vitro, terminal tight junction complexes have been shown to develop during 
urothelial cytodifferentiation in vitro under the influence of the nuclear receptor 
PPARγ (Varley et al. 2006).  Regulated expression of specific claudin proteins, 
including claudins 3, 4, 5 and 7, form the basis of the primary seal-forming fibrils in 
urothelium and concurrent expression of zonnula occludens proteins plays a likely 
role in maintaining structural support for these tight junctions, by linking the 
cytoplasmic face of tight junction complexes to the actin cytoskeleton (Varley et al. 
2006, Smith NJ et al. 2015).  Previous reports have suggested that a compromised 
urothelial barrier, demonstrated by decreased expression of claudins, ZO-1 and 
occludin, may contribute to benign disease states including interstitial cystitis and 
painful bladder syndrome (Slobodov et al. 2004, Southgate et al. 2007, Lee et al. 
2014).   
 
4.8.1 Cx32 and barrier function of NHU cultures 
Data presented here provides direct evidence that the gap junction protein Cx32 
performs a distinct role in urothelial barrier acquisition.  Inhibition of Cx32 
expression by RNA interference with three independent Cx32 shRNAs, resulted in a 
striking delay in barrier formation when NHU cells were differentiated in culture.  
This was associated with a time-delay in expression and assembly of tight junction 




tight junctions, as assessed by TEM.  A complete knock-out of Cx32 was not 
achieved by RNA interference and Cx32 protein expression did increase in Cx32 
shRNA cultures during the differentiation period.  The accumulation of dimeric Cx32 
in these knock-down cultures was slower than in control cells but did eventually 
reach comparable expression levels.  This may indicate the formation of a stable 
membrane pool with low turnover, which eventually reaches a maximum 
expression level necessary for function.  It is not possible to speculate as to whether 
a complete Cx32 knock-out in NHU cultures would ablate barrier function and the 
development of tight junction complexes altogether, or whether Cx32 expression 
enhances the rate of barrier development but is not essential to the final barrier 
outcome.  It is possible that the role of Cx32 in barrier development could be 
compensated by other connexins.  The urothelia in Cx32 knock-out mice and 
patients with Cx32-linked Charcot-Marie-Tooth disease have not previously been 
reported to be defective, however this could be an interesting avenue for future 
study.  
 
4.8.2 Connexin/tight junction interactions 
It is believed that the primary function of gap junctions is for communication; to 
allow individual cells within a tissue to behave in a co-ordinated manner.  However, 
gap junctions are often found to be located within tight junction complexes and it 
has been proposed that several connexins have a secondary role to function within 
multi-protein complexes for regulation of cell polarity, with influence on the 
assembly or maintenance of tight/adherens junctions (reviewed in Herve et al. 
2012).  This role is supported by evidence from thyroid epithelial cells, where co-
expressed connexins were found to differ in their membrane locations, with Cx43 
being located within tight junction regions and Cx32 in the lateral membrane 
domain (Guerrier et al. 1995).  It is interesting to note that although thyroid follicles 
co-express both Cx32 and Cx43, when thyrocytes are cultured as a monolayer they 
lose expression of Cx32, which they then regain when in vitro conditions are 




comparable to the expression of Cx32 in NHU cells, where monolayers of 
undifferentiated cells do not express Cx32, however differentiated stratified cell 
sheets do.  Co-immunoprecipitation studies with cultured mammary epithelial cells 
have described interactions between Cx43 and Cx32 with ZO-2 and alpha- and beta-
catenins (Talhouk et al. 2008).  Cx43 was shown to be crucial for tight junction 
development in Sertoli cells (Li et al. 2010). 
The epithelium of the intestine is, like urothelium, a key barrier epithelium where 
tightly regulated paracellular transport is paramount for function.  It has been 
reported that Cx26 interacts with occludin in polarised sheets of intestinal epithelial 
cells (Nusrat et al. 2000). 
Cx32 expression has been associated with the expression of tight junction proteins 
in primary cultured rat hepatocytes, where Cx32 (but not Cx26) co-
immunoprecipitates with occludin, claudin 1 and ZO-1 (Kojima et al. 2001).  
Immortalised mouse hepatocytes lacking Cx32 were transfected with human Cx32 
and northern blot analyses demonstrated a concurrent induction of occludin and 
claudins 1 and 2 (Kojima et al. 1999).  In addition Cx32 was found to co-
immunoprecipite with occludin in these cells.    
 
Current knowledge of the temporal coincidence of gap and tight junction proteins 
indicates that a role for Cx32 interacting at the urothelial tight junction is entirely 
plausible.  The proximity-ligation assay (PLA) data presented in this study is 
evidence of direct interactions between Cx32/ZO-2 and Cx32/occludin (but not 
Cx32/ZO-3).  A recent study using PLA technology in WIF-B9 hepatocytes 
demonstrated that Cx32 and claudin 2 are co-localised and that this interaction is 
disrupted by the presence of cadmium (Boucherie et al. 2013).  Cadmium is a highly 
toxic environmental pollutant and a known human and animal carcinogen.  Is has 
been held responsible for tumour formation in several organs including the 
prostate, lungs and testes (Bertin et al. 2006) and has very recently been linked to 
urothelial carcinogenesis as a result of occupational cadmium exposure (Colt et al. 




interaction between claudin 2 and Cx32 is crucial for hepatocyte barrier function, 
although they did not present evidence of any barrier defect as a direct result of 
cadmium treatment in the study.   
4.8.3 Tight junction assembly in NHU cultures 
In the present study, the timecourse of Cx32 and tight junction protein expression 
demonstrated that development of the urothelial tight junction is a multi-step 
process involving timed appearance of protein constituents.  Expression of dimeric 
Cx32, and ZO3 were markedly enhanced following the switch to physiological 
calcium concentrations, coinciding with barrier development.  The presence of tight 
junction proteins by immunoblotting does not necessarily imply functional 
assembly at the cell junction, however immunocytochemistry demonstrated that 
assembly of both ZO-1 and ZO-3 were compromised in Cx32 knock-down cultures at 
day 6 post-differentiation (along with a compromised barrier function).   This might 
indicate that functional expression of ZO-3 or Cx32 performs a critical final step in 
the construction of a functional tight junction.   
 
4.8.4 Cx32 assembly in NHU cultures 
Overexpression of Cx32 (both wild-type and mutated) in NHU cell cultures resulted 
in a large number of bands by immunoblotting which were not observed in cells 
transduced with the vector alone.  Monomeric and dimeric Cx32 bands were 
identified; however there were many higher molecular weight bands which may 
represent a large pool of whole or partially assembled/broken down connexons.  
Further work into Cx32 turnover in NHU cells may shed further light on the stability 
of Cx32 in these cultures (in both normal and Cx32 overexpressing states).  
Proteosome inhibitors (e.g. MG132) or inhibitors of intracellular protein transport 
(such as Brefeldin A or temporarily reducing the temperature of cultures), would be 
useful tools for this.  The antibody used in this study reacts with the C-terminal 
domain of Cx32 and the band observed at approximately 13 kD has previously been 
reported to be due to the loss of the C-terminal tail during Cx32 breakdown 




labelling of Cx32 in overexpressing cultures suggests that at least some of the 
overexpressed Cx32 is being broken down by the cell and may be present in a state 
of partial assembly/disassembly.  However, large membrane plaques of Cx32 at cell 
borders in overexpressing cultures, along with an increase in dimeric Cx32 
expression, suggests that there is a significant increase in assembled Cx32 at gap 
junction plaques as a result of the overexpression.  Dye-transfer studies further 
support the finding that much of the overexpressed Cx32 is functional in gap 
junction plaques, since overexpression of Cx32WT significantly enhanced dye-
transfer, whilst the dominant negative mutant Cx32T134A overexpression blocked 
dye-transfer when compared to control (non-overexpressing) cultures.     
 
4.8.5 Cx32 pore-closed dominant-negative mutant 
This is the first investigation in which the T134A mutation in the third 
transmembrane helix of Cx32 has been demonstrated to function in a dominant 
negative fashion, although it has previously been predicted (Beahm et al. 2006).  In 
studies involving several other connexins (Cx26, Cx43 and Cx50), Beahm et al. 
demonstrated that mutation of this conserved thronine does not impede the 
synthesis or trafficking of connexins, insertion into gap junctions or docking with 
partner connexons on adjacent cells; however they observed a completely non-
communicating channel which mimicked a pore-closed state, with an approximate 
reduction in pore size of 17% at the edge of the pore, as examined by cryo-electron 
microscopy.  This threonine residue is strictly conserved in α- and β-connexin 
subgroups (but not γ-connexins) and was demonstrated to block functionality of 
homomeric and hereromeric channel combinations.  Channels comprising 50% 
wild-type and 50% mutated connexin demonstrated total loss of function 
demonstrating the powerful dominant-negative effect of the mutation.  Although 
the T134A mutation was specifically predicted by Beahm et al. to block function of 
Cx32 channels, it was not demonstrated as part of the study, however it was 
independently documented to be the most cytoplasmic pore-lining residue in Cx32 




identified with mutations spanning the entire third transmembrane helix of Cx32, 
including those residues immediately adjacent to T134A, however the T134A 
mutation has not been reported in CMTX patients, which led Beahm et al. to 
speculate that mutations in this residue might be embryonically lethal in man.  
However, Cx32 knock-out mice are known to give birth to live young, although with 
an extremely dysfunctional physiology (Nelles et al. 1996, Scherer et al. 1998).   In 
addition, a small number of CMTX patients with a complete deletion of the coding 
sequence for Cx32 have since been identified, which suggests that embryonic 
lethality is unlikely (Gonzaga-Jauregui et al. 2010). 
The exact mechanism which results in the lack of functionality in this T134A mutant 
is not fully understood.  Cryo-EM demonstrated that the pore size is reduced in the 
mutant pore, by approximately 17% compared with wild-type pores (Beahm et al. 
2006).  However, it is unknown if this occurs at the cytoplasmic or extracellular 
surface and it may be possible that the constriction on diameter is even greater 
within the pore.  It has since been demonstrated in Cx26 that the channel features 
a wide cytoplasmic opening which then narrows into a funnel structure within the 
central pore region (Maeda et al. 2009).   Since the mutant connexins retain the 
ability to form oligomers, traffic and dock successfully there is a possibility that this 
mutation may have influences on channel gating, although the mechanism 
supporting the permanently closed state is not clear.  Several studies have 
described the effects of cytoplasmic pH, calcium concentration and junctional 
voltage (Vj) on gap junction open/closed states (reviewed in (Oshima 2014)).  In 
addition there is a “plug-gating” model which supports the idea that a hydrogen 
bond network set up by the six connexin N-termini may be collapsed to regulate 
channel closure when necessary (Maeda et al. 2009).  A further “ball and chain” 
model reports channel opening/closing as a result of the flexible C-terminus 
“clumping” into a ball and physically blocking the channel pore mouth, with 
evidence for calcium-dependent confirmation changes in the C-terminal domain of 
Cx43 (Delmar et al. 2004, Liu et al. 2006).  However, the T134A mutation described 
here lies in the third transmembrane domain, close to the cytoplasmic loop, making 




of the mutation on neighbouring amino acids and the overall inter-helical 
interactions within the pore may be complex. 
 
4.8.6 Cx32 channel communication and barrier function  
The T134A mutant was of particular use in the current study, since by stable 
overexpression of Cx32T134A or Cx32WT, it was possible to infer whether or not 
behaviours attributable to Cx32 in NHU cells were mediated by intercellular 
communication, rather than just presence.  Cx32T134A mutant NHU cultures did not 
exhibit a defect in barrier generation, whereas Cx32 knock-down cells did, inferring 
that the role of Cx32 in urothelial barrier development is independent of Cx32 
mediated cell-cell communication, but dependent on Cx32 expression.  This is 
further evidenced by the finding that inhibition of cell-cell communication using the 
generic gap junction inhibitor 18α-GA, did not interfere with barrier development.   
 
However, an in vitro study in porcine blood-brain barrier endothelial cells 
demonstrated that Cx40 and Cx43 co-immunoprecipitated with occludin, ZO-1 and 
claudin 5 at tight junctions (Nagasawa et al. 2006); and that disrupting cell-cell 
communication with the gap junction inhibitor 18β-glycyrrhetinic acid inhibited 
barrier function in these cells (as measured by TER), suggesting that intercellular 
communication mediated by Cx40 and/or Cx43 might be necessary for barrier 
development in some cell types.  In addition, in epithelial cells from the intestine 
Cx26 expression was found to be tightly linked to tight junction expression and use 
of the gap junction inhibitor 18β-glycyrrhetinic acid inhibited barrier function in 
these cells (Morita et al. 2004). Conversely Cx26 expression, but not mediated 
intercellular communication was observed to contribute to expression and function 
of tight junctions in human airway epithelial cells (Kojima et al. 2007).  Interactions 
of connexins with tight junction proteins may be cell-type and/or species specific 
and evidence suggests that tight junctions may be in part controlled by connexins 





Given that Cx32 knock-down resulted in a defective barrier development in NHU 
cell cultures, it might have been predicted that Cx32 overexpression could act to 
enhance the rate of barrier development.  This was not observed, implying that 
although Cx32 is required for barrier development, its expression alone is not 
sufficient to instigate barrier formation or an enhancement in the expression of 
tight junction proteins.  This may support a role for Cx32 as an integral component 
of the tight junction complex in urothelial cells, where expression is essential to the 
stabilisation of other proteins at the tight junction complex, but that Cx32 is not 
responsible for the recruitment of these proteins.  The interactions between 
tight/gap junction proteins are highly complex and it may be reasonable to assume 
that loss of any one of these components could destabilise the tight-junction and 
thus deplete barrier formation.   
It should be noted that differences in the rate of barrier development were 
observed in the three transduced cells lines selected for the Cx32 shRNA and also 
Cx32 overexpression studies.  This is particularly evident with the Y1277 
overexpressing cell line, which was the only non-ureteric NHU cell line (renal pelvis 
derived) and gave a rapid tight barrier, in comparison to the other ureteric cell 
lines.  It is plausible that the tissue source of the NHU cells may be linked to the rate 
of barrier development.  However, a large number of studies in which barrier 
function is measured over time have been performed in our lab and variability in 
NHU barrier development rate is common (data not shown here).  This is one of the 
caveats of working with patient-derived samples and does not detract from the 
ability to draw conclusions based on the appropriate controls (control shRNA or 





4.8.7 Cx32 and differentiation of NHU cultures 
In addition to a compromised barrier function and delayed tight junction 
expression, Cx32 knock-down cultures demonstrated a loss of two markers 
associated with urothelial cytodifferentiation: cytokeratin 13 and E-Cadherin.  This 
may indicate potential for a compromised differentiated phenotype in cultures 
lacking Cx32 expression.  A more detailed analysis of differentiation-associated 
proteins including terminal markers of differentiation (such as uroplakins and CK20) 
as well as transcriptional regulators of differentiation in NHU cells did not form part 
of this study, but could for the basis of future studies to further unravel the role for 
Cx32 in urothelial cytodifferentiation.   
 
4.8.8 Summary of findings 
In summary, the results shown here suggest that Cx32 expression is essential for 
the barrier function of this epithelial tissue and that it is likely to be stably 
associated with proteins at the urothelial tight junction complex.   It is unclear 
whether the contribution of Cx32 to urothelial physiology is purely structural at the 
tight junction and independent of gap junction intercellular communication, or 
whether it serves a further role supporting the differentiation and homeostasis of 
the urothelium.  Work presented in the final results chapter will focus on the 








5. Defining the role of Cx32 in Urothelial Wound 
Repair 
 
Data presented in results chapters 3 and 4 identified Cx32 as a gap junction protein 
which was highly up-regulated during human urothelial cytodifferentiation where 
its expression, but not channel-mediated communication, was demonstrated to be 
closely linked to the generation of functional tight junctions and a tight barrier.   
 
This final chapter will consider a further significant aspect of urothelial biology: the 
ability to regenerate and maintain a functional barrier in response to insult or 
injury.   
 
The rate at which a subpopulation of cells migrates into a damaged region is central 
to tissue healing.  Analysis of wound healing in many in vitro and in vivo systems has 
revealed a complex association between connexin expression and the coordination 
of wound healing (Becker et al. 2012).  Connexin-mediated cell-cell communication 
may be required for relaying damage signals to initiate wound-repair in some 
systems, however in others, the expression of connexins is thought to be inhibitory 
to wound migration, for example connexins 31 and 43 are thought to inhibit 
epidermal wound closure (Kretz et al. 2003).  As a further complication, it is 
emerging that connexins may play a key role in cell adhesion (Yang et al. 2011) and 
cell cycle-mediated events (Dbouk et al. 2009), both of which may affect the 








The focus of this chapter was to examine the specific role of Cx32 and Cx32-
mediated cell-cell communication in the repair and regeneration of urothelial 
barrier function, using the differentiated in vitro urothelial cell system (ABS/Ca2+) 
described in earlier chapters. 
 
Specific objectives were to: 
 
 study the role of Cx32 and associated cell-cell communication in 
coordinating the rate of migration during urothelial wound healing (section 
5.1).   
 
 identify signal transduction pathways which may be involved in coordinating 
cell migration in wound healing as a response to intercellular 
communication through Cx32 channels (section 5.2). 
 
 examine the phenotype of differentiated NHU cells during urothelial wound 
repair, with specific focus on the polarity and proliferation status of cells at 
the leading edge of migration (section 5.3). 
 
5.2 Experimental Approach 
To study the relevance of Cx32 and associated cell-cell communication to wound 
healing of differentiated NHU cells, a scratch-wound analysis of Cx32-modified 
cultures was performed.  Retroviral transduction and details of cell lines generated 
are detailed in chapter 4.  Cx32 shRNA knock-down or Cx32 overexpressing (wild-
type and dominant negative) cultures were used to perform this analysis.  As 




(T134A) is correctly synthesised, trafficked and inserted into the plasma membrane; 
however passage of signalling molecules through the channel is disabled, enabling 
the impact of Cx32-mediated communication (rather than just expression) to be 
assessed in wound healing assays.   
 
Transduced cells were differentiated using the ABS/Ca2+ method, before scratching 
with a sterile pipette tip to generate a wound of 750-1000 µm wide across the 
culture.  Time-lapse microscopy was used to image the wound area and establish 
wound-healing healing rates, by measuring the relative decrease in the denuded 
area over time in an environmental chamber (see fig 5.1).   
 
To further verify the relationship between Cx32 and urothelial wound healing, 
parallel cultures grown on Snapwell™ permeable membrane supports were 
differentiated to develop a tight barrier and wounded using the same technique, 
after which the restoration of barrier function was monitored by measuring the TER 
at regular intervals post-wounding, until a tight barrier was achieved.   
 
On the basis of these experiments candidate signalling cascades that may promote 
or inhibit epithelial wound migration were interrogated.  Overexpressing Cx32 wild-
type, Cx32-T134A (dominant negative, pore-closed mutant) and control empty 
vector transduced NHU cells, were scratched multiple times following ABS/Ca2+ 
differentiation.  These cultures were lysed for immunoblotting to enable analysis of 
proteins which may be modified as a result of signalling cascades which may 
influence NHU cell migration (Fig 5.2).  Immunofluoresence on parallel wounded 
cultures was also performed to study protein localisation.    Two pathways closely 





a) The Rho-kinase pathway, known to be a key effector of cell shape and 
movement, via ROCK 1 and 2 proteins.  ROCK 1 and 2 are known to exert 
downstream effects on cytoskeletal organisation by altering the 
phosphorylation status of the actin polymerisation/depolymerisation factor 
cofilin (Rho kinase pathway summarised in Fig 1.3).   
 
b) The canonical TGFβ-receptor (TGFβR) mediated cell signalling pathway was 
also studied.  TGFβR signalling is known to be positively associated with a 
wound-healing phenotype in differentiated NHU cell cultures, where it has 
been shown to promote migration in a process that involves direct 
phosphorylation of the cytoplasmic mediator SMAD3 by activated TGFβRI 
(Fleming et al. 2012).     
 
On the basis of these results, further study of the TGFβR pathway in Cx32-modified 
cultures was performed. The rate of migration of Cx32-modified cultures during 
wound repair was studied following addition of a) exogenous TGFβ1 ligand and b) 
the TGFβRI tyrosine-kinase inhibitor, SB431542.  A single ligand (TGFβ1) and 
inhibitor (SB431542) were selected on the basis that they had previously been 
demonstrated to activate and inactivate TGFβR signalling (respectively) at 
previously defined concentrations (Fleming et al. 2012). RT-PCR analysis of TGFβ 
ligand and receptor genes was performed in non-wounded Cx32-modified cultures 
and during wound-healing, to determine if Cx32-mediated effects on migration rate 
were associated with expression changes of TGFβ ligand or receptor genes.  To 
further elucidate whether ligand released from differentiated NHU cells acts in a 
paracrine manner to drive TGFβ/SMAD3-mediated cell migration following 
wounding, conditioned medium from Cx32WT and Cx32T134A cell cultures was 
harvested from non-wounded and wounded cultures.  This conditioned medium 
was applied to non-transduced (proliferating) NHU cells, which were lysed and 
assessed for SMAD3 activation by immunoblotting with an antibody which 




Immunofluorescence labelling of the SMAD3 transcriptional co-activator CREB 
(cAMP response element binding protein) and its PKA-activated form pCREB 
(ser133) were studied in Cx32-modified cultures, to examine possible changes in 
protein expression and or intracellular localisation, which may be linked to changes 
in migratory behaviour as a consequence of Cx32 channel status.   
 
Examination of PPARγ protein expression in Cx32-modified cultures was also 
studied, since in some biological systems, PPARγ has been demonstrated to 
negatively regulate phosphorylation of SMAD3 (activation), by a physical interaction 
between SMAD3 and PPARγ (Fu et al. 2001).   
 
The wound-healing phenotype of differentiated (non-transduced) NHU cells was 
studied by immunoblotting and immunocytochemistry during wound repair, to 
determine whether migration of cells at the wound edge was associated with a loss 
of urothelial polarity or adhesion.  
 
Finally, the effects of Cx32 channel status on the proliferative capacity of 
differentiated NHU cells was determined by the study of Ki67, a cellular marker 
associated with proliferation.  Expression of Ki67 was determined in non-wounded 






Figure 5.1  Analysis of Differentiated NHU Transductants during Wound Healing. 
Example image to demonstrate wound healing analysis.  Confluent NHU cultures 
were differentiated by the ABS/Ca2+ method and scratched across the centre of the 
culture to generate a wound approximately 750-1000 µM wide.  The denuded area 
was imaged every 2 h and for each time point, the wound area was calculated by 
using the CellM software to outline the wound edge (shown in yellow).  The extent of 
repair was calculated as a percentage, relative to the original wound.  Six replicate 
cultures were wounded for each experimental condition.   






Figure 5.2  Analysis of Protein Expression in Wounded NHU cultures. 
Transduced NHU cells were differentiated following the ABS/Ca2+ method in 6 cm 
culture dishes and scratched eight times by hand with a sterile pipette tip, following 
a grid guideline positioned under the dish.  After incubation for a fixed number of 
hours, whole-cell lysates were harvested to study proteins by immunoblotting 
during the wound-healing process.  Cultures were not washed immediately after 
scratching, to ensure that any factors released by the damaged cells were 
maintained in the growth medium for influence on migrating cultures.  However, 





5.3 The Effects of Cx32 on the Rate of Wound Healing 
of Differentiated NHU Cell Cultures 
5.3.1 The effects of Cx32 knock-down on the wound healing 
rate of differentiated NHU cell cultures 
After scratch-wounding, time-lapse microscopy analysis revealed that control 
shRNA cultures (Y1151, P4) took longer to heal than parallel Cx32 shRNA knock-
down cultures.  Six replicate control cultures took 22-24 h to fully heal (Fig 5.3A), 
whilst Cx32 shRNA cultures took 12-14 h for 100% healing to occur.  The mean time 
taken for a 50% closure (Wc50) was significantly different between the 
transductants, with a Wc50 of 13 h for control shRNA cultures and 7.6 h for Cx32 
shRNA cultures (Fig 5.3B).   Examination of cultures by phase contrast microscopy 
revealed that control and Cx32 shRNA cultures were similar in appearance 
immediately following wounding, containing a heterogeneous population of spindly 
and stratified cells, characteristic of a differentiated phenotype (Fig 5.3C).  
However, 10 hours after wounding, the appearance of Cx32 shRNA cells close to the 
wound edge was altered, with an elongated appearance, aligned in the direction of 
forward movement as if being pulled or stretched forward towards the wound site 







Figure 5.3  Wound Healing Analysis of control and Cx32 shRNA Cell Cultures. 
(A) Cultures of Y1151 (P4) control shRNA and Cx32 shRNA transduced cells were 




1000 µM wide) was generated in 6 replicate cultures which were imaged in an 
environmental chamber every 2 hours.  The mean percentage closure of the wound 
space was plotted against time to demonstrate the rate of wound healing.   
(B) The mean time point at which the wound was 50% closed (Wc50).   Data from 
closure of 6 replicate cultures.  All error bars shown are ± Standard Deviation.   
***P-value =0.0002 considered extremely significant (Unpaired t-test).  
(C) Representative bright field images of Y1151 control or Cx32 shRNA cells 
immediately after wounding and at 10h post-wounding.  Note: red arrow indicates 
regions where cells showed an elongated appearance.   
Scale bar = 500 µM 
 
5.3.2 The effects of Cx32 knock-down on the restoration of 
barrier function after wounding 
Restoration of barrier function after wounding was measured in control and Cx32 
shRNA cultures by scratch-wounding of differentiated (ABS/Ca2+) cell sheets grown 
on Snapwell™ membranes and measuring the TER immediately after wounding, and 
then at regular intervals during wound repair.  Immediately prior to wounding, 
mean TER measurements of control and Cx32 shRNA cultures were 2565 Ω.cm2 
(± SD =348) and 2478 Ω.cm2 (± SD = 351) respectively.  Mean TER measurements 
were reduced to 381 Ω.cm2 and 330 Ω.cm2 for control and Cx32 shRNA cultures 
respectively, immediately following scratch-wounding (Fig 5.4) and TER values for 
both remained <500 Ω.cm2 for 3 h post-scratching, with no significant difference 
observed between the two cell types.  However, from 5 h post-scratching, barrier 
recovery was considerably more rapid in Cx32 shRNA cultures than control shRNA 
cultures, with a significant difference in barrier function at 5, 7 and 9 h post-
wounding.  By 24 h post-wounding, mean TER values in control shRNA cultures had 
increased to a similar value as observed in Cx32 shRNA cells (difference between 






Figure 5.4  Recovery of Transepithelial Electrical Resistance in Cx32 shRNA Cultures 
Following Wound Damage. 
Y1151 (P4) control shRNA and Cx32 shRNA cells were seeded onto Snapwell™ 
permeable membranes and differentiated for 10 days by the ABS/Ca2+ method.  A 
single scratch (750-1000 µM wide) was generated in 6 replicate cultures and TER 
values were measured at intervals over a 24 h period.  Mean TER values were 
plotted against time to demonstrate the rate of barrier repair.  All error bars shown 
are ± Standard Deviation. 





5.3.3 The effects of Cx32WT and Cx32T134A overexpression on 
the wound healing rate of differentiated NHU cell 
cultures 
After scratch-wounding, time-lapse microscopy analysis revealed differences in the 
rate of wound-healing between differentiated cultures of empty-vector control, 
Cx32WT and Cx32T134A transduced cells.  Measurement of mean wound-healing rates 
from two independent cell lines revealed that Cx32WT overexpressing cells were 
slowest to heal and the dominant negative overexpressing cells (Cx32T134A) were 
fastest, with control empty-vector cell cultures healing at an intermediate rate (Fig 
5.5 A & C).  In both cell lines tested (Y1270 and Y1392), analysis of Cx32WT and 
Cx32T134A cultures revealed a significant difference in the number of hours taken for 
the wounded cultures to heal by 50% (Wc50) (Fig 5.5 B & D).  In Y1270 cells, the 
difference in Wc50 time between control (empty vector) and Cx32WT or Cx32T134A 
cultures was not significant (Fig 5.5 B).  In Y1392 cells, a significant difference in 
Wc50 time was observed between control and Cx32WT cells, but this was not 
significant between control and Cx32T134A cells (Fig 5.5 D). 
 
5.3.4 The effects of Cx32WT and Cx32T134A overexpression on 
the restoration of barrier function after wounding. 
Restoration of barrier function after wounding was measured in differentiated 
empty vector control, Cx32WT and Cx32T134A overexpressing cultures, by measuring 
the TER during wound repair.  Mean TER measurements were reduced to 
<500 Ω.cm2 immediately following scratch-wounding (Fig 5.6) and TER values in all 
three transduced cultures remained low (<500 Ω.cm2) for 6 h post-scratching, with 
no significant difference observed between the three data sets.  However, from 8 h 
post-scratching, barrier recovery was substantially more rapid in pore-closed 
Cx32T134A cultures than empty-vector control cultures and conversely, Cx32WT 
cultures displayed a much slower rate of barrier recovery than control cultures, 




cultures observed at 24 h post-scratch. By 48 h post-wounding, TER values in all 
three cultures had reached a plateau such that the difference in mean TER was no 






Figure 5.5  Wound Healing Analysis of Cx32WT and Cx32T134A Overexpressing 
Cultures. 
Y1270 (P4) and Y1392 (P4) NHU cells transduced to overexpress wild-type or pore-
closed Cx32 (pLXSN-Cx32WT and pLXSN-Cx32T134A) were differentiated in 24-well 
plates following the ABS/Ca2+ procedure.  pLXSN-empty vector transduced cells were 
included as a control.  A single scratch wound (750-1000 µM wide) was generated in 
6 replicate cultures which were imaged in an environmental chamber for 34 h.  The 
mean percentage closure of the wound space was plotted over time to demonstrate 
rates of wound healing in both cell lines respectively (A and C).  B & D represent the 
mean time point at which the wound was 50% closed (Wc50).   Data from closure of 
6 replicate cultures.  All error bars shown are ± Standard Deviation.   
NS = not significant *P<0.05 ***P<0.001 (One way ANOVA with Tukey-Kramer 






Figure 5.6  Recovery of Transepithelial Electrical Resistance in Cx32 Overexpressing 
Cultures Following Scratch Wound Damage. 
Y1270 (P4) cells transduced with pLXSN-empty, pLXSN-Cx32WT and pLXSN-Cx32T134A 
retroviral vectors were seeded onto Snapwell™ permeable membranes and 
differentiated with ABS/Ca2+ for six days.  A single scratch (750-1000 µM wide) was 
generated in 6 replicate cultures for each group and TER values were measured 
immediately after scratching and then at intervals over a 48 h period.  The mean 
TER was plotted against time to demonstrate the rate of barrier repair.  All error 
bars shown are ± Standard Deviation.  ***P<0.0001 (extremely significant) for 
comparisons of the three transductants. (Empty versus WT, WT versus T134A and 
empty versus T134A)  NS = not significant. (One-way ANOVA with Tukey-Kramer 
multiple comparisons post-test). 
Note: Mean TER values for empty vector, Cx32WT and Cx32T134A prior to scratch 
wounding (at day 6) were 2853 Ω.cm2 (± 260 SD), 2573 Ω.cm2 (± 134 SD) and 3373 





5.4 Examining the Adverse Effects of Cx32-mediated 
Communication on Migratory Signalling Events in 
Differentiated NHU Cell Cultures 
5.4.1 Examination of rho-kinase pathway proteins in 
wounded Cx32WT and Cx32T134A cultures by 
immunoblotting 
Y1277 (P4) cells transduced with pLXSN-empty, pLXSN-Cx32WT and pLXSN-Cx32T134A 
retroviral vectors were differentiated following the ABS/Ca2+method, before repeat 
scratching as detailed in Fig 5.2.  Immunoblotting of lysates collected at 1 h and 6 h 
post-wounding (with non-wounded control), confirmed that Cx32 overexpression 
was retained during wound healing of cultures (Fig 5.7).  Expression of the 
biologically-inactive phosphorylated form of RhoA (ser188), was observed in all 
cultures, whether wounded or not and was not changed between Cx32WT and 
Cx32T134A cultures.  Downstream expression of ROCK1 was not altered in any of the 
cultures.  Identification of a band specific for ROCK2 was difficult, due to a triple 
band which appeared at the predicted 160 kD molecular weight, although clear 
changes in any of the three bands between the cultures were not observed.  
Downstream expression of cofilin (actin depolymerising) and its phosphorylated 
form (ser 3; actin-stabilising) were also unchanged at the protein level.  β-actin 







Figure 5.7  Immunoblotting of Wounded Cx32WT and Cx32T134A Overexpressing 
Cultures for Rho-kinase Signalling Pathway Proteins. 
Y1277 (P4) cells transduced with pLXSN-empty, pLXSN-Cx32WT and pLXSN-Cx32T134A 
retroviral vectors were seeded onto 6 cm culture dishes and differentiated following 
the ABS/Ca2+ procedure.  Whole cell lysates were harvested from non-wounded 
cultures and cultures at 1 h and 6 h post-wounding (see Fig 5.2).  Immunoblotting 
was performed using antibodies to label Cx32, p-Rho A (ser 188), ROCK1/2, cofilin 
and p-cofilin (ser 3), as well as β-actin (loading control). 
 
5.4.2 Examination of rho-kinase pathway proteins in 
wounded Cx32WT and Cx32T134A cultures by indirect 
immunofluorescence 
Examination of ROCK1 and ROCK2 expression in both Cx32WT and Cx32T134A cells at 
2 h and 8 h after wounding was weakly cytoplasmic, with some weak membrane-
associated labelling, in particular towards the wound margin (Fig 5.8 A & B).  In 




ROCK2 labelling at pronounced borders was observed (Fig 5.8 arrows), at both 2 h 
and 8 h post-wounding.  However, these cells were unusually large compared to 
other cells and very rare within the culture.  They were found both adjacent and 
remote to the wound edge.  Cofilin was expressed distinctly at cell borders with 
weak cytoplasmic labelling in both Cx32WT and Cx32T134A cells, with no clear 
difference in expression between the two cell types at 2 h or 8 h post-wounding (Fig 
5.8 C).   
 
 











Figure 5.8  Immunofluoresence Labelling of Wounded Cx32WT and Cx32T134A Cultures 
to Examine Protein Localisation of ROCK and Cofilin. 
Y1392 NHU cells transduced with Cx32WT and Cx32T134A overexpression vectors were 
differentiated following the ABS/Ca2+ method on glass slides.   Cultures were 
scratched to generate a wound approximately 750-1000 µm wide and allowed to 




anti- ROCK1 (A), ROCK2 (B) and cofilin (C) antibodies (or no primary negative control 
(D)).  Fluorescence microscopy images were taken along the wound edge.    
Hoechst 33258 images for each region are shown in the corner of each image and 
arrows depict bright border labelling of ROCK1 and 2.   
Low mag = low magnification.   Scale bar = 50 µm 
 
5.4.3 Assessment of the TGFβ signalling pathway in wounded 
Cx32WT and Cx32T134A cultures by immunoblotting and 
immunocytochemistry of activated SMAD3. 
To determine whether differences in TGFβ signalling might account for changes in 
wound-healing rates between Cx32WT (pore open) and Cx32T134A (pore closed) 
cultures, expression of activated SMAD3 (pSMAD3) was examined.   Y1392 (P4) and 
Y1277 (P4) cells transduced with pLXSN-empty, pLXSN-Cx32WT and pLXSN-Cx32T134A 
retrovirus were differentiated following the ABS/Ca2+ method, before repeat 
scratching as detailed in Fig 5.2.  Immunoblotting of lysates collected at 1 h and 6 h 
post-wounding (with non-wounded control), confirmed that in both cell lines, 
Cx32WT cells had a reduced pSMAD3 expression compared to cultures of empty 
vector or Cx32T134A cells (Fig 5.9).  In Y1392 cells, this reduction in pSMAD3 
expression was more pronounced at 6 h post-wounding, as determined by 
densitometry.  However, even in non-wounded cells, pSMAD3 expression was 
reduced in both cell lines compared with Cx32T134A and empty-vector control cells.  
β-actin immunoblotting confirmed equivalent loading.   
By immunocytochemistry, expression of pSMAD3 was nuclear and profoundly 
decreased in Cx32WT cultures following scratching, when compared with pLXSN-
empty vector control cells.  Expression was more intense towards the wound 
margin in Cx32WT and empty vector control cultures, whereas in Cx32T134A cultures, 




post-wounding and the decreased rate of wound migration in Cx32WT cells was 
apparent by the large wound area observed after fixation.   
 
 
Figure 5.9  pSMAD3 Immunoblotting of Wounded Cx32WT and Cx32T134A 
Overexpressing Cultures. 
Y1392 (P4) and Y1277 (P4) cells transduced with pLXSN-empty, pLXSN-Cx32WT and pLXSN-
Cx32T134A retrovirus were seeded onto 6 cm culture dishes and differentiated for 7 days 
following the ABS/Ca2+ procedure.  Whole-cell lysates were harvested from non-wounded 
cultures and cultures at 1 h and 6 h post-wounding with a pipette tip (see Fig 5.2).  
Immunoblotting was performed using antibodies to detect pSMAD3 and β-actin (loading 
control).  Densitometry analysis was performed and relative expression (after normalisation 





Figure 5.10  pSMAD3 immunolabelling of wounded Cx32WT and Cx32T134A 
overexpressing cultures. 
Y1270 NHU cells transduced with control empty-vector, Cx32WT and Cx32T134A 
overexpression vectors were differentiated with ABS and Ca2+ on glass slides for 7 days.   
Cultures were scratched to generate a single wound approximately 750-1000 µm wide and 
allowed to heal for 8 h before fixing.  Indirect immunofluorescence was performed using an 
anti-pSMAD3 antibody (or no primary negative control).  Fluorescent microscopy images 
were taken along the wound edge of pSMAD3 (top row) or the Hoechst 33258 nuclear 
counterstain (bottom row). Scale bar = 200 µm 
Note: the wound margin observed in Cx32WT cultures at 8 h is markedly wider than in 
Cx32T134A or empty vector control at the same time point, since wound healing was retarded 




5.5 Examination of TGFβ/TGFβRI Mediated Cell 
Migration in Cx32-modified Cultures 
5.5.1 Wound-healing rates in Cx32-modified cultures in the 
presence of exogenous TGFβ1 
The rate of wound-healing was examined in ABS/Ca2+ differentiated Cx32WT and 
Cx32T134A transduced cultures (Y1284), with or without the addition of exogenous 
TGFβ1 (Fig 5.11).  When compared with vehicle control cultures, addition of 2 ng/ml 
TGFβ1 did not affect the rate of wound repair.  At 18 h post-wounding, no 
significant difference was observed in the mean percentage wound closure 
between control cultures and those cultures which contained 2 ng/ml TGFβ1 (Fig 
5.11 A).  Note, the concentration of TGFβ1 was previously titrated for effectiveness 
(Fleming et al. 2012).  However, in both treatment sets, an extremely significant 
difference was observed in the mean percentage wound closure between Cx32WT 
and Cx32T134A cultures observed at 18 h.   Addition of 4 ng/ml TGFβ1 significantly 
accelerated the rate of wound migration in both Cx32WT and Cx32T134A cultures (Fig 
5.11 B).  At 18 h post-wounding, vehicle control cultures had healed by an average 
of 60% and 84% in Cx32WT and Cx32T134A cultures respectively, whereas cultures 
treated with 4 ng/ml TGFβ1 had healed by 76% and 99% respectively.  As previously 
observed, a significant difference was observed in the mean percentage wound 
closure between Cx32WT and Cx32T134A cultures, regardless of treatment with TGFβ1 
or vehicle control.   
 
5.5.2 Investigating wound-healing rates in Cx32-modified 
cultures in the presence of the TGFβR tyrosine kinase 
inhibitor SB431542. 
The rate of wound-healing was examined in Cx32WT and Cx32T134A transduced 
cultures (Y1277), with or without the addition of SB431542 (Fig 5.12).  Addition of 




rates of both in Cx32WT and Cx32T134A cultures.  Measurement of wound areas at 18 
h post-wounding revealed that Cx32WT and Cx32T134A cultures were healed by 59% 
and 90% respectively in vehicle control-treated cells, whereas parallel cultures 
treated with SB431542 were healed by 18% and 35% respectively indicating that 
inhibition of TGFβRI tyrosine kinase activity reduced wound healing rates in both 
Cx32WT and Cx32T134A cultures.  As previously observed, a significant difference was 
observed in the mean percentage wound closure between Cx32WT and Cx32T134A 
cultures, regardless of treatment with SB431542 or vehicle control.   
 
5.5.3 Investigating gene expression of TGFβ and TGFβ-
receptors in wounded and non-wounded Cx32-modified 
cultures  
RT-PCR, performed with cDNA generated from Cx32WT and Cx32T134A cultures 
following ABS/Ca2+ differentiation revealed that both TGFβ1 and 2 were expressed 
(Fig 5.13 A).  There was no clear difference in expression between Cx32WT and 
Cx32T134A cells, although a reduction in TGFβ1 transcript expression was noted in 
both cultures following wounding, compared with non-wounded cultures.  
Although expressed in both non-wounded and wounded Cx32WT and Cx32T134A 
cultures, no change in transcript of TGFβR 1 or 2 was observed between the two 






5.5.4 Examination of SMAD3-activation by paracrine factors 
released from Cx32-modified cultures 
Medium was harvested from non-wounded and wounded Cx32WT and Cx32T134A 
cultures and applied to cultures of non-transduced NHU cells to determine if 
paracrine factors released by Cx32WT or Cx32T134A cells were capable of 
activation/suppression of SMAD3.  SMAD3 activation was examined using an anti-
pSMAD3 antibody and immunoblotting revealed that treatment of NHU cells with 
conditioned medium from Cx32WT or Cx32T134A cultures did not alter the activation 
of SMAD3 compared to NHU cells treated with comparable, non-conditioned 
medium (Fig 5.13 B).  Controls behaved as expected: following stimulation with 
exogenous TGFβ1, amounts of pSMAD3 were strongly enhanced.  Baseline 
expression of pSMAD3 was abrogated by addition of the TGFβR tyrosine kinase 






Figure 5.11  Wound-healing of Cx32WT and Cx32T134A Overexpressing Cultures in the 
Presence of Exogenous TGFβ1. 
Y1284 (P4) NHU cells overexpressing Cx32WT and Cx32T134A were induced to differentiate 
following the ABS/Ca2+ procedure in 24-well plates.  Cultures were pre-treated with 2 ng/ml 
(A) or 4 ng/ml TGFβ1 (B) for 3 h before scratching.  A single scratch wound (750-1000 µM 
wide) was generated in each of six replicate cultures which were incubated in an 
environmental chamber for 18 h before imaging.  Graphs show mean percentage wound 
closure at 18h for vehicle control or TGFβ1-treated cultures.  All error bars shown are ± 
Standard Deviation.   
NS = not significant. **** (P <0.0001) extremely significant. ** (P <0.01) very significant. * 
(P<0.1) considered significant (One way ANOVA with Tukey-Kramer multiple comparisons 





Figure 5.12  The Effects of TGFβRI Inhibition on Wound-healing of Cx32WT and 
Cx32T134A Overexpressing Cultures. 
Y1277 (P4) NHU cells overexpressing Cx32WT and Cx32T134A were induced to differentiate 
following the ABS/Ca2+ procedure in 24-well plates.  Cultures were pre-treated with 10 µM 
SB431542  for 3 h before scratching.  A single scratch wound (750-1000 µM wide) was 
generated in 6 replicate cultures which were incubated in an environmental chamber for 
18h before imaging.  Graphs show mean percentage wound-closure at 18h for vehicle 
control or SB431542-treated cultures.  All error bars shown are ± Standard Deviation.   
**** (P <0.0001) extremely significant. ** (P <0.01) very significant.  (One way ANOVA with 






Figure 5.13  TGFβ/TGFβR Expression and Activity in Cx32WT and Cx32T134A 
Overexpressing Cultures. 
A – Y1284 (P4) NHU cells overexpressing Cx32WT and Cx32T134A were induced to differentiate 
following the ABS/Ca2+ procedure in 6-well plates.  After 7 days, RNA was harvested from 
non-wounded (NW) cultures and cultures at 2 h and 4 h post-wounding with a sterile 
pipette tip.  RT-PCR was performed using primers to amplify TGFβ (1 and 2) and TGFβR (1 
and 2) from each culture.  Reaction controls included: β-actin (to demonstrate equivalent 
loading) and a reverse transcription negative (RT-) control (to rule out amplicon/genomic 
contamination). 
B – Conditioned medium was harvested from  Cx32WT and Cx32T134A cultures used in (A) 
immediately prior to RNA extraction and used to treat proliferating (50% confluent), Y1545 
NHU cells for 3 h at 37 oC.  Lysates were harvested for immunoblotting with pSMAD3 
(ser423/425) and β-actin loading control antibodies.  Control treatments included non-
conditioned ABS/Ca2+ (Ctrl) and culture medium containing 10 µM SB431542 (+SB) or 





5.5.5 Examination of active SMAD3 and CREB protein 
localisation inwounded Cx32WT and Cx32T134A cultures 
Activated SMAD3 (pSMAD3) was strongly expressed in differentiated NHU cells 
overexpressing mutant Cx32T134A, both adjacent to and remote from the wound 
edge (Fig 5.14), confirming previous observations (Fig 5.10).  pSMAD3 expression 
was predominantly nuclear with some weak cytoplasmic expression.  In Cx32WT 
cells, pSMAD3 expression was extremely weak, with very occasional positive 
nuclear labelling.  Expression of pSMAD3 in control (empty vector) cells was less 
intense than in Cx32T134A cells; occasional positive nuclei were observed and 
expression was enhanced in a small population of cells along the wound-edge 
where both nuclear and cytoplasmic labelling was abundant.    Expression of the 
SMAD3 transcriptional coactivator CREB and its cAMP-dependent, PKA-activated 
form pCREB (ser133) were strongly expressed in the nuclei of Cx32WT, Cx32T134A and 
empty vector cells, with no difference observed between the three transductants.  
Expression of both proteins was consistent whether adjacent or remote from the 







Figure 5.14  Immunofluoresence Labelling of Wounded Cx32WT and Cx32T134A 
Cultures to Examine pSMAD3 and CREB Protein Localisation. 
Y1392 NHU cells transduced with Cx32WT and Cx32T134A overexpression vectors were 
differentiated by the ABS/Ca2+ method on glass slides.   Cultures were scratched to generate 
a wound approximately 750-1000 µm wide and allowed to heal for 8 h before fixing.  
Indirect immunofluorescence was performed using anti- pSMAD3, CREB and pCREB (ser133) 
antibodies.  Fluorescent microscopy images were taken along the wound edge (shown with 
white dashed line).   Hoechst 33258 images for each region are shown in the corner of each 





5.5.6 Examination of SMAD3 and PPARγ protein localisation 
in wounded Cx32WT and Cx32T134A cultures 
As PPARγ has been shown to negatively regulate SMAD3 activation in previous 
studies, its expression was assessed in wounded Cx32WT and Cx32T134A cultures.  
Localisation of SMAD3, pSMAD3 and PPARγ was assessed by indirect 
immunofluoresence in differentiated, Y1284 Cx32WT and Cx32T134A cultures during 
wound-healing, in regions adjacent to and remote from the wound edge.  
Furthermore, SMAD3 expression was observed to be of similar intensity in Cx32WT 
and Cx32T134A cells, with a strong nuclear and weakly cytoplasmic distribution (Fig 
5.15 A).  SMAD3 expression was observed to be of similar intensity whether cells 
were adjacent or remote to the wound edge.  Activated SMAD3 (pSMAD3) was 
strongly expressed in Cx32T134A cells with a strong nuclear and weak cytoplasmic 
distribution (Fig 5.15 B).  Expression in Cx32WT cells was weakly cytoplasmic close to 
the wound edge and not visible in regions remote to the wound edge.  PPARγ 
expression was more distinctly nuclear in Cx32WT cells, where nuclear expression 
was strong in regions adjacent to and remote from the wound (Fig 5.15 C).  A strong 
nuclear expression was also observed in Cx32T134A cells; however, cytoplasmic 
labelling was also apparent which gave the appearance of a more diffuse PPARγ 
distribution throughout the cells.  In order to quantitatively assess the PPARγ 
distribution, image analysis was performed in order to determine relative PPARγ 
fluorescence in nuclear and cytoplasmic cell compartments.  Image analysis of 
PPARγ fluorescence (using Tissue Gnostics software), confirmed the observation 
that PPARγ expression was more distinctly nuclear in Cx32WT cells (Fig 5.15 D).  The 
PPARγ nuclear:cytoplasmic labelling intensity across the culture was found to be 











Figure 5.15  Immunofluoresence labelling of wounded Cx32WT and Cx32T134A cultures 
to examine SMAD3 and PPARγ protein localisation. 
Y1284 NHU cells transduced with Cx32WT and Cx32T134A overexpression vectors were 
differentiated with ABS and Ca2+ on glass slides.   Cultures were scratched to generate a 
wound approximately 750-1000 µm wide and allowed to heal for 8 h before fixing.  Indirect 
immunofluorescence was performed using antibodies raised against  SMAD3 (A), pSMAD3 
(ser423/425) (B) and PPARγ (clone E8 which is specific for an epitope present in the C-
terminal ligand binding domain) (C).  Lower and higher magnification images were taken 
along the wound edge (scratch border is depicted by white line) and higher magnification 
images taken of a region in the centre of the culture (remote from wound edge).   Hoechst 
33258 images for each region are shown in the corner of each image.  Scale bars for each 
vertical row are shown in the top image and represent 50 µm.   
PPARγ labelling in nuclear and cytoplasmic regions was quantified using TissueQuest 
software, with the Hoechst 33258 image used to set the nuclear mask algorithm for 
separation of nuclear and cytoplasmic components.  Mean relative fluorescence intensities 
within nuclear and cytoplasmic compartments of a 1.5 mm2 area (including the wound 






5.6 Morphology of Differentiated NHU cells During 
Wound Repair 
5.6.1 Tight junction expression and distribution during 
differentiated NHU wound healing 
To examine whether the migratory behaviour in differentiated urothelial cultures 
(non-transduced) coincided with a loss of cell polarity, the distribution of several 
tight junction proteins as well as Cx32 was examined during wound-healing (8 h 
post-wounding).  Cx32 was localised to cell borders and was expressed in all cells, 
including those at the wound-margin, with no changes in expression close to the 
wound-edge (Fig 5.16A).  A similar trend was observed with the tight junction 
proteins occludin, ZO-1 and claudin 5.  The tight junction proteins examined were 
distributed at cell borders with no evidence of enhanced or reduced expression 
towards the wound margin. 
 
To assess if Cx32 overexpression (in wild-type or dominant-negative form) affected 
the expression of tight junctions and adherens junctions during wounding, 
immunoblotting of differentiated non-wounded and wounded transduced NHU 
cultures was performed (Fig 6.16B).  In non-wounded cultures there was no change 
in expression of E-cadherin, occludin or claudin 5, in Cx32 wild-type or dominant-
negative overexpressing cells compared with empty vector control.  In addition, 
there was no observed change in expression of these proteins in any of the 
transductants during the process of wound-healing, as assessed at 1 h and 6 h post-






Figure 5.16 Assessment of Cx32 and Tight Junction Proteins During Wound-healing 
of Differentiated NHU Cultures (Non-transduced and Cx32 Overexpressing). 
(A) Y1268 (P3) non-transduced NHU cells were differentiated on 12-well glass slides 
using the ABS/Ca2+ method.  A single scratch of approximately 750 µM wide was 
generated across each well and cultures were returned to the incubator for 8 h 




Claudin 5 antibodies, as indicated.  Images showing nuclei labelled with Hoechst 
33258 are shown in the bottom corner of each image.  Scale bar = 100 µm 
(B) Y1270 (P4) cells transduced with pLXSN-empty, pLXSN-Cx32WT and pLXSN-Cx32T134A 
retroviral vectors were seeded onto 6 cm culture dishes and differentiated following 
the ABS/Ca2+ procedure.  Whole-cell lysates were harvested from non-wounded 
cultures and cultures at 1 h and 6 h post-wounding with a pipette tip (see Fig 5.2).  
Immunoblotting was performed using antibodies to label E-cadherin, occludin and 
claudin 5 to assess cell adhesion and polarity, as well as β-actin as a loading 
control.  
 
 5.6.2 Assessment of Ki67 expression in differentiated Cx32WT 
and Cx32T134A transduced NHU cells during wound 
healing 
The proliferative capacity of Cx32WT and Cx32T134A overexpressing cultures during 
wound healing was examined by assessment of Ki67 expression, a cellular marker 
associated with proliferation.  Immunocytochemistry in ABS/Ca2+ wounded cultures 
demonstrated that Cx32T134A (pore closed) cultures had a high proportion of cells 
which were Ki67 positive (49%), reflecting high cell cycle activity (Fig 5.18A).  
However, Ki67 expression was notably absent from cultures in which Cx32WT was 
overexpressed (0% of cells considered to be above the positive threshold set using 
Tissue Gnostics TissueFAXS software).  Transcript expression of Ki67 was not 
observed in non-wounded Cx32WT cell cultures, but expression was weakly 
upregulated as a response to wounding, with low expression observed at 4 h 
following wounding (Fig 5.18B).  In Cx32T134A cultures, Ki67 transcript expression 
was apparent in both non-wounded and wounded cultures, with expression 





Figure 5.18  Expression of the proliferation marker Ki67 in wounded Cx32WT and 
Cx32T134A overexpressing cultures. 
A - Y1284 (P4) cells transduced with pLXSN-Cx32WT and pLXSN-Cx32T134A retroviral vectors 
were seeded onto glass slides and differentiated following the ABS/Ca2+ procedure.  A single 




returned to the incubator for 8 h, before fixation and immunolabelling with an anti-Ki67 
antibody.  A no-primary antibody, negative control was included.  Images showing nuclei 
labelled with Hoechst 33258 are shown in the bottom corner of each image.   Scale bar = 50 
µm, Low mag = low magnification image. 
B – Y1284 (P4) cells transduced with pLXSN-Cx32WT and pLXSN-Cx32T134A retroviral vectors 
were differentiated in 6cm cell culture dishes following the ABS/Ca2+ method.  RNA was 
harvested from non-wounded (NW) cultures and cultures at 1 h and 4 h post-wounding with 
a pipette tip (see Fig 5.2).   RT-PCR was performed using primers to amplify Ki67 and Cx32 
from each culture.  Reaction controls included: β-actin (to demonstrate equivalent loading) 





5.7 Discussion  
The key function of urothelium is to provide a protective urinary barrier; if this is 
damaged it must be rapidly repaired through a series of wound healing events 
which involve both migratory and proliferative mechanisms (Kreft et al. 2005, 
Shabir et al. 2008, Fleming et al. 2012).  Data presented in this chapter using 
methods to study the rates of wound-healing and migration in differentiated NHU 
cultures, suggests that Cx32 expression has a potent and negative effect on the 
migratory and proliferative behaviour of NHU cells during scratch wound repair.   
 
5.7.1 Cx32 and migration of NHU cultures 
When Cx32 function was inhibited, either by shRNA knock-down or overexpression 
of a dominant-negative pore-closed mutant, the resulting cultures were faster 
migrating and showed enhanced ability to restore barrier function upon wounding.  
Conversely, forced overexpression of functional (wild-type) Cx32 retarded the rate 
of scratch wound healing and barrier restoration.   
 
Since connexins appear to have communication-associated functions as well as 
alternative structural functions (for example integration into tight junctions), it is 
relevant to dissect whether the effects of Cx32 on wound migration are driven by a 
communication-dependent mechanism.   
 
Overexpression of functional Cx32 had an opposite effect on wound migration 
compared with pore-closed Cx32, supporting the conclusion that a communication-
dependent behaviour is responsible for driving a less-migratory phenotype in 
differentiated NHU cells.  This indicates that specific signalling events through Cx32 
channels are likely to be exerting a negative influence on wound healing.  Whilst 




effect on the population was a delay in wound-healing as these cultures were 
capable of completing the repair in time.   
 
5.7.2 Cx32 and wound healing in the liver 
Cx32 is a well-studied marker of differentiation in liver and its expression in 
hepatocytes in vitro is often used as a tool to confirm differentiation.  The liver is 
known to have a remarkable regenerative capacity and a small number of studies in 
rodents have demonstrated links between Cx32 expression and the rate of liver 
regeneration following partial hepatectomy (Kren et al. 1993, Dagli et al. 2004).  In 
the Kren study, a temporary reduction in Cx32 and Cx26 mRNA and protein were 
observed in rat livers following 70% partial hepatectomy suggesting that down 
regulation of Cx32 is associated with wound-healing.  The Dagli study observed a 
delay in liver regeneration in transgenic mice expressing a dominant-negative 
mutant Cx32 (driven under a liver-specific albumin promoter), due to reduced 
levels of hepatocyte proliferation in mutant livers.  The mutant Cx32 used in the 
study (V139M) was defective for membrane localisation and thus the delayed 
regeneration cannot be presumed to be associated with Cx32-mediated 
communication.  Nevertheless, the results of the study might suggest that Cx32 in 
the mouse liver regulates regeneration, which contradicts both the Kren study and 
the results observed in the present study performed in human urothelial cells.   
 
The Dagli study also reported increased susceptibility to chemical-induced 
hepatocarcinogenesis in the same dominant-negative mice, for which no clear 
explanation was suggested.  It was acknowledged that Cx32 appeared to be playing 
a role in promoting a wound-healing phenotype, but at the same time acting in a 
tumour-suppressive fashion. Other studies support the latter finding, where 
transgenic mice deficient in Cx32 appear to manifest a higher susceptibility to 
chemical hepatocarcinogenesis (Evert et al. 2002); however, without chemical 




further study was able to show that cells with membrane-associated Cx32 were 
suppressive for the development of hepatocellular carcinoma (Li et al. 2007), 
however, when Cx32 expression was forced in hepatocellular carcinoma cell lines, 
localisation was aberrant (golgi/cytoplasmic) and resulted in enhanced motility and 
potential for metastasis. 
 
5.7.3 Connexins and cell migration in the other systems 
Although liver regeneration is heavily dependent on increased hepatocyte 
proliferation, the evidence from several model/experimental systems is that some 
connexins can directly regulate cell migration.  Brain slices from Cx43 knock-out 
mice show an irregular distribution of astrocytes (Perez Velazquez et al. 1996) and 
several other studies support a role for Cx43 in supporting neuronal migration 
(Nadarajah et al. 1997, Wiencken-Barger et al. 2007).  However, evidence from a 
study in which different mutants of Cx43 were probed suggests that Cx43 channel 
communication properties are not essential for promoting migration and the study 
indicates that gap junction-mediated adhesion is crucial for neuronal migration 
(Elias et al. 2007).   
 
Recent studies in human skin models have demonstrated that Cx43 channels also 
exert an anti-migratory influence in keratinocytes.  Cx43 expression is reduced at 
wound margins during wound healing of normal skin and expression of Cx43 at 
wound margins was observed to be associated with poor wound healing rates in 
diabetic non-healing ulcers (Brandner et al. 2004). Although the Cx43 gap junction 
network in the epidermis is rapidly remodelled to support migration of cells into the 
wound space, this does not appear to occur with Cx32 expression during migration 
of differentiated NHU cultures, since Cx32 expression was not downregulated 
during wound migration.   Transfected expression of Cx32 in HeLa cells was found 
to significantly increase cell adhesion and inhibit cell migration (Yang et al. 2011), as 




general gap junction inhibitor oleamide, enabling the authors to conclude that 
Cx32-mediated communication was responsible for inhibition of migration.   
 
Blockade of Cx43 function using a connexin-mimetic peptide (GAP27) was observed 
to stimulate skin wound healing, even in growth conditions which are known to 
mimic type II diabetes (Wright et al. 2009, Wright et al. 2013).   The authors of the 
latter study suggest that one possibility is that connexin-mimetic peptides may 
interfere with cell-cell adhesion (via interference with Cx43 interactions with PDZ 
domains, found for example in ZO-1) or cell-ECM adhesion, although these 
mechanisms were not considered as part of that particular study.  However, a 
recent study in mice demonstrated that Cx43 deficiency accelerated skin wound 
healing and ECM remodelling (Cogliati et al. 2015).   
 
Some analogies may be drawn between Cx43 in repair of the skin and Cx32 in the 
repair of NHU cultures.  Application of Cx43 antisense oligonucleotides had an 
effect of speeding up the rate of migration of keratinocytes and similarly, so did 
application of connexin mimetic peptides which can block the communication 
properties of docked gap junctions, reviewed in (Becker et al. 2012).  This suggests 
that Cx43-mediated communication acts to inhibit the rate of migration, rather 
than merely expression, similar to the findings with Cx32 in the current study.  In 
addition, treatment of keratinocytes with Cx43 antisense oligonucleotides, 
increased the expression of TGFβ-1, supporting a role for Cx43 in the suppression of 
the TGFβ signalling pathway, as observed in the present study with Cx32.  However, 
the Cx32T134A dominant negative cells used in the current study did not appear to 
alter their expression of TGFβ-1, only the downstream expression of SMAD3 






5.7.4 Cx32 and cell adhesion 
In the present study, expression of proteins associated with cell-cell adhesion (tight 
junction and E-cadherin proteins), were not compromised in rapidly migrating Cx32 
pore-closed mutant cell cultures.  Differentiated NHU cultures (non-transduced) 
appear to migrate in a manner in which the integrity of tight and adherens 
junctions is largely maintained, ruling out a typical epithelial-mesenchymal 
transition.  Although the role of Cx32 in promoting a more adhesive phenotype (less 
migratory) was considered, the effects of Cx32 expression on cell-ECM interactions 
was not and may form an interesting avenue for further study.   
 
5.7.5 Migratory signalling pathways in the urothelium 
In the current study the Rho-kinase and TGFβR pathways were two signalling routes 
selected for analysis, due to the changes observed in the migratory behaviour of 
urothelial cultures in response to changes in the pore state of Cx32 channels.  The 
Rho-kinase pathway is a key mediator of cell shape and motility (Van Aelst et al. 
2002); however the current study did not find any major changes in regulation of 
RhoA/ROCK signalling as a response to changes in Cx32-mediated cell-cell 
communication.   This was with the exception of a rare population of cells observed 
only in faster migrating Cx32T134A cultures (pore-closed), in which expression of the 
RhoA downstream mediators ROCK1 and 2 was observed to be membrane-
associated.  It is reported that ROCK can act directly at cell membrane ruffles to 
induce actomyosin contraction (Fackler et al. 2008).  Since the Cx32T134A were more 
migratory than Cx32WT cell cultures, it may be expected that more ROCK activity be 
observed, however it is unclear as to why membrane expression would be so rare 
within the rapidly migrating Cx32T134A cell population and the findings were too 
subtle for clear interpretation.  cAMP-induced phosphorylation of RhoA at serine 
188 renders it inactive, thus exherting negative effects on the Rho kinase signalling 
pathway (Ellerbroek et al. 2003).  However, changes in expression of pRhoA 
(ser188) were not observed in Cx32WT cultures, suggesting that it is unlikely that 




NHU cultures.  The roles of cdc42 and Rac in directed forward movement of NHU 
cells and the presence of lamellipodia and filopodia were not directly studied in this 
project (see introduction Fig 1.4 A), however further studies as to the directional 
movement of NHU cultures provide huge scope for further study. 
 
Cell signalling through TGFβ-receptor activation is associated with increased cell 
migration and invasion in several human cancer cell lines (Muraoka et al. 2002, 
Halder et al. 2005) and a potent inhibitor of TGFβRI kinase activity (SB-431542), was 
observed to inhibit repair of wounded differentiated NHU cultures (Fleming et al. 
2012).  In the latter study, evidence suggested that the repair of differentiated 
urothelial cultures was mediated in part by pSMAD3 activation at the wound edge.  
These findings were confirmed in the present study; SMAD3 was weakly activated 
(phosphorylated) in control cultures and became more apparent during migration 
at the wound edge.  In Cx32-overexpressing cultures (both Cx32WT and Cx32T134A), 
SB-431542 acted to inhibit wound healing rates, whilst addition of exogenous 
TGFβ1 acted to promote migration rate of wounded differentiated urothelial 
cultures.  This further supports the role of autocrine/paracrine TGFβR signalling in 
urothelial repair and suggests that inhibition or activation of this pathway has the 
ability to modulate the rate at which migration occurs in this system.    
 
Cx32 (wild-type) overexpression resulted in downregulation of activated pSMAD3 
coinciding with retarded wound-healing, suggesting that Cx32 expression has an 
inhibitory effect on this pathway.  Conversely, overexpression of pore-closed 
mutant Cx32 (T134A) had the opposite effect, enhanced expression of nuclear 
pSMAD3 with rapid wound-healing rates.  This further supports SMAD3 activation 
as a key event in urothelial wound healing, but also demonstrates that Cx32-
mediated cell-cell communication is involved in regulating this process, with high 
levels of Cx32-mediated communication resulting in cultures where wound-healing 





There were two key findings as part of this study which suggested that TGFβ ligand 
or receptor were unlikely to be involved in explaining the differences observed in 
wound-healing rates between the wild-type and dominant negative Cx32-
overexpressing cultures.  Firstly, there were no observed differences in transcript 
expression of TGFβ (I and II) and TGFβR (I and II) between Cx32WT and Cx32T134A 
cultures.  Secondly, treatment of NHU cells with conditioned medium from Cx32WT 
or Cx32T134A cultures (wounded and non-wounded), neither inhibited nor enhanced 
pSMAD3 expression, implying that differences in the release of TGFβR ligands by 
the two cell types (thus affecting SMAD3 phosphorylation downstream) was not 
supported. 
 
Furthermore, expression of a key transcriptional coactivator of pSMAD3, CREB was 
unaltered between in wounded Cx32WT or Cx32T134A cultures.  When activated, 
CREB is phosphorylated at serine 133 and interacts directly with pSMAD3 and a 
second coactivator P300, to drive expression of key genes including a subset 
involved in ECM biosynthesis (Ghosh et al. 2000, Schiller et al. 2010).   
 
Inactivation of SMAD3 has been proposed to occur in response to activation of the 
nuclear receptor PPARγ in several studies;  PPARγ ligands have been demonstrated 
to inhibit TGFβ-induced phenotypic changes in retinal pigment epithelial cells by 
influence on SMAD3 (Hatanaka et al. 2012).  PPARγ-null mouse embryonic 
fibroblasts show constitutive SMAD3 phosphorylation and interaction with its 
transcriptional co-activator P300, coinciding with enhanced collagen biosynthesis, 
even in the absence of exogenous TGFβ (Ghosh et al. 2008).  A further study 
demonstrated that PPARγ exerts negative effects on SMAD3 activity by direct 






5.7.6 PPARγ activation and wound migration 
The question therefore arises as to whether wound healing in differentiated NHU 
cultures is inhibited in response to PPARγ activation, with effects on SMAD3 
activation in a mechanism independent of ligand binding to TGFβR.  
Immunocytochemistry demonstrated that PPARγ expression is significantly more 
nuclear in Cx32WT overexpressing cultures than Cx32T134A cultures which may imply 
enhanced activity, although future studies to assess potential interactions between 
PPARγ and SMAD3 would be required to shed further light on this theory.    
 
In differentiated NHU cultures, the immediate and predominant feature of wound-
closure was shown to be cell migration with some proliferation as indicated by 
expression of Ki67 further back from the wound edge (Fleming et al. 2012).     
 
5.7.7 Cx32 and proliferation of NHU cultures 
Ki67 expression is observed during all active phases of the cell cycle (late G1, S, G2 
and mitosis), but is absent from resting cells (G0) making it an excellent marker for 
estimating the population of cells undergoing growth (reviewed in Scholzen et al. 
2000).  In the present study, enhanced expression of Ki67 suggested an unusually 
high rate of proliferation when Cx32 function was inhibited by overexpression of 
the dominant negative channel.  This was also the case in non-wounded cultures 
suggesting changes in cell-cycle control were observed in the cell community in 
general, rather than as a response to wound-healing.  Natural and synthetic PPARγ 
ligands have been demonstrated to inhibit proliferation of NHU cells in vitro, 
arresting cells in the G0/G1 phase of the cell cycle (Kawakami et al. 2002).   
In the present study Ki67 labelling was not performed on Cx32 shRNA knock-down 
cultures. However, given that Cx32 shRNA cultures are significantly faster at wound 




follow up experiment.  It would determine whether the effects on proliferation are 
linked to Cx32 expression rather than the Cx32-mediated GJIC.  This would be of 
particular interest given the channel-independent roles of connexins on cell growth, 
in particular through the C-terminal tail (reviewed in (Vinken et al. 2012)).   
 
In addition, other markers which would give further insight into the effects of Cx32 
overexpression on the cell cycle of NHU cultures would be worthy of study.  Whilst 
Ki67 provides evidence that cells are in active stages of the cell cycle, it does not 
give direct evidence of proliferation and BrdU pulsing of NHU cultures followed by 
antibody labelling would provide more direct evidence of proliferation.  One study 
demonstrated that enhanced expression of Cx43 resulted in a delay in cell cycle 
progression in HeLa cells and human fibroblasts, in association with increased 
expression of the cell cycle inhibitor p21 (WAF1/CIP1) (Johnstone et al. 2010).  p21 
is a potent cyclin-dependent kinase inhibitor and prevents progression of the cell 
cycle between G1 and S phase and it would be relevant to consider the expression 
of p21 in Cx32 overexpressing (WT and T134A) cultures, especially following 
wounding.  It has been demonstrated that proliferation of vascular smooth muscle 
cells can be stimulated in response to activation of a SMAD3/ERK MAPK signalling 
pathway, in a process which involves nuclear export of the cyclin-dependent kinase 
inhibitor p27 (Suwanabol et al. 2012).  Given the links observed between SMAD3 
activity and Ki67 in the current study, it would also be worth studying the 
expression of activated ERK and p27, as part of a larger panel to shed light on the 
pathways promoting proliferation following inhibition of Cx32 signalling. 
 
SMAD3 knock-out mice show reduced susceptibility to chemical carcinogenesis in 
skin, compared with wild-type litters (Li et al. 2004) and there is mounting evidence 
that TGFβ signalling through SMAD mediators is a positive regulator of tumour 
growth and metastasis in many systems (Massague 2012).  The TGFβ pathway has 
been linked to bladder cancer progression (Miyamoto et al. 1995, Hung et al. 2008) 




fibroblasts drives EMT and a more invasive phenotype in urothelial bladder cancer 
cells (Zhuang et al. 2015).  It may therefore be of critical importance to NHU cells 
that Cx32 channel signalling acts to balance the level of SMAD3 activation, for 
controlled cell growth and balanced proliferation when needed.   
    
5.7.8 Overview 
In other systems such as skin and liver, connexins have been shown to be down 
regulated during tissue repair.  In line with these findings, data presented here 
confirms that Cx32-mediated cell-cell communication acts to supress the repair rate 
of differentiated NHU cultures and that this is likely to be mediated in part by 
suppression of SMAD3 activity, a critical element of the machinery which supports 
migration in differentiated urothelial cultures, but also in part by a reduced capacity 
for proliferation in wild-type overexpressing NHU cultures.  It is possible that PPARγ 
activity plays a role in inhibition of SMAD3 activity, but could also contribute to the 
reduction in proliferation capacity.   
 
Several questions arise from these findings.  What messenger molecules might be 
signalling through Cx32 channels to control migration?  Whilst the general nature of 
messenger molecules which are gap junction permeable are similar for all gap 
junctions (<1 kDa, water-soluble), it has been observed that different connexins 
display permeability preferences (Goldberg et al. 2002, Goldberg et al. 2004), 
although the biochemistry underlying this selectivity is poorly understood.  In a 
system in which several connexins are expressed the potential for function overlap 
would make this a challenging challenging question to answer.  Some second 
messengers such as inositol 1,4,5-triphosphate (IP3) (Niessen et al. 2000) and 
adenosine (Goldberg et al. 2002), have been identified as having preferential 
passage through Cx32 channels when compared with other selected connexins.  As 
a starting point for future work, it may be exciting to pursue the possibility that 




prostaglandin 15-deoxy PGJ(2) has a molecular mass of 316 Da, comfortably within 
the range which could be accommodated by Cx32 gap junction pores.  This would 
be of particular interest due to the increased nuclear expression of PPARγ in Cx32WT 
overexpressing cells, suggesting that activated PPARγ is more abundant when Cx32 
is overexpressed.  It has been demonstrated that ligands of PPARγ suppress cell 
proliferation in Th17 cells (Kim et al. 2015) and also that PPARγ can interfere with 
SMAD3 activity and therefore PPARγ may be the common factor which interferes 
with both proliferative and migratory pathways.    
 
Another question of interest is why might Cx32 expression physiologically 
important in vivo in supressing migration of human urothelium?   The urothelium 
can be damaged in a variety of ways including injury caused by microorganisms, 
urinary toxins, mechanical damage or in disease states.  Treatment of rat bladders 
with protamine sulphate invokes selective sloughing of superficial cells in a model 
used to mimic interstitial cystitis, which results in loss of TER and increased 
urothelial permeability  (Lavelle et al. 2002).   Repair occurs rapidly and it is thought 
that basal/intermediate cells proliferate and migrate to heal the wound, before 
differentiation at the superficial surface to generate new umbrella cells.   Since 
Cx32 expression in vivo was found to be restricted to the basolateral membrane of 
umbrella cells (chapter 2), damage or shedding of the superficial cells might prove 
to be a key event in promoting regeneration.  Insult resulting in a loss of superficial 
cells would remove the population of Cx32 expressing cells, thereby reversing the 
Cx32 channel-mediated block on cell proliferation and migration, which might 
initiate wound repair at an appropriate time.  When urothelial cells are cultured in 
serum-free medium, they adopt a basal-like phenotype with high proliferation rates 
and lose expression of markers associated with differentiation (Southgate et al. 
1994, Varley et al. 2005), including Cx32 (chapter 2).  In non-diseased states in vivo, 
the urothelium is a quiescent epithelium (Walker 1960) and it is plausible that 





A potential physiological role for Cx32 in the urothelium is that it may or may not 
function in a hemichannel state.  In intestinal epithelial cells, connexin 
hemichannels composed of Cx26, Cx32 and Cx43 have been located to the basal 
membrane (Clair et al. 2008).  It is believed that bacterial invasion promotes 
hemichannel opening in this setting, allowing release of ATP which in turn enhances 
bacterial dissemination (Tran Van Nhieu et al. 2003).  Whether connexin 
hemichannels are located in the urothelium and play a role in the spread of urinary 
tract infection is not known, however subsets of patients suffer recurrent urinary 
tract infection and the study of Cx hemichannels may certainly prove relevant to 
this.  Additionally, stretch-evoked release of ATP from urothelial cells has been 
demonstrated to act on P2X receptors in afferent nerves to transmit signals of 
bladder filling (Cockayne et al. 2000).  It has been suggested that release of ATP 
from stretched urothelial cells occurs in response to elevated Ca2+ levels and that 
ATP may be released through anion channels or Cx hemichannels (Miyamoto et al. 
2014).  However there is currently little evidence to support this hypothesis, 
although it seems a likely area for future mechanosensation studies.   
 
It is possible that Cx32 gap junctions are critical for the delicate balance required to 
achieve a differentiated, low-turnover, impermeable epithelium which can rapidly 
switch to regeneration when necessary due to Cx32 loss.  Data presented in this 
chapter suggests that normal Cx32 function exerts a negative effect on NHU cell 








It is considered that the urothelium serves as the tightest barrier epithelium in the 
human body (Negrete et al. 1996) ; barrier function is maintained by intercellular 
tight junctions and apical membrane plaques.  Furthermore the urothelium has an 
impressive capacity to switch into a migratory and proliferative phenotype 
following damage to ensure barrier restitution.  A role for gap junctions in directing 
the balance between barrier development and epithelial tissue repair has not 
previously been considered, however in vitro studies using normal human urothelial 
(NHU) cells provided an ideal model system to pursue this. 
Prior to this thesis, the expression of Cx26 and Cx43 had previously been reported 
in human and rat bladders (Grossman et al. 1994, Lorentz et al. 2012, Sunagawa et 
al. 2015), however a detailed analysis of the expression and localisation of connexin 
isoforms in urothelium had not previously been reported.   
The present study provides the first detailed characterisation of connexin 
expression in the urothelium, demonstrating that NHU cells alter their connexin 
expression profile during cytodifferentiation to produce specific channels.  The 
results provide the first evidence for a direct functional role for Cx32 in urothelial 
homeostasis.  Cx32 gap junctions were upregulated as part of the urothelial 
differentiation programme in response PPARγ activation and were identified in vitro 
as a key element in controlling both differentiation and regenerative behaviours.  
 
6.2 Urothelial expression of connexins 
Eight connexins were identified with gene expression in normal human urothelial 
cells.  Of particular interest was Cx32, since its expression uniquely coincided with 
NHU cell differentiation and immunochemical studies indicated localisation of Cx32 
protein to cell borders in the barrier-forming superficial cell layer in situ.  Thus Cx32 





be a molecular marker of urothelial cytodifferentiation.  Of particular relevance was 
the finding that knock-down of Cx32 resulted in compromised urothelial 
cytodifferentiation in vitro, suggesting that Cx32 expression is a requirement for the 
normal development of a functional barrier urothelium. It was further shown that 
tight junctions, which are paramount in defining the tight barrier properties, were 
disrupted as a consequence of Cx32 shRNA knock-down, resulting in a significant 
reduction in barrier function in knock-down cultures from three independent Cx32 
shRNA’s, demonstrating that Cx32 expression is closely associated with tight 
junction development. 
 
6.3 Connexins and tight junctions. 
Previous studies have demonstrated that some connexins (including Cx32) have the 
ability to influence the assembly of both tight and adherens junctions (Kojima et al. 
2001, Talhouk et al. 2008, Herve et al. 2012).  In the current study, the finding that 
Cx32 shared molecular interactions with ZO-2 and occludin indicated that in 
urothelium, Cx32 forms a structural component of tight junction complexes.  Given 
that forced expression of a pore-closed dominant negative Cx32 channel did not 
impact on barrier development, it is probable that the influence of Cx32 on tight 
junction development is structural and independent of Cx32 channel function.  In 
other tissue networks such as intestinal and airway epithelia and in liver, close 
relationships have been observed between connexins and tight junctions in both 
communication-dependent and independent mechanisms and it is therefore in 
keeping with findings from other studies that Cx32 was observed at tight junction 
strands with influence on barrier function in urothelial cells.   
The Cx32 mutant (T134A) generated in this study was predicted to function as a 
dominant negative (Beahm et al. 2006).  This property has been demonstrated in 
studies for other connexins as this particular residue is strictly conserved amongst 
α- and β-connexin subgroups.  However, this is the first investigation to have 





useful experimental tool for investigating Cx32 function in both in vitro and in vivo 
studies. 
 
6.4 Cx32 and the regenerative phenotype 
A surprising finding was that Cx32-mediated cell-cell communication exerted a 
negative impact on both the migration and proliferative capacity (loss of Ki67 
expression) of differentiated NHU cultures following scratch wounding.  Data 
presented here provides compelling evidence that signalling events occurring 
through Cx32 gap junction channels act to block the regenerative capacity of NHU 
cells.  A comparison may be drawn to liver regeneration, in which Cx32 was found 
to be downregulated prior to stimulation of proliferation in hepatocytes, but then 
re-expressed during the differentiation which occurs following repair (Neveu et al. 
1995). 
Whilst the exact mechanisms underpinning this process are largely unknown, 
exploration of molecular pathways which promote urothelial repair indicated that 
this process involved suppression of SMAD3 activity, a critical element of the 
machinery which supports migration in differentiated urothelial cultures (Fleming 
et al. 2012).  The synchronous increase in the nuclear localisation of PPARγ which 
was observed may prove to be key to unravelling the effects of Cx32 channel 
behaviour on regeneration.  Active PPARγ has previously been demonstrated to be 
inhibitory to SMAD3 activity (Fu et al. 2001, Ghosh et al. 2008, Hatanaka et al. 2012) 
and PPARγ ligands have been demonstrated to inhibit proliferation of NHU cells in 
vitro (Kawakami et al. 2002, Varley et al. 2008).  Pursuing a potential link between 
PPARγ behaviour and SMAD3-driven NHU cell migration would be a clear goal for 
future studies arising from this thesis.   
In vitro, NHU cells exhibited a switch to a regenerative phenotype when Cx32 
channel activity was blocked.  In vivo, this could occur as a direct result of shedding 
of the Cx32-expressing superficial cells, which may occur as a response to insult or 





involving Cx32 channel gating, as has been extensively demonstrated in Cx43 
channels (Moreno 2005), where phosphorylation events and changes in voltage are 
impact on channel gating.  This would enable NHU cells to open/close Cx32 
channels to block or drive a proliferative and migratory phenotype as necessary 
(see Fig 6.1). 
In summary, the evidence presented in this thesis suggests that Cx32 gap junctions 
are of ultimate importance to urothelial barrier function where they play a role in 
the delicate balance required to achieve a differentiated, low-turnover, 
impermeable epithelium which can rapidly regenerate when necessary, followed by 
restitution of barrier function.  The working hypothesis (chapter 1) that specific 
connexins may be involved in a differentiated urothelial phenotype and barrier 
function was demonstrated to be true for Cx32 in this study.  However, evidence 
presented here supports a clear inhibitory role for Cx32-mediated GJIC in wound 
migration, which although not anticipated, does compare with connexins in other 
systems (e.g. Cx43 in migration of keratinocytes).   
 
6.5 Future Work Plans 
Since it has been described as the tightest barrier epithelium in the body, the close 
association of Cx32 with tight junctions is of particular relevance to the urothelium.  
However, whilst worthy of reporting, there are many tissue types including liver, 
gut and airway epithelial cells in which Cx32 has been demonstrated to interact at 
tight junction strands.  Therefore future work plans to follow up from this study 
would focus on the role of Cx32-mediated intercellular communication on the 
suppression of NHU cell proliferation and migration, since these findings provide 
scope for a more unique study into Cx32 biology.  Further work to determine the 
proliferative capacity of Cx32 overexpressing cells (both WT and T134A dominant 
negative) might include a more detailed analysis of the cell cycle in these 
transductants, considering markers such as PCNA, cyclins, p21, p27 and pERK as 
well as performing growth curves of these transduced cells in a differentiated state.  





believed that differentiated NHU cells do not proliferate unless wounded, however 
mutant Cx32T134A cells may have a greater proliferative capacity even in the absence 
of wounding).   
Give the close associations between hyperproliferation and sustained SMAD3 
activity with carcinogenesis/metastasis in many tissues (including bladder), 
alongside evidence which suggests that both Cx32 and PPARγ are candidate tumour 
suppressor genes, it seems highly relevant to pursue a more detailed analysis of 
Cx32 in bladder cancers.  I would propose a detailed immunohistochemical analysis 
of Cx32 in bladder tumours, combined with a study of Cx32 gene and protein 
expression in a range of bladder cancer cell lines of different stages and grades.  A 
study in which Cx32 is overexpressed in selected cancer cell lines might offer some 
interesting findings on cancer cell growth and differentiation capacity, especially in 
light of the data presented here which suggests PPARγ may be modified by Cx32-
mediated GJIC.  Activated SMAD3 would serve as an excellent marker for TGFβ-
pathway involvement and it would be worth linking expressionof Cx32 to pSMAD3 
in a variety of tumours and/or cancer cells.  Finally, an examination of the bladders 
of Cx32 knock-out mice might provide further insight as to how essential Cx32 is to 
bladder physiology and whether there is evidence of hyperplasia or compromised 









Figure 6.1  Proposed mechanisms for the balance between urothelial barrier 





Appendix 1 – Suppliers 
Company Name Web Address 
Abcam Ltd www.abcam.com 
Agar Scientific www.agarscientific.com 
Agilent www.genomics.agilent.com 
Ambion www.lifetechnologies.com 
Applied Biosystems www.appliedbiosystems.com 




Cell Signaling www.cellsignal.com 
Clontech www.clontech.com 
Corning www.corning.com 
Civco Medical Solutions www.civco.com 
DAKO UK Ltd www.dako.com 
Eurofins Genomics www.eurofinsgenomics.eu 
FEI www.fei.com 
Fisher Scientific www.fisher.co.uk 
GraphPad www.graphpad.com 
Greiner www.greinerbioone.com 
Harlan Sera-labs www.seralab.co.uk 
Hycult Biotechnology www.hycultbiotech.com 
Leica Biosystems www.leicabiosystems.com 
Li-Cor www.licor.com 
Jencons www.jenconsusa.com 
Life Technologies Ltd www.lifetechnologies.com 
Merck-Millipore www.merckmillipore.com 
Nalgene www.thermoscientific.com 
New England Biolabs www.neb.com 









Raymond A Lamb www.fisher.co.uk 
Roche www.roche.co.uk 
R&D Systems www.rndsystems.com 
Sarstedt www.sarstedt.com 
Scientific Laboratory Supplies Ltd 
(SLS) 
www.scientificlabs.co.uk 
Sigma-Aldrich Ltd www.sigmaaldrich.com 
SLS www.scientificlabs.co.uk 
Solent Scientific www.solentsci.com 
Starlab (UK) Ltd www.starlab.co.uk 
Syngene www.syngene.co.uk 
Tebu Bio Ltd www.tebu-bio.com 
Thermo Scientific www.thermoscientific.com 





Appendix 2 - Recipes for Stock Solutions 
Appendix 2.1  General Solutions 
Phosphate Buffered Saline (PBS) 
137 mM NaCl, 2.7 mM KCl, 3.2 mM Na2HPO4, pH 7.2 in ddH2O.  PBS was prepared 
from tablets (Sigma) and autoclaved. 
Tris Buffered Saline (TBS) 





Appendix 2.2  Cell Culture Solutions 
Cholera Toxin 
Cholera toxin (Sigma) prepared to 30 ng/ml (sterile) in KSFM (without 
supplements).  Aliquots of 5 ml stored at 4oC and diluted 1:1000 in KSFMc for use. 
Collagenase IV 
Collagenase (Sigma) diluted to a final concentration of 100 U/ml in Hank’s Balanced 
Salt Solution (Invitrogen; containing Ca2+ and Mg2+ ) and 10mM HEPES (pH 7.6). 
Filter sterilised 5 ml aliquots stored at -20C. 
EDTA 
0.1% or 1% (w/v) EDTA (Fisher Scientific) stock solutions made in PBS and 
autoclaved. 
L-Glutamine 
5 ml aliquots of L-glutamine (Sigma) stored at -20oC. 
Transport Medium 
500 ml Hank’s Balanced Salt Solution (Invitrogen; containing Ca2+ and Mg2+ ), 10 mM 
HEPES and 500,000 kallikrein inactivating units (KIU) Aprotinin (Nordic Group). 
Stripper Medium 
500 ml Hank’s balanced salt solution (without Ca2+ and Mg2+), 10 mM HEPES, 
500,000 KIU Aprotinin (Nordic Group) and 0.1% (w/v) EDTA. 
Trypsin in Versene (TV) 
20 ml Trypsin (Sigma), 4 ml 1% EDTA, 176 ml Hank’s balanced salt solution (without 






Trypsin Inhibitor (TI) 
100mg Trypsin Inhibitor (from Soybean; Sigma) dissolved in 5 ml PBS and filter 
sterilised.  100 µl aliquots stored at -20oC (note: one aliquot of TI inhibits the 






Appendix 2.3 Histology and Immunohistology 
Solutions 
PBS complete (PBSc) 
PBS prepared with 0.5 mM MgCl2 and 0.9 mM CaCl2 
Formalin Fixative  
3.7% Formalin (v/v) in PBSc 
Citric Acid Buffer 
10 mM citric acid in dH2O, adjusted to pH 6.0 with NaOH 
Tris-EDTA Buffer 
10 mM Tris and 1 mM EDTA in dH20, adjusted to pH 9.0 before addition of 0.05% 
(w/v) Tween®20 
DAB 
One SIGMAFAST™ 3,3′-Diaminobenzidine tablet was dissolved in 5mls distilled 
water with one Urea Hydrogen Peroxide tablet.  Vortexed until fully dissolved and 
prepared fresh for every use (DAB peroxidase substrate tablet set, Sigma) 
Mayer’s Haematoxylin  
0.3 g sodium iodide, 1 g citric acid, 50 g chloral hydrate, 50 g aluminium potassium 
sulphate added sequentially to 850 ml dH2O.  Add 20 ml ethanol containing 15% 
(w/v) haematoxylin.  Add 120ml glycerol, mix and store in a darkened bottle.  Filter 
prior to use. 
Scotts Tap Water 
2% (w/v) MgSO4 and 0.35% (w/v) NaHCO3 in dH2O 
Hoechst 33258 




TBS Azide + BSA 
50 mM Tris-HCl (pH7.4), 150 mM NaCl with 0.1% (w/v) sodium azide and 0.1% (w/v) 
bovine serum albumin (Sigma), dH2O to 1 L 
Antifade 






Appendix 2.4  Immunoblotting Solutions 
SDS Electrophoresis Sample Buffer (2x) 
125 mM Tris-HCl (pH6.8), 20% glycerol (w/v), 200 mM sodium fluoride, 2 mM 
sodium orthovanadate, 40 mM tetra-sodium pyrophosphate, dH2O to 50 ml.  
Aliquot (1 ml) and store at -20oC.   
Ponceau (10x) 
5 g Ponceau, 10 ml glacial acetic acid, dH2O to 100 ml 
Western Blot Transfer Buffer 






Appendix 2.5  Molecular Biology Solutions 
DEPC (nuclease-free) water 
0.1% Diethylpyrocarbonate (Sigma) in 1 L dH2O.  Autoclavedmto inactivate. 
10 x TBE 
108 g Tris, 55 g Boric acid, 20 ml 1M EDTA, to 1 L in dH2O 
Luria Bertani (LB) broth 
5 g yeast extract, 10 g bacto-tryptone, 10 g NaCl, adjust to pH 7.0 with NaOH, dH2O 
to 1 L.  Aliquot (200 ml) into glass bottles and autoclave to sterilise.   
LB-Agar plates 
5 g yeast extract, 10 g bacto-tryptone, 10 g NaCl, adjust to pH 7.0 with NaOH, add 
dH2O to 1 L then supplement with 15 g agar.  Aliquot (200 ml) into glass bottles and 
autoclave to sterilise (store at ambient temperature).  Melt to 40oC and pour into 


















ABS – Adult bovine serum 
AQP – aquaporin 
AUM –asymmetric unit membrane 
CK - cytokeratin 
Cx – Connexin 
dsDNA (double-stranded deoxyribonucleic acid) 
FBS - Fetal bovine serum 
GJIC – Gap Junctional Intercellular Communication 
IC – interstitial cystitis 
KSFM – Keratinocyte Serum Free Medium 
LY – Lucifer Yellow 
NHU – Normal Human Urothelial 
PPAR - Peroxisome Proliferator-activated receptor 
PPRE - peroxisome proliferator response elements 
RhoD – Rhodamine-dextran 
RXR- retinoid x receptor 
SDM – Site-directed mutagenesis 
SPRINP- Single-Primer Reactions In Parallel 
TJ – tight junction 
TER – Transepithelial Electrical Resistance 
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